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ABSTRACT
A working hypothesis within the Laboratory of Vascular Research is that
mechanical loading on vascular smooth muscle cells (VSMCs), especially due to solid
contact from endovascular devices, contributes to the development of restenosis. In order
to better understand the role of mechanical loading on VSMCs in vascular disease
development, it is imperative to understand the mechanical properties of VSMCs
themselves. To measure the viscoelastic and frictional properties of living VSMCs in an
in vitro setting, an atomic force microscope (AFM) was utilized, thereby allowing for
mechanical testing of living cells in a fluid environment. In the first phase of research, it
was found that proliferative VSMCs, similar to those commonly found in atherosclerotic
lesions, had lower stiffness and higher hysteresis values than quiescent VSMCs.
Furthermore, measured stiffness values did not appear to deviate greatly within the
central region of adherent cells. As VSMCs are viscoelastic, rather than purely elastic in
their mechanical behavior, phase two involved the development of an AFM-based stress
relaxation technique, in order to quantify VSMC viscoelastic behavior. Suitable
mechanical models, including the QLV reduced relaxation function and a simple powerlaw model, were identified and applied to accurately describe VSMC stress relaxation. In
addition, the roles of two major cytoskeletal components, actin and microtubules, in
governing stress relaxation behavior, were quantified via the aforementioned mechanical
models. In phase three, the surface frictional properties of VSMCs were focused upon,
and a novel method to quantify surface shear forces on VSMCs using lateral force
microscopy was developed. It was determined that VSMC frictional properties are
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greatly influenced by cell stiffness, and elastohydrodynamic lubrication was proposed as
a possible cellular lubricating mechanism. During research phase four, each of the
techniques developed during the preceding phases was employed to test the effects of a
clinically relevant biomolecule, oxidized low-density lipoprotein (oxLDL) on VSMC
mechanical properties. It was concluded that oxLDL is associated with decreased cell
stiffness, and decreased viscosity, as measured by stress relaxation and indentation tests.
Furthermore, frictional coefficients were found to correlate positively with more fluidlike cells. This research project has led to a better understanding of VSMC mechanical
behavior, as well as the development of AFM-based techniques and models that will be
useful in determining cellular mechanical and frictional effects of various stimuli in an in
vitro environment.
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CHAPTER ONE
LITERATURE REVIEW
The current doctoral research project addresses vascular restenosis following stent
implantation. It is hypothesized that one of the key factors in restenosis is a shift in
vascular smooth muscle cell mechanical properties, caused in part by the associated
inflammatory response. Overall this research is intended to help understand this
relationship both from a basic science perspective, and with a long-term goal of finding
novel preventative treatments for vascular disease.
Vascular diseases, including atherosclerosis and restenosis, are among the world’s
most widespread, costly, and lethal medical conditions [1]. This remains true, despite
recent advances in treatment, including the advent of drug eluting stents, as well as
pharmaceutical treatments such as statins. At their core, atherosclerosis and restenosis
are both inflammatory diseases with significant biomechanical components [2, 3]. A
highly complex inflammatory process coupled with cellular mechanical environment
both play crucial roles in the development and duration of vascular disease. Recent
evidence has begun to demonstrate that cellular mechanical behavior, inflammation, and
disease progression are inextricably linked [2, 3] . With the rapid development of the
fields of bioengineering, biochemistry, and molecular biology, it is now possible to study
these phenomena at the single cell or even single molecule level. It is this link between
vascular disease as an inflammatory disease and a biomechanical disorder that serves as
the primary motivation for this research. The literature review that follows is a summary
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of current knowledge regarding vascular diseases as inflammatory and mechanical
disorders, as well as cell mechanics theory and experimentation.

Atherosclerosis: An Inflammatory Disease
Atherosclerosis is the leading cause of mortality in the Western world, accounting
for approximately 55% of all deaths [4]. This mortality rate remains staggeringly high,
despite recent advances in treatments such as the introduction of drug eluting stents, as
well as an increased understanding of preventative measures relating to diet and exercise.
Atherosclerosis refers to a vascular disease characterized by accumulation of lipids and
fibrous components in medium and large sized arteries, although the word itself means
hardening of the arteries. It is a complex, multi-stage disease process that is associated
with a number of risk factors, including elevated blood pressure (hypertension), obesity,
diabetes mellitus, smoking, elevated low-density lipoprotein (LDL) cholesterol levels,
family history and advanced age [2]. Many of the aforementioned factors have a strong
genetic component, while others are environmental in origin [1]. In general,
atherosclerosis can be thought of as a multi-stage inflammatory disease. Among the most
significant phenomena observed during the pathogenesis of atherosclerosis, are
endothelial dysfunction, a significant and prolonged inflammatory response, alterations in
the extracellular matrix (ECM) of the affected region, and vascular cell proliferation [5,
6]. Interestingly, many dangerous lesions are often non-occlusive and therefore difficult
to diagnose by angiography. However, active inflammation is evident in these nonocclusive lesions. Plaque inflammation can be detected through various screening
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methods, as it is generally associated with increased plasma concentrations of fibrinogen
and C-reactive protein (CRP) [6]. Local inflammation is also associated with increased
temperature and lower pH levels, which can thus be used to measure inflammatory
response in the plaque [6]. The information contained here regarding the progression of
atherosclerosis is by no means complete. Given the complexity of the disease, such an
undertaking would require a far lengthier discussion. For the purposes of this literature
review, the information is meant to give a basic background and to support the idea that
atherosclerosis is both an inflammatory disease and a biomechanical disorder, caused by
an immune response gone awry. In addition, some, but not all, of the major biochemical
players in atherosclerosis are discussed. Much remains to be learned regarding the
disease’s pathology, which is why there is a vast amount of ongoing research dedicated to
further elucidating these disease mechanisms. The current research was motivated both
by the idea of gaining a greater understanding of atherosclerosis from a basic science
perspective, and by the search for more effective and targeted treatments.

Endothelial Dysfunction
The disease process is believed to begin with endothelial dysfunction, which can
be the result of numerous stimuli, including smoking, hypertension, diabetes, genetic
alterations, elevated homocysteine concentrations, and infectious microorganisms [6].
The vascular endothelium secretes a wide variety of active molecules (vasoactive
substances, matrix products, procoaguluant factors, antithrombotic factors, growth
factors, inflammatory mediators), and performs a myriad of functions including: acting as
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a barrier to free passage of molecules and cells, mediating endothelium-dependent
vasodilation, inhibiting leukocyte adhesion, migration, platelet adhesion, and
aggregation, inhibiting VSMC migration and proliferation; inhibiting coagulation,
promoting fibrinolysis, and participating in immune and inflammatory reactions [6]. An
early marker of endothelial dysfunction is the reduction of nitric oxide (NO) activity, a
regulator of vessel tone [6]. In animal models, an atherogenic diet causes endothelial
cells (ECs) to express surface adhesion molecules (intracellular adhesion molecules
(ICAMs) and vascular adhesion molecules (VCAMs)) that act as receptors for
glycoconjugates and integrins present on monocytes and T-cells [6].

Onset of the Inflammatory Response
Following the changes that occur to the endothelial layer, monocytes are recruited
to the affected area, and subsequently they migrate through the irregularly functioning
endothelial layer with the help of chemoattractants (MCP-1 is responsible for migration
of monocytes) [6, 7]. Monocytes may initially play a protective role, however, their
continued accumulation is ultimately one of the key factors in the development of an
atherosclerotic lesion [1]. The monocytes differentiate into macrophages under the
influence of macrophage-colony stimulating factor (M-CSF) [6], take up accumulated
lipids (forming foam cells, Figure 1.1), and eventually form fatty streaks, which can be
found in the human aorta in the first decade of life [1].
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Figure 1.1. Diagram of the various components of an atherosclerotic lesion, including the
necrotic core, foam cells, and fibrous regions. Figure from Jerome (2006)[8]

Foam cells eventually die, contributing their contents to what is known as the
necrotic core (Figure 1.1). If the initial inflammatory response resulting from endothelial
dysfunction fails, the inflammatory process continues, which leads to VSMC migration
and proliferation [6].

VSMCs migrate to the intima from the media, secreting ECM

components such as collagen and various proteoglycans. Lesions initially grow towards
the adventitia, until a critical point is reached, when they begin to expand towards the
lumen [1]. As the disease progresses, continued recruitment of inflammatory cells and
lipids, and proliferation of SMCs, leads to the development of a mature atherosclerotic
plaque. A fibrous cap separates this underlying conglomeration of lipids, SMCs, and
ECM constituents from the luminal blood flow (Figure 1.2).
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Figure 1.2. Schematic representation of a healthy artery wall (a) and an atherosclerotic
lesion (b) with plaque and fibrous cap formation. Figure from Steffens and Mach
(2004)[7].

The fibrous cap is most likely formed by migration of SMCs from the media, and
their collagen production [6]. Thinning of this fibrous cap may lead to rupture of the
plaque, and an acute ischemic event such as a cardiac infarction or stroke, depending on
the origin of the lesion. Plaque rupture, which typically occurs in regions of high
tangential stress and collagen depletion, sustained inflammation, macrophage
accumulation, and apoptosis, (often at the shoulders of the lesion) is responsible for 80%
of fatal myocardial infarctions (MI) in men [6]. Half of all infarctions occur in arteries
that have < 50% stenosis, and the presence of inflammation seems to be a key
characteristic. It has been found that the occurrence of acute coronary events is more
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heavily dependent on the composition of the plaque, rather than the degree of stenosis
caused by the lesion [1]. Additionally, the stability of atherosclerotic lesions may
depend upon the degree of calcification [1].
Numerous signaling molecules and immune cells interact with one another during
lesion formation. All of these components contribute to the formation of a vicious cycle,
characterized by increased lesion thickening and growth (Figure 1.3) [6].

Figure 1.3. Major events occurring during development of an atherosclerotic lesion,
beginning with endothelial dysfunction, and leading to a vicious cycle of ECM
production, VSMC migration/proliferation, and intimal thickening. Figure from
Kaperonis, et al. (2006)[6].
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Among the biomolecules that play roles in atherosclerotic lesion development and
inflammtion are lipoproteins, cytokines, and adhesion molecules. A brief overview of the
interaction among some of these key players is given here.

Lipoproteins
One of the main culprits in the development of atherosclerosis is LDL cholesterol
[9], which is present in blood plasma. Low-density lipoprotein is responsible for
transport of lipids to peripheral tissues such as arteries, while high-density lipoprotein
(HDL) is responsible for the removal of lipids from these tissues. Hence, HDL has an
anti-atherogenic effect, while high LDL levels can be detrimental to one’s health. Native
LDL, is not taken up by macrophages rapidly enough to form foam cells, however
oxidized LDL does contribute to foam cell formation [1]. Oxidation of the LDL takes
place from a reactive oxygen species (oxidative waste) produced by endothelial cells,
macrophages, and SMCs. Nitric oxide (NO) is an oxidizing agent produced by
endothelial cells and macrophages, and evidence suggests that it can have either
atherogenic or atheroprotective effects, depending on its source [7]. Oxidized LDL can
inhibit the production of NO, possibly leading to increased lesion development due to the
potential anti-atherogenic properties of NO [10]. Oxidized LDL can also penetrate the
endothelium, upregulate adhesions molecules on endothelial cells, as well as induce the
expression of monocyte chemoattractant protein (MCP)-1, and a number of growth
factors [11, 12]. Areas of the endothelium subject to disturbed flow patterns such as
bifurcated or curved regions, are susceptible to increased LDL permeability and
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atherosclerotic lesion development [13]. The atheroprotective effects of HDL may be in
part due to to its anti-inflammatory and anti-oxidant properties, as HDL particles can
carry anti-oxidant enzymes [6].

Adhesion Molecules
As mentioned above, various adhesion molecules mediate the adherence and
migration of leukocytes across the endothelial layer (Figure 1.4) [7]. A group of
adhesion molecules known as selectins (including E-selectin and P-selectin) mediate the
rolling of inflammatory leukocytes across the endothelial layer during the early stages of
atherogenesis [14]. Intracellular adhesion molecules (ICAM-1) and vascular adhesion
molecule (VCAM-1), along with integrins, play similar roles in the attachment, arrest,
and subsequent migration of leukocytes [15, 16]. Macrophages and endothelial cells
produce ICAM-1 in response to a number of inflammatory cytokines, including IL-6, IL1, Tumor Necrosis Factor (TNF)-α, and interferon (IFN). On the other hand, VCAM-1 is
only expressed by endothelial cells [14], and its expression precedes macrophage and Tlymphocyte recruitment [17].
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Figure 1.4. The role of various adhesion molecules in endothelial-leukocyte interactions.
Figure from Blankenberg, et al. (2003)[15].

Gap Junctions
Important ion and metabolite exchange channels known as gap junctions have
also been found to contribute to leukocyte migration and the development of
atherosclerosis [18]. Gap junctions are formed by the connexin (Cx) family of proteins,
with changes in Cx37, 40, and 43 expression all having been implicated in the
development of atherosclerosis [18].
Cytokines
The elevation and modification of lipoproteins associated with atherosclerotic
lesion development leads to the release of cytokines and attraction of cells expressing
receptors for these cytokines [19]. Cytokines can in turn promote lesion development or
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block it, depending upon which ones are involved. Opposing effects can be exerted by
pro- and anti-inflammatory cytokines during the course of lesion development [20].
Some of the proinflammatory cytokines, such as TNF-α, are inducers of other cytokines
and chemokines, which results in an autoamplification system that makes it difficult to
distinguish the effects of each particular cytokine in the atherosclerotic process [19].
Proinflammatory cytokines can be produced by, and act on, numerous cell and tissue
types (Figure 1.5) [20].

Figure 1.5. Action of the proinflammatory cytokines IL-1b, IL-6 and TNF-α on various
cells and tissues. Figure from Tousoulis, et al. (2006)[20].

It has been shown that certain cytokines can alter SMC phenotype and modulate
the nature of matrix synthesis and secretion [21]. The proinflammatory cytokines MCP-1,
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SDF1alpha, and CCL11 have been implicated in the promotion of SMC migration and
proliferation following acute injury from a balloon or wire [22]. Other injury models
have found that IL-1 and TNF-α both appear to promote SMC accumulation after injury
[23]. Some murine models have suggested that neither IL-1β nor TNF- α, two cytokines
associated with atherosclerotic lesions, appear to strongly affect the accumulation of
SMCs within those lesions. It is however, believed that TNF-α plays a significant role in
the induction of SMC adhesion molecule expression [19]. Thus, discrepancies are often
noted among different atherosclerotic models [19]. The cytokine MIF (macrophage
migration inhibitory factor) induces disease progression as a potent stimulant of SMC
accumulation and matrix deposition following vascular injury and in atherosclerosis [24].
Adipose tissue can synthesize cytokines, including TNF-α and IL-6, meaning that obesity
can promote inflammation and advance atherogenesis, independently of its effect on
insulin resistance and lipoprotein metabolism. Both TNF-α and IL-6 have been found to
be associated with 1-year mortality in patients with critical limb ischemia [25]. In terms
of negative regulation of VSMC proliferation, both IL-10 and IL-18 appear to play that
role in vivo, with the majority of other involved cytokines leading to enhanced
proliferation [26, 27]. Similarly, it should be noted that IL-10 and TGF- β are potent
inhibitors of the pleiotropic (controlling several distinct and unrelated phenotypes) NF-κβ
signaling pathway, which has been linked to atherosclerosis [19]. Transforming growth
factor (TGF)-β is a cytokine that plays a significant role in the inflammatory component
of atherosclerosis. Studies conducted under various experimental conditions have found
conflicting results, but the most recent data indicate that TGF- β plays a protective role.
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Other cytokines, such as M-CSF, which stimulates the proliferation and differentiation of
macrophages, have been shown to play an atherogenic role and contribute to lesion
formation [28]. Taken together, this suggests that certain anti-inflammatory cytokines
may limit SMC modulation during the atherosclerotic and restenotic disease processes.
Given the vast number of cytokines involved in vascular disease, along with their
complex interactions and conflicting data regarding their roles, it is clear the further
research in this area is needed.

VSMC Physiology and Phenotypic Modulation
One significant result of the physiologic action of lipoproteins, adhesion
molecules, and immune cells, is an alteration in smooth muscle cell function and
phenotype. In fact, the phenotypic state of VSMCs can be affected by numerous different
stimuli, including humoral factors, cell-cell interactions, and mechanical forces (Figure
1.6).
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Figure 1.6. Phenotypic state of SMCs can vary greatly from fully differentiated (right) to
synthetic (left) based on influence of numerous stimuli. Figure from Owens, et al.
(2004)[4].
Smooth muscle cells are unique among the three major types of muscle cells (skeletal,
cardiac, smooth) in their retention of phenotypic plasticity, where as both skeletal and
cardiac muscle cells are terminally differentiated [4, 29]. It is likely that the plasticity of
VSMCs evolved as a means of repairing damaged blood vessels and remodeling for
blood pressure regulation [4]. However, with the increasing life-expectancy of humans,
this reparative mechanism can often give rise to the development of atherosclerotic
lesions. In the adult blood vessel, SMCs exhibit extremely low proliferation and
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migration rates, and express a unique set of contractile proteins, including smooth muscle
α-actin, smooth muscle γ-actin, sm-MHC (myosin heavy chain), calponin, h-caldesmon,
SM22, smoothelin, and metavinculin [4, 29]. The principal function of SMCs in their
healthy contractile state is the regulation of blood vessel tone, blood pressure, and blood
distribution [4]. In certain cases, such as during vascular development, and in disease
states such as atherosclerosis and restenosis, a shift from a contractile to a synthetic
phenotypic takes place. This shift from the normal contractile state to a synthetic state is
known as modulation, and is associated with a decrease in contractile protein content, as
well as increased rates of proliferation, migration, and matrix production [29]. In
addition to atherosclerosis, changes in SMC phenotype and function have been observed
in numerous other diseases, including asthma [30] and cancer [31], as all types of SMCs
can undergo modulation. According to Owens, et al. [4], the key points regarding
phenotypic modulation of SMCs are that; changes in phenotype of SMC vary as a
function of disease stage and location within lesion; it is difficult to identify whether
lesion cells were or were not derived from preexisting SMC; environmental cues that
exist within atherosclerotic lesions are different from those of a healthy vessel; and
phenotypically modified SMCs contribute to alterations in ECM. These key points will
now be discussed further.
Intimal SMCs found in atherosclerotic lesions are often characterized by
increased DNA synthesis, decreased protein expression, alterations in contractility, and
loss of myofilaments [4]. There are several protein markers expressed by SMCs that are
indicative of their relative state of differentiation, including SM-α-actin, SM-MHC, h1-
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calponin, SM22 α, ACLP, desmin, metavinculin, h-caldesmon, metavinculin, telokin, and
smoothelin, but it must be noted that no single marker is exclusively unique to SMCs. It
is also important to recognize that SMC phenotype is a continuum, with no set contractile
or synthetic cells [32]. Additionally, it has been found that even within a single blood
vessel, there is a great deal of heterogeneity among resident SMCs, as evidenced by
differing levels of protein expression [33]. The most commonly utilized marker of SMC
differentiation is SM-α-actin, due to its abundance, crucial role in SMC contraction, and
the availability of its antibodies. Identification of SMC lineage on the other hand
however, requires a more SMC specific marker, for which SM-MHC is suitable, due to
the fact that it is not expressed in any other cell types, as is SM-α-actin [4]. A positive
marker of modulated synthetic phenotype SMCs is SMemb (SM MHC embryonic),
which is relatively specific for synthetic and embryonic SMCs [4]. Despite the vast
amount of research in the area, very little is actually known regarding the regulation of
SMC differentiation and maturation in vivo. Among the important factors that play a role
however, are mechanical forces, contractile agonists, ECM components, neuronal factors,
reactive oxygen species, endothelial-SMC interactions, and various cytokines [4]. The
only factor thus far positively identified that directly promotes phenotypic modulation of
SMCs is platelet derived growth factor-BB (PDGF-BB), a chemoattractant produced by
activated platelets and macrophages [34] which induces proliferation and downregulation
of SMC marker genes in vitro [35]. Other factors thought to play a role in phenotypic
regulation of SMCs include TGF-β, which promotes SMC differentiation in cell culture
by upregulating SM-selective markers such as SM-alpha actin and SM MHC [36], and
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MMPs, which contribute to degradation and remodeling of plaque ECM, and in turn can
cause SMC phenotypic switching [37]. Current understanding of the in vivo effects of
these factors is poor, as most of our information is based on in vitro studies. Despite the
ever-increasing library of knowledge regarding SMC physiology and its relationship to
atherosclerosis, it is still not yet known if phenotypic modulation is a cause or an effect of
atherosclerosis.

VSMCs and ECM Components
Some of the most noticeable changes that occur during the progression of vascular
disease involve the ECM and its components. Interaction of VSMCs with surrounding
ECM is mediated by several types of transmembrane receptors. The principal receptors
for ECM components on vascular cells include integrins, CD44, and RHAMM [38].
There is a great deal of evidence to suggest that different ECM constituents have varying
effects on vascular cell function [32, 38, 39]. A healthy artery will generally by
composed of an intima (endothelial cells, minimal subendothelial ECM enriched in
proteoglycans and hyaluronan ); media (SMCs embedded in ECM comprising elastin,
collagen, proteoglycans); and adventitia (fibrillar collagen, fibroblasts, vaso vasora) [38].
One of the main ECM constituents, collagen, is composed of a triple helix of 3
polypeptide α chains, each having a gly-x-y repeating sequence [40]. The predominant
forms of collagen found in arteries are types I and III, providing tensile strength to the
vessel wall [38]. While collagen provides tensile strength, it is also exhibits elastic
behavior, which provides the recoil necessary in an environment with cylic pressure

17

pulses [41]. Elastic fibers that are synthesized by VSMCs are arranged in concentric
lamellae that separate the different layers of the artery. Following balloon injury of a
health artery, a neointima forms that is composed mainly of SMCs that migrate from the
media to the intima. Injury of an already atherosclerotic vessel however, leads to
neointimal accumulation of monocytes and lymphocytes, followed by SMC migration
and proliferation [42, 43]. Lesions that are rich in lipids and macrophages typically
contain less collagen, while fibrous plaques contain areas rich in collagen I and III [44].
In situ fibronectin assembly by neointimal SMCs has been observed 12 days after injury
in rats. Fibronectin also assembled a fibrillar network associated with the surface of
synthetic SMCs during early atherosclerotic and restenotic lesion development [45, 46].
Using 2D monolayers in vitro, fibronectin and collagen I have been found to induce shifts
towards a synthetic state, while laminin and collagen IV induce the opposite [32, 39].
Proteoglycans and hyaluronan are hydrophilic molecules that represent another
main ECM constituent. These proteoglycans consist of a core protein linked to one or
more polysaccharides that have diverse roles in regulating connective tissue structure and
permeability. Hyaluronan is a large molecule consisting of many repeats of a simple
disaccharide stretched end to end, which binds a large amount of water forming a viscous
hydrate gel. This allows the ECM to resist compressive forces. In addition,
proteoglycans and HA are known to interact with vascular cells [38].
The adhesive glycoproteins fibronectin and laminin form connections between
other ECM and cells via specific integrin receptors. Fibronectin is a multifunctional
adhesive protein present in plasma and synthesized by vascular cells. It is a large
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disulphide-linked, glycoprotein dimer that binds collagen, fibrin, and proteoglycans via
specific domains as well as vascular cells through specific integrins. Laminin is the most
abundant glycoprotein in endothelial and SMC basement membranes. Cells are bound to
laminin through specific integrins and interacts with other ECM, such as collagen IV and
heparin sulphate [38].
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Atherosclerosis: Biomechanical Phenomena
Vascular smooth muscle cells are continuously exposed to cyclic mechanical
stretch from arterial blood pressure [3]. When the mechanical environment acting on
VSMCs changes, a number of contractile proteins are downregulated, including SMMHC isoforms, α -actin, h-caldesmon, and calponin [3]. Increased stresses resulting
from hypertension lead to myofilament loss, the development of extensive endoplasmic
reticulum, and large Golgi complexes, which are all events indicative of the shift towards
a synthetic phenotype. In addition, contractile ability is lost, protein secretion is
increased, and the cells become more responsive to autocrine and paracrine growth
factors that are produced in response to mechanical stress. These growth factors can then
lead to further hypertrophy and/or hyperplasia [42]. Biomechanical stress on arterial
walls can be increased as much as 30% in cases of severe hypertension, leading to
significant changes in the arterial tissue structure [47]. Evidence of the important role of
stress states in the development of atherosclerosis is also provided by the fact that lesions
occur most frequently in areas of bifurcation or otherwise disturbed stress states [48].
Given the abundant evidence implicating altered stress states in the development of
atherosclerosis and restenosis, it has been hypothesized that physical forces can initiate
signaling pathways which in turn lead to cell death, an inflammatory response, and
VSMC proliferation. A proposed mechanism for this sequence of events is the altering of
receptor conformation that may be cause by mechanical stresses [3].
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VSMC Mechanosensors
A number of different types of mechanosensors exist on the surface of SMCs.
Perhaps the most important in terms of mechanical signal transduction are integrins.
These are a family of transmembrane receptors that mediate cell attachment to the ECM
at focal contact sites [49]. Integrins are heterodimeric, and consist of non-covalently
bound transmembrane α and β subunits, of which there are at least 15 α and 8 β that can
heterodimerise to produce more than 20 different receptors (Figure 1.7).

Figure 1.7. Involvement of different of α / β integrin pairings in forming adhesions to
various ECM components, and regulating phenotype. Figure from Moiseeva (2001)[50].
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Importantly, integrins also transmit extracellular mechanical stimuli to intracellular
signaling events [42], in turn activating numerous downstream signals potentially
leading to phenomena such as cell migration and cytoskeletal reorganization [3]. In
cultured VSMCs, mechanical stress has been shown to increase DNA synthesis when the
substrate is collagen, fibronectin, or vitronectin, but not laminin or elastin. This suggests
some level of specificity in the cell-ECM interactions that lead to biochemical responses
when external stresses are applied [3]. Integrin signaling is also associated with the
formation of new focal adhesion complexes consisting of clustered integrins with various
cytoskeletal proteins, such as talin and paxillin [3]. It has been shown that focal adhesion
kinase (FAK) binds both to the cytoplasmic regions of integrins and to cytoskeletal
proteins, providing a direct linkage for signal transduction leading to MAPK activation
[51]. Integrin mediated autophosphorylation of FAK can lead to subsequent tyrosine
phosphorylation of various cytoskeletal proteins and cytoskeletal remodeling, as a result
of mechanical stimuli [3].
Mechanical stresses have been shown to alter the structure and organization of
intracellular actin (Figure 1.8) [52]. Vascular SMCs contain a reservoir of unpolymerized
globular (G) actin, which their skeletal and cardiac counterparts do not possess.
Intravascular pressure leads to a decrease in G-actin concentration, and in increase in
filamentous (F) actin [53]. Depolymerization of F-actin with substances such as
cytochalasin D leads to an increase in G-actin content, and cell relaxation, while
polymerization of F-actin causes cell contraction and decreased G-actin content [52].
Such formation of F-actin could very well be involved in mechanical signal transduction
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and increased force production. The exact mechanism by which mechanical forces
induce actin polymerization is not known, but it most likely involves integrin-mediated
signal transduction.

Figure 1.8. Increased intravascular pressure leads to activation of numerous cross-talking
signaling pathways, along with an increased F/G-actin ration, formation of stress fibers,
and greater force production. Figure from Cipolla, et al. (2002)[52].
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Platelet derived growth factors (PDGF) are homo- or heterodimers of A and B
polypeptide chains that can combine to form form three different dimers, PDGF-AA, BB,
and AB. Thus far, two distinct PDGF receptors have been described, PDGF receptor-α,
which binds all PDGF forms, and PDGF receptor-β, which binds PDGF-BB and AB [54].
It has been shown that PDGF receptor-MAPK signaling pathways can be directly
activated by mechanical forces [55], suggesting a role in modulation of VSMCs.
Vascular endothelial growth factor (VEGF) is also upregulated by VSMCs in response to
mechanical stress. It is possible that normal physiological levels of stress are necessary
to produce sufficient levels of VEGF, and therefore maintain a healthy endothelium [4].
Another significant phenomenon observed with regard to VSMC response to
mechanical force is the opening of mechanically gaited ion channels, which leads to a
transient influx of calcium and sodium. This cause depolarization of the membrane and a
subsequent myogenic response [56]. It is likely that this calcium influx, along with
increased levels of angiotensin leads to increased MAPK activation in cases of
hypertension. Mechanical stress has also been shown to increase protein kinase C (PKC)
activity in VSMCs, leading to formation of PKC particulates and subsequent VSMC
proliferation in the case of cyclic strain [57]. It is likely that PKC is involved in a
number of signaling pathways, due to the many signaling molecules that it can activate.
Mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated
kinases (ERKs), p38, and c-Jun N-terminal kinases (JNKs), are also activated in response
to mechanical stress. This is significant because MAPKs regulate such important cellular
processes is DNA synthesis, proliferation, mitosis, and apoptosis [4]. Some kinases, such
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as MAPK phosphatase-1 and PKA (cyclic AMP-dependent protein kinase), may actually
serve as negative feedback regulators by blocking mechanical signal transduction [58,
59].
Smooth muscle cell apoptosis often occurs in atherosclerotic lesions, and is in part
affected by mechanical stresses. In restenosis, VSMC apoptosis is an acute event that
occurs in response to vascular injury induced by balloon-catheter or angioplasty. This
medial VSMC cell death has been demonstrated in vivo using animal models [60].
Apoptosis after cell injury is governed by activation of MAPK signaling pathway and
expression level of antiapoptotic genes. Among the factors relating SMC apoptosis in
response to mechanical stress are endothelin receptor expression, p38, p53, and DNA
oxidation [61-63]. Mechanical stresses play a significant role in the mediation of the
VSMC inflammatory response during atherosclerosis. Increased mechanical stresses lead
to increased production of leukocyte adhesion molecules and promote VSMCs to produce
proteglycans. These proteoglycans bind and retain LDL particles, leading to their
oxidative modification which promotes inflammatory responses within atherosclerotic
lesions [64]. Production of ICAM-1 by VSMCs has also been shown to be induced by
mechanical stresses in animal models [65].
Atherosclerosis Summary
It can be seen that atherosclerosis and the abnormal physiologic behavior of
VSMCs associated with it, are affected by numerous stimuli working in conjunction with
one another. This complexity makes understanding and treating vascular disease all the
more formidable of a task. However, at its core, it is now beginning to be understood that
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atherosclerosis is essentially a chronic inflammatory disease, which is greatly affected by
the mechanical state of the cells and tissues involved. Therefore a better understanding
of the link between atherosclerosis as an inflammatory disease and a biomechanical
disorder, may yield important information to aid in the development of novel treatments.

Treatment of Atherosclerosis
Stents and Restenosis
In recent years, stenting has become the preferred method for percutaneous
treatment of coronary artery disease, due to its advantages of preventing elastic recoil of
the artery, preventing acute vessel closure, and improving long-term patency [66]. In the
year 2000, over one million percutaneous coronary procedures were performed in the US,
almost half of which included placement of intracoronary stents [66]. One of the most
frequent difficulties encountered following stent implantation is that of restenosis, which
is a re-occlusion of the treated vessel region. Restenosis is generally caused by vascular
elastic recoil and negative remodeling of the vessel wall (Figure 1.9) [67]. Stents reduce
the level of recoil, but also stimulate the formation of neointimal tissue, especially in
smaller caliber arteries [67].
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Figure 1.9. Restenosis after angioplasty (a-b) and after stenting (c-d). Figure from
Kivela, et al. (2006)[68].

Stent deployment is a traumatic event that can alter local vessel conditions in a
number of ways. Stainless steel stents are placed via balloon-driven expansion, often
requiring a second dilation, leading to overexpansion of the vessel [69]. This initial
injury caused by balloon inflation and the stent itself, leads to the migration of
macrophages and polymorphonuclear neutrophils to the damaged region [70-72]. These
immune cells then release chemokines, increasing the amount matrix metalloproteinase
(MMP), and subsequently leading to remodeling of the ECM and SMC migration.[73,
74]. Mitogenic SMC genes are stimulated as well [75]. Furthermore, stenting has been
shown to raise systemic levels of inflammatory markers such as IL-6 and C-reactive
protein (Figure 1.10) [76].

27

Figure 1.10. Interaction of local (cytokine release) and systemic (CRP production)
inflammatory responses in the onset of restenosis. Figure from Gaspardone, et al.
(2005)[77].

Improper stent deployment can alter the normally athero-protective local blood
flow conditions, leading to a greater risk of restenosis [78]. The presence of the stent
itself can lead to an overexpansion of the artery, as well as decreased compliance and
extendibility, all of which increase stresses on the vessel wall [67, 79]. These stresses, in
turn, lead to proliferation of SMCs and the formation of neointimal tissue [80].
Formation of the neointima following stent placement is associated with the action of
numerous leukocytes, as well as platelets and growth factors (Figure 1.11) [68]. Taking
all of these factors into account, it is the expansion of the stent which is one of the most
important factors contributing to restenosis, as the stent not only causes tissue damage,
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but is itself a foreign body which will itself illicit an immune response and impair healing
[67].

Figure 1.11. Role of cytokines, leukocytes, platelets, and growth factors in the
development of restenosis. Figure from Kivela, et al. (2006)[68] .

Histological analyses have revealed that the degree of penetration of stent struts is
directly related to the thickness of neointimal tissue [81]. When strut penetration is less
severe, there is only a moderate layer of new SMC-rich tissue. In the first days following
stent implantation, stent struts are typically surrounded by fibrin and neutrophils. Within
two to three weeks however, these are replaced by the presence of macrophages and
SMCs [81]. After 3-18 months post-implantation, there is typically a restenotic tissue
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extremely rich with proteoglycans (including versican and hyaluronan) that is infiltrated
with α-actin positive SMCs. Towards the end of the first 18 months post-implantation,
type I collagen begins to prevail. After 18 months, SMC density and stent stenosis are
reduced [82, 83]. These observed patterns of ECM constituents and phenomena are
typical of a tissue that is incompletely healed.
The intial clotting response following stent implantation may play a significant
role in restenosis, as platelet derived growth factor (PDGF) is one of the most potent
stimulators of SMCs and macrophages [84]. However, at later stages following stent
placement, there is little or no sign of markers suggesting an active inflammatory
response or of replication SMCs [85, 86]. Star-shaped SMCs dispersed in a loose
proteoglycan-based ECM is the most frequent finding in studies of later stage tissue, with
the cellularity of the neointima decreasing with time after stenting. Furthermore, SMCs
in late stage neointimal tissue are typically not in a synthetic state. This has led some
authors to suggest that it is primarily the ECM which the main culprit in restenosis, rather
than the cells themselves [85, 86]. The pattern that is emerging suggests that neointimal
tissue changes from inflammatory, to proliferative, to secreting as time passes [67]. From
this progression, one can divide the process of restenosis into two main phases. The first
is the wound healing process, including clotting, followed by inflammation, and
infiltration by myofibroblasts derived from SMCs, macrophages, and other progenitor
cells. The second phase is that of neointimal hyperplasia, where myofibroblasts reduce
their proliferation rate and enter a synthetic phenotype which secretes abundant ECM
[67]. Mechanical and chemical stimuli working in conjunction are likely responsible for
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the phenotypic changes in VSMCs during restenosis. Numerous studies have been
conducted examining the effects of mechanical stresses on SMCs [67], with no clear
consensus. It is speculated that in cases with greater intimal penetration of struts, a
higher mechanical forces may be applied to the VSMCSs, resulting in the phenotypic
shift to a proliferative state [67]. The shift to a synthetic phenotype may explain an early
triggering of SMCs to participate in neointimal formation, but it does not explain the lack
of proliferative cells in later stages [67].
A number of strategies have been employed to reduced restenosis rates and
improve the overall performance of stents. Initial attempts to reduce restenosis rates
involved the use of various systemic anti-platelet and anti-thrombus drugs. On the whole
however, these efforts have not been very successful [87]. Some researchers have taken
the approach of decreasing the stresses applied to the vessel wall with different stent
designs, including using self-expandable stents [88], low-pressure deployment [89], and
varying strut thickness [90]. There are data indicating that increased strut thickness cause
excessive damage and thereby lead to higher restenosis rates [91]. A number of factors
relating to the stent material itself play a significant role in host tissue response. Stainless
steel, for instance, has excellent mechanical performance but possesses significant
disadvantages relating to its biocompatibility[92, 93]. The corrosion resistance of
stainless steel has been improved by adding more chromium to the alloy, but there is still
the problem that nickel is one of the ions that can potentially be released [94]. Nitinol is
currently the main alternative stent material to stainless steel. Its largest advantage is that
deployment does not require balloon, due to its shape memory properties. Unfortunately,
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analyses have demonstrated that nitinol has not brought any significant advantage in
reducing restenosis rates thus far [67]. Improvements in nitinol biocompatibility can be
achieved by inducing a titanium oxide surface, which can increase clotting time, reduce
fibrinogen absorption and platelet activation, and allow for SMCs to retain their
contractile phenotype, therefore reducing SMC proliferation when compared to stainless
steel [95, 96].
Various coatings have been applied to stents in order to improve performance as
well. Initially, researchers applied carbon or gold to alter material surface properties.
Carbon coating does appear to have some beneficial attributes, most likely due to reduced
thromobgenicity, although the studies were not randomized or controlled [97]. Gold
coatings on the other hand have yielded discouraging results on the whole, actually
resulting in increased neointimal tissue proliferation compared to bare metal stents [98].
Silicone-carbide [99], phosphorylcholine [100], and heparin coatings [101], have also
exhibited little or no beneficial effects with regard to restenosis. The most success thus
far has come from anti-proliferative agents, which are usually contained within polymeric
stent coatings. Two of these, rapamycin and paclitaxel, have reduced restenosis rates to
single digits since their introduction [102, 103]. Rapamycin (trade name Sirolimus) is an
antibiotic discovered in a microbe on Easter island. It acts as an anti-proliferative agent
on SMCs by inhibiting growth factor and cytokine-induced cell division and migration
[104, 105]. Paclitaxel (trade name TAXUS) is a derivative of Taxol with anti-mitotic
properties. It works by inhibiting microtubule depolymerization, therefore arresting the
cell cycle, and halting cell proliferation [66]. Despite the success of these anti-
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proliferative agents, there are still a number of concerns relating to the long term success
of drug-eluting stents. For example, some evidence suggests that localized drug delivery
may lead to hypersensitivity reactions and SMC drug resistance [106, 107]. Other
complications from drug-eluting stents include inflammation at the stent extremities,
delayed endothelialization, and a relatively high cost to the healthcare system [106-108].
Furthermore, several meta-analyses have thus far failed to yield any strong evidence that
drug-eluting stents significantly reduce the risk of mortality or myocardial infarction (MI)
[108]. In fact, there have actually been non-statistically significant increases in these
two endpoints (mortality and MI) with drug eluting stents [109]. Currently, more than
85% of all coronary interventions in the U.S. are performed with drug eluting stents,
many of which are cases for which they are not approved [109]. The major clinical trials
which are often touted as evidence for the superiority of drug eluting stents have several
methodological flaws, including the use of inferior thick-strutted stents as controls,
biased protocol-mandated angiography, questionable clinical relevance of angiographic
outcomes such as binary restenosis, and a lack of data from high risk patients [109].
These trials may have also relied too heavily on “soft outcomes” such as restenosis and
revascularization, as opposed to “hard outcomes” such as MI or death. In addition there
is recent evidence suggesting the drug eluting stents may result in higher levels of
thrombosis, especially in cases where anti-platelet therapy is discontinued prematurely
[109]. Lastly, relative costs associated with drug eluting stents may have been
underestimated [109]. Some general goals with regard to stent implantation and design
that should be considered are reducing excessive dilation of the stent (possible through
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better self-expandable stents), and gaining a better understanding of the host response
[67]. Despite all the knowledge that has been gathered, and the technological advances
that have been made, there is still much to be discovered regarding the underlying causes
of restenosis in terms of an immune response, and the effects of mechanical stresses on
underlying tissue. It is clear that restenosis exhibits histological features distinct from
those of atherosclerosis, yet increasing evidence shows that both result from
inflammatory responses. Essentially, restenosis is an incomplete healing process
resulting from an inflammatory response, and the presence of the implant is clearly
associated with its formation, as the stent challenges vessel wall tissue by threatening its
integrity, subjecting it to elevated mechanical forces, and exposing it to a foreign surface.

Cell Mechanics
The mechanical properties of cells reflect cytoskeletal state and health. Any
deviation in cellular structural and mechanical properties can result in the breakdown of
physiological functions [110]. Furthermore, the structural integrity of individual cells
can affect overall tissue mechanics, due to cell-ECM interactions [110]. Most soft
materials will exhibit a combination of solid- and fluid-like mechanical characteristics,
and cells are no exception [111]. The cytoplasmic fluid component of a cell is distinct, as
it depends on the rate at which force is applied as opposed to the magnitude. The
viscoelasticity of cytoplasm is about 10-100 times that of water, reflecting high
concentration of proteins in the fluid [111]. Overall however, a cell’s behavior is that of
a solid, as it will not flow without limit as a true liquid does [111]. A cell’s mechanical
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properties are largely determined by its cytoskeleton, which is an interconnected structure
composed of three main types of filamentous biopolymers [112]. The first type is actin
filaments, which carry tensile forces that are actively generated by the cell’s contractile
apparatus and passively through attachments to its substrate [112]. The diameter of
these filaments is typically in the range of 5-10 nm, with elastic moduli on the order of
GPa. Actin filaments can also be found in bundles known as actin stress fibers, which
carry both tensile and compressive forces. Actin filaments are crosslinked by specific
proteins such as alpha-actinin and filamin [111]. Due to their small size, actin filaments
undergo thermal fluctuations, which are overcome when force is applied, after which the
intrinsic elastic modulus dominates mechanical behavior. The magnitude of this elastic
response is determined by the concentration of actin and the concentration of crosslinks
[111]. The second major type of cytoskeletal element is the microtubule. Microtubules
are tubule biopolymers (o.d. ~ 24 nm, ~ i.d. 12 nm) that carry compressive forces in order
to resist contraction of the cytoskeletal network. It has been proposed that the
contribution of microtubules to balancing prestress depends inversely on the extent of cell
spreading [113]. The third type of cytoskeletal filament is the intermediate filament,
which have a diameter of ~ 10 nm. Their role in cytoskeletal mechanics is less well
understood than actin or microtubules, but it is believed that they carry tension at large
strains of greater than 20% [112]. Microtubules tend to have the highest bending
stiffness, while actin filaments have greater tensile strength at short extensions, although
a shorter elongation to break (Figure 1.12) [114].
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Figure 1.12. Tensile properties of the three main cytoskeletal constituents; actin,
microtubules, and intermediate filaments. Figure from Humphrey (2002)[114].

An increase in contractile stress from this cytoskeletal network corresponds to an increase
in cell stiffness. Adherent cells also exhibit several distinct mechanical features,
including viscoelasticity, creep, stress relaxation, strain hardening, and hysteresis [112].

Mechanotransduction
In recent years, it has become recognized that mechanical factors are equally
important as chemical events in terms of physiological regulation and response [115].
Mechanical forces can influence both chemical equilibria and molecular polymerization
events [116]. Cellular mechanotransduction is the process by which mechanical stimuli
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are converted into biochemical signals. This process is mediated by numerous elements,
including cell-cell-adhesion, cytoskeletal properties, and the cell membrane, among
others (Figure 1.13).

Figure 1.13. The various mediators of cellular mechanotransduction. Figure from Ingber
(2006)[116].

It is believed that mechanotransduction involves structural hierarchies that span
several size scales from whole organs and tissues, down to individual molecules within
cells [116]. Therefore, the mechanical properties and level of prestress that exist at each
level along this pathway can have significant effects on the eventual response [116].
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Processes as varied as cell growth, differentiation, polarity, motility, contractility, ECM
synthesis, and apoptosis are all influenced by physical deformation of cells of all types
[115, 117, 118]. When a whole tissue is deformed, the forces are transmitted to cells via
adhesions to the ECM [115]. Furthermore, the mechanical properties of the ECM itself
also contribute significantly to the cellular mechanotransduction response. Different cell
types respond to different force magnitudes. Chondrocytes and osteocytes, for example,
show a biological response to forces of ~20 MPa, while endothelial cells respond to small
force of < 1 Pa [111]. And within single phenotypes, it is likely that different structures
are responsible for different forms of mechanical sensing. Cellular response to
mechanical stimulation requires both an element that is directly altered by the applied
force, and second element that transmits this information to the desired target. Currently
however, knowledge regarding these mechanosensors is scarce. The most well
characterized and probably most important class of receptor in terms of force
transmission are integrins, as they have been shown to provide greater mechanical force
transmission than other types of receptors [119]. Integrins are clustered at focal adhesion
sites [120] containing multiple actin-associated proteins such as talin, vinculin, paxillin,
and zyxin [116], and act to distribute externally applied stresses through the cytoskeleton.
The mechanical coupling that exists between integrin and cell nucleus is largely mediated
by intermediate filaments, but also to a lesser extent by actin filaments, and the efficiency
of this intracellular mechanotransduction is greatly affected by cytoskeletal prestress
[116]. Applying mechanical stress to integrins results in recruitment of proteins to the
site in order to strengthen itself [119]. Application of mechanical forces to bound
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integrins promotes focal adhesion assembly by activating small GTPase Rho and
stimulating its downstream targets mDia1 and ROCK, which promote actin filament
polymerization and cytoskeletal contraction respectively [121, 122]. Other
transmembrane molecules such as cadherins and selectins can transmit mechanical forces
across the cell membrane, but in a much less significant manner [116]. Another type of
membrane protein involved in mechanotransduction are G proteins, which are localized
at focal adhesion sites. Application of mechanical force causes a conformational change
to G proteins, initiating a signal cascade, generation of second messengers, and eventual
cell growth [118]. Receptor tyrosine kinases (RTKs) also play a significant role in
integrin-mediate mechanical signal transduction, as do mitogen-activated protein kinases
(MAPKs), which transduce mechanical forces into gene expression and protein synthesis
through their complex pathways [118]. Because only certain molecular and structural
channels within a cell transmit mechanotransductive signals, other intracellular molecules
are left unaffected by mechanical stimulation [116]. In addition to protein-mediated
signal transduction, the lipid bilayer may also play a role, although this hypothesis is
more controversial [111].
The importance of a cell’s intrinsic mechanical properties (prestress) in regulating
response to stimuli has also been demonstrated in several studies [123]. Hence it is
important to understand how cellular mechanical properties are altered under different
conditions. Biological responses of cells to mechanical loading vary greatly, and are
largely dependent on the strength and type of loading (i.e. cyclic, static, biaxial, uniaxial,
etc.), the time of exposure to the mechanical forces, cell type, and the ECM or substrate
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constituents [118]. When mechanical stresses are applied to a cell, the cytoskeletal
filaments will distort, thus altering the shape of some the molecules that make up the
filaments. Changing the shape of a molecule can alter its biophysical and biochemical
properties. As many signaling molecules are located on the cytoskeleton near focal
adhesion sites, this provides a mechanism for the alteration of signal transduction through
the application of mechanical force [115]. In addition, all cells contain mechanically
gaited ion channels that can increase or decrease the level of ion flux through a
membrane upon the application of mechanical stresses [124]. Abnormal stress states and
abnormal responses to mechanical forces may both contribute to the development of a
very large number of diseases.

Vascular Smooth Muscle Cell Mechanics
A handful of studies have been performed examining the tensile properties of
vascular smooth cells [125-127]. All of these studies have examined non-adherent
vascular smooth muscle cells which were stretched using a custom-built dual micropipette system. Consistently, it has been observed that synthetic VSMCs have a lower
tensile modulus than contractile VSMCs. For example, Nagayama and co-workers [127]
found that freshly isolated contractile VSMCs had an average tensile modulus of 11 kPa,
while cultured synthetic VSMCs had an average modulus of 2.6 kPa. Another study
found that the tensile elastic moduli of cultured bovine VSMCs were about 1/5 that of
freshly isolated rat VSMCs [125]. Miyazaki and co-workers found that both VSMC
phenotypes showed almost the same load-elongation relations in small elongation ranges,

40

however tensile load was higher in contractile VSMCs at elongations greater than 20 um,
and there were significant differences at 25 and 30 um elongation [126]. One major
cytoskeletal difference that has been noted is that actin filaments in cultured cells were
less abundant and almost uniform in direction, while actin content in fresh SMC was so
abundant as to look uniformly stained [127]. Actin bundles much thicker in contractile
cells than synthetic ones. The tensile modulus of cultured SMCs was also reduced by
approximately 50% upon disruption with cytochalasin D, and it was observed that the
cellular tensile properties were affected not only by the amount of actin filaments, but
also by their organization and distribution [127]. Furthermore, SM-MHC are SM-α-actin
are typically observed in contractile, but not synthetic VSMCs [4, 126]. Smooth muscle
α-actin is found in the contractile apparatus of the cell, while β- and γ-actin are found in
the cytoskeleton [126] . During phenotypic modulation, smooth muscle α-actin is
downregulated by, while β- and γ-actin are upregulated, and non-muscle β-actin is found
heavily in synthetic SMCs [126]. Intact arterial medial sections, which are largely
composed of smooth muscle cells, have also been examined using atomic force
microscopy[128]. In that study, Engler and co-workers found a medial apparent elastic
modulus of 5.7 ± 0.3 kPa.

Cellular Mechanical Models
Measurements of cellular mechanical properties have now advanced to the point
where forces smaller than a piconewton and displacements smaller than a nanometer can
be induced and/or measured [129]. Cellular deformation can be studied in any number
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of ways, including uniaxial and biaxial tension or compression, pure shear, hydrostatic
pressure, bending, twisting, or a combination of these methods (Figure 1.14).

Figure 1.14. The various methods of studying cellular deformation: a) AFM b) magnetic
beads c) micropipette aspiration d) optical trap e) shear flow f) membrane stretching.
Figure from Bao and Suresh (2003)[129].

One can study cellular mechanical behavior with local probes deforming the cell, whole
cell loading, or simultaneous stressing of a larger population of cells. Measurements of
cellular apparent elastic modulus have yielded values between 102 and 105 Pa, with much
of the deformability being determined by the cytoskeleton [129]. However, an important
concept to take into account is that cellular mechanical properties are dynamic in nature.
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That is, cells alter their cytoskeletal structures actively in response to applied forces, and
during physiologic processes including cell division, crawling, spreading, rounding, and
actin-based motility [129].
Given the advancements made in cellular mechanical measurement technologies,
it has become necessary to develop appropriate mechanical models. Mechanical models
for cells can be broadly categorized as either continuum models or micro/nanostructural
models [110]. Micro/nanostructural models consider the cytoskeleton to be the prevailing
structural component. The prevailing micro/nanostructural model for adherent cell
mechanical behavior is that of a tensed cable network, or more specifically, the tensegrity
model (Figure 1.15) [115, 130].

Figure 1.15. Illustration of the tensegrity model, showing the force balance achieved
through actin microfilament (MF) and intermediate filament (IF) tension and compressed
microtubules (MT).
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The tensegrity model suggests that the cytoskeleton is composed of tensile elements
(actin and intermediate filaments) that are balanced by compressive elements or struts
(microtubules and actin bundles). The ECM also balances some of this tension through
integrin-ECM connections. When compression reaches a critical level, the microtubules
will buckle, allowing cellular deformation. The actin network carries “prestress”, giving
the cell shape stability. The strain hardening phenomenon observed in cells is explained
by the tensegrity model to be a result of reorientation and change in spacing of
cytoskeletal components in the direction of applied load. The tensegrity model is the best
current model of cellular mechanical behavior in a 3D in vivo environment. One
significant drawback however, is that structurally based models such as the tensegrity
model are static and therefore not sufficient in describing the dynamic properties of a
cell. For example, it has been observed that elastic and frictional moduli of cells increase
with frequency according to a weak power law, and that at a given frequency these
moduli increase linearly with increasing cytoskeletal prestress. All of this information
underscores the complex and dynamic behavior of living cells, and the difficulty in
characterization of this behavior.
The continuum approach to cellular mechanical modeling treats cells as being
comprised of materials with certain continuum material properties. Appropriate
constitutive material models and parameters are derived through experimental
observations [110]. This method gives less detail into specific molecular events that take
place, but is easier for interpreting mechanical responses at the whole-cell level.
Continuum models can be further divided into liquid drop models and solid models [110].
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Liquid drop models can be yet again divided into Newtonian, compound Newtonian,
shear thinning, and Maxwell sub-categories. Liquid models such as these are most
suitable certain mechanical characteristics of non-adherent cells, such as erythrocytes and
neutrophils. Solid models generally assume the cell to be homogeneous, modeling it as
either an incompressible elastic solid or a viscoelastic solid [110]. Assumption of
homogeneity allows for simplification of analysis and fewer parameters. The
experimental basis for such models is that an equilibrium state can be achieved after a
certain amount of loading [110]. The linear elastic and viscoelastic models differ in
neglect and use of a time factor, respectively. With linear elastic solid models, the
apparent elastic modulus that is found does however depend on loading rate and history.
Cells must maintain sufficient structural integrity to behave like a solid under mechanical
stresses, but most also exhibit more fluid-like behavior for processes such as crawling
and spreading [131]. The linear elastic and viscoelastic models are suitable for transient
loading conditions, including the understanding of creep and stress relaxation. However,
for dynamic loading, power law structural damping models have been developed.
Cellular power law behavior suggests that under an applied stress, cells deform
continuously and that this process is timescale invariant (does not depend on loading
frequency) [131]. Often, this is accomplished through oscillatory indentation with an
AFM, through which a storage modulus (G’) and a loss modulus (G”) are found. The
loss modulus is dependent on a weak power-law with an exponent 0 < α < 1 below ~ 10
Hz, but viscous components become more significant at higher frequencies. Dynamic
rheological properties of adherent cells are related to contractile stress, with larger
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stresses corresponding with high dynamic moduli. The power law exponent α decreases
with increasing prestress (α is an index of deformability, with 0 corresponding to elastic
solid, and 1 corresponding to flowing liquids). So, fact that alpha changes with prestress
suggests that this regulates the transition between solid and fluid-like behavior [131].
Power-law structural damping has been said to suggest behavior like that of a soft-glassy
material (such as slurries of foams) close to its glass transition temperature [110]. On
the macroscale, this results in slow cell deformation over a wide range of timescales
[131].
Whole tissues have often been modeled using Fung’s theory of quasilinear
viscoelasticity (QLV) [132], in which it is assumed that the reduced relaxation function
G(t) is independent of initial strain [133]. Stress is normalized by the peak stress at the
completion of a step strain. Strain independence is an essential feature necessary for
QLV modeling. While the QLV model has been applied to numerous soft tissues, it has
to data never been used for describing the viscoelastic behavior of individual cells.

Mechanical Measurements Using Atomic Force Microscopy
As discussed above, there are many physiologic processes and disease states that
can alter cellular mechanical properties, and such differences have been detected in cells
including myocytes, chondrocytes, and hepatocytes, among others. Establishing both the
normal and abnormal properties of the cells affected by disease could aid in the in vitro
identification of effective treatments [134]. Information including detailed knowledge of
stress/strain relationships, viscoelasticity, and hysteresis, could all be of benefit [134]. It
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is theoretically possible that any disease altering the composition, organization, kinetics,
or crosslinking of the cytoskeleton may be detectable using cell mechanics measuring
techniques [134]. Cytoskeletal properties, particularly those relating to actin, have been
found to have the greatest effect on measured cell stiffness [135] . Cell morphology,
height, and degree of attachment also play significant roles [135]. Viscous properties
and/or elastic properties may be altered in diseased cells, so it is important to take both
into account when performing cellular mechanical measurements [134, 136] . In
addition to soft tissue, mechanics of mineralized tissues have also been investigated using
nano-indentation [137]. At present however, there is a lack of information regarding
tissue mechanics in disease progression, tissue repair, and remodeling mechanisms
associated with medical treatments [137].
There are a number of techniques for measuring cellular mechanics, including
magnetic twisting cytometry, magnetic tweezers, optical stretching, and atomic force
microscopy (AFM), among others [134]. Among these, the AFM has emerged as one of
the most effective and useful tools in the field of mechanobiology [134, 138, 139]. The
AFM is a member of the scanning probe microscope family, and was originally
developed to overcome the limitations of the scanning tunneling microscope (STM) in
imaging non-conducting materials [140]. In terms of cell biology, AFM usage can be
divided into several categories, including imaging, micromanipulation, material property
investigation, and binding force investigation [140]. Several advantages that the AFM
possesses over other mechanical measurement techniques are the ability to combine highresolution scanning with nano-indentation, the direct mechanical interaction between
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probe and sample, high sensitivity, high spatial resolution, the capability of being used
for real-time measurements in a physiologic aqueous environment, and commercial
availability [134]. An aqueous environment has also been found to be important due to
the fact that sample drying increases elastic modulus [137]. The small probe size of an
AFM allows for testing of smaller samples, such as biopsy specimens or tissue samples
from small animal models [137]. Other emerging capabilities of the AFM for biological
research include the ability to monitor dynamic processes, study molecular and adhesion
forces (such as between RGD and integrins), and elucidate intracellular force
transduction [140].
The basic operating principles of the AFM are as follows. The deflection of a
silicon-nitride cantilever probe, usually 100 to 300 microns long and approximately 0.5
micron thick, is measured by reflecting a laser off the probe’s topside onto a photodiode
(Figure 1.16).
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Figure 1.16. Schematic representation of the basic operating components of the atomic
force microscope. Adapted from Alessandrini and Facci (2005)[140].

The photodiode can detect movements on the order of 0.1 nm. A cantilever spring
constant, k, (N/m, either the nominal value or experimentally determined) is used to
convert deflection into force. Cantilever deflection leads to a shift of the reflected laser
spot, and thus a reduced signal on one segment of the photodiode, and an increased signal
on the other. The size and shape of this spot size can also influence sensitivity [141].
Typically values for k range from 0.01 N/m to 1.0 N/m. The cantilever’s mechanical
properties have a significant effect on the AFM’s performance [141]. Methods of
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experimentally determining the cantilever spring constant include using cantilever
geometrical factors, measurement of static deflection applying known force to cantilever,
measuring dynamic properties with different masses on cantilever, and thermal noise (the
most common method, cantilever is treated as a simple harmonic oscillator excited by
thermal noise, 15-20% accuracy) [140]. Cantilevers with higher resonant frequencies, a
property related to thickness, length, density, and modulus, are less subject to
disturbances from external vibrations [141]. Contact mode cantilevers are usually Vshaped, in order to increase lateral stiffness and prevent fracture [141]. On the underside
of the cantilever is the tip, which is usually pyramid-shaped with a blunted point of radius
of 50-100 nanometers. For biological applications, the probe is typically moved relative
to a stationary sample, which can be heated to the desired temperature and kept in an
aqueous environment. Movement in the z-direction is accomplished using a piezoelectric
actuator and has a range on the order of 6 microns, while maximum x-y movement is
usually 100 x 100 microns [134]. The piezoelectric crystal itself is subject to both
hysteresis and creep behavior, which can affect measurement accuracy [141]. Sample
cells are typically adhered to a hard underlying substrate via an ECM component protein,
such as collagen or fibronectin, or through the use of a positively charged material such
as poly-l-lysine [135]. Glass or polymer microspheres can be attached to the underside of
the cantilever, for the purposes of creating an easier to characterize contact geometry,
increasing contact area, or attaching any number of biologically relevant molecules [134].
AFM tips can also be functionalized, for what is commonly referred to as chemical force
spectroscopy. The most commonly used method, and the one with the best reliability, is
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the attachment of thiol groups (-SH) to gold coated AFM tips [141]. Thiols will form a
close-packed monolayer on the gold, simply by immersing the AFM probe into a thiol
solution (with ethanol or dichloromethane) [141]. Other functional groups, such as
carboxyl, hydroxyl, methyl, or amine, can then be added as needed.
There are two primary modes of AFM imaging, tapping and contact mode.
Tapping mode involves oscillating the probe near its resonant frequency, and maintaining
the height baseline, frequency, and amplitude of oscillation as the probe encounter
different sample features [134, 139]. This mode is best for use with fragile samples that
would be damaged with direct contact. Contact mode on the other hand, involves
scanning the tip over the sample and using a feedback system to maintain constant
cantilever deflection, and is best suited for obtaining mechanical properties of the sample.
Both height and deflection images can be yielded using the AFM in imaging mode
(Figure 1.17). The height image represents the z-distance between the substrate surface
and each point on the sample, while the deflection image represents a more detailed
topographical view of the sample.
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Figure 1.17. Height (left) and deflection (right) images of a human fibroblast. Figure
from Alessandrini and Facci (2005)[140].

The amount of indentation into a sample is calculated using the equation D=(Z-Zo)-h,
where D is sample indentation, Zo is the contact point between probe and sample, (Z-Zo)
is the extension of the probe from the contact point, and h is probe deflection [134].
Varying the rate of indentation can also be used to measure viscoelastic properties, as the
level of hysteresis has been shown to vary with different probe speeds [142].
Measurements such as these can be taken in separately, or in combination with imaging,
which is known as force mapping. This allows for determining intracellular variation in
mechanical properties. When a sample is probed, both and indentation and a retraction
curve are curve, with the difference in area between the two representing the level of
hysteresis [143] . Adherence of the probe to the sample can lead to negative deflections,
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which is useful for measuring such things as receptor-ligand and cell-cell interactions
[134, 140].
Once the force curves have been obtained, the AFM data must be analyzed, which
is typically done using the Hertz model of contact between two elastic bodies [142-144] .
The Hertz model is based on a number of simplifying material assumptions, including
homogeneity, isotropicity, linear elasticity, axisymmetry, infinitesimal deformation,
infinite sample thickness and dimensions, and a smooth sample surface. The equations
relating force and depth for AFM probe indentation are: F = (2/π)(E/1-υ2) tan (α)D2 and F
= (4/3)(E/1-υ2)(RD3)1/2 for a cone and sphere respectively [134]. In the preceding
equations, α is the semi-included angle of the cone tip, R is the sphere radius, and υ is the
Poisson’s ratio, which is typically taken to be 0.5 for cells due to their high water content.
Correlation between micro- and macroscale properties using the Hertz model is largely
dependent on the satisfaction of key assumptions listed earlier. Several recent studies
have examined alternative methods of AFM force curve analysis [145, 146]. Among the
other important procedures in AFM force curve analysis are the accurate identification of
the contact point (which is particularly difficult with soft samples), calibration of the
probe spring constant, and representation of tip geometry. Furthermore, mechanical
properties of cells are substrate dependent, and have been shown to vary with difference
ECM constituents [147]. Cells are also known to exert greater forces on stiffer surfaces,
although the mechanism by which they do so is unknown [111]. All of these variables
can have significant effects on the final data.
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Several methods have been developed to directly measure and account for the
viscoelastic properties of cells using the AFM. Among them are the “force modulation
method” whereby sinusoidal loading is applied on the cell surface via AFM indentation
and the phase and amplitude of the tip response is measured for probing the cell
viscoelasticity, and the “force mapping method” in which the AFM tip touches and
dwells over a period of time on the cell surfaces, and then indents slowly into the cell
body [148]. Others have used closed-loop feedback to apply constant deflection and
measure stress relaxation [149]. Standard viscoelastic testing methods such as creep and
stress relaxation have recently become more feasible with advances in AFM technology
[149]. The most easily observed viscoelastic material behavior is creep (sinking of
indenter into material under constant load). When loading is followed by unloading
without a hold at peak load, displacement increases slightly in the initial portion of the
unloading phase, because creep rate is initially higher than the imposed unloading rate. A
hold period can be used prior to unloading to allow the material to reach equilibrium.
Appropriate hold time selected based on creep and unloading rates used in experiments
vary from ~ 3 to 120 seconds [137] . Darling and coworkers recently developed a
mathematical model for AFM stress relaxation experiments based off of the commonly
used Hertz models, by employing LaPlace transformations [149].
The effect of drugs and naturally occurring soluble biomolecules on cell
mechanics is another area of study possible using AFM force measurements. This can
lead to information such as cell morphology and mechanical compliance, furthering our
knowledge of how cells move, generate, and respond to force, as well as how drugs affect
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cell behavior at the functional level [150]. Receptor-ligand binding at the cell surface
can be visualized and quantified, yielding a binding force FR (Figure 1.18) [151].

Figure 1.18. Illustration of receptor-ligand interaction measured using biomolecues
bound to an AFM tip via a biofunctional linker. Figure from Van Vliet and Hinterdorfer
(2006) [150].

Receptor distribution can be mapped with nanometer spatial resolution superior to that
afforded by immunocytochemical staining, and can be directly correlated with structural
and mechanical subcellular features such as cytoskeletal filament association [150, 151].
Unbinding or rupture force FR (on order of 50 to 1000 pN for cells on rigid substrates) is
measured directly through bending of the cantilever and can be related to binding
affinities that characterize ligand-binding kinetics [151]. This allows comparisons of
binding affinities among different ligands and possibly indentification of previously
unknown receptors. This approach is well suited for ligands that are not compatible with
conventional methods (fluorophore or radioactive isotope labeling) and receptors with
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low spatial density and mobility. Typically, one or more ligand molecules are
permanently tethered to the AFM tip, usually by covalent linking with a flexible linker
molecule [151]. Use of a linker allows the ligand to freely move over the volume area
allowed by the linker’s length. The dissociation process of the receptor-ligand process is
followed over time. Force-time profiles allow the monitoring of conformational changes
during receptor-ligand dissociation. It is possible to detect energy barriers that are
difficult to detect by conventional, near-equilibrium assays and also to probe the free
energy surface of proteins and molecular complexes [151]. Rates of lateral diffusion and
internalization of receptors within the cell membrane must be considered with respect to
experimentally attainable scanning rates and resolutions [150]. Validation of probe
functionalization is necessary, in order to ensure that molecule is tethered and oriented so
that it can bind to its receptor. Accurate characterization of the cantilever spring
constant, as well as demonstration of binding specificity through competitive binding that
eliminates measurable FR with the soluble ligand or ion-dependent disruption of receptor
binding are also necessary [150] . Quantification of ligand-receptor rupture force has
been demonstrated for a large number of proteins, with one tethered to probe, and other
to rigid substrate. Ligand-receptor interactions were initially required “blindly”, meaning
many ligand receptor force responses were gathered at individual, randomly selected or
topographically interesting sites, or by acquisition of single force responses at each of
many pixels comprising an image. The drawback of this approach is that it does not
allow mapping of ligand-receptor interactions with molecular-scale spatial resolution.
The direct binding approach (termed recognition imaging) provides the potential to image
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receptor distribution and gather ligand-receptor force distributions of cell surfaces.
Cantilever deflection during oscillation of a ligand or anti-body functionalized probe can
be deconvolved into a recognition image (image contrast is a function of probe-surface
binding), and a topography image. By adhering whole cells to AFM cantilevers, the
ligand-receptor interactions governing adhesion can be explored at the single-cell level.
Such experiments are technically complex, and do not quantify receptor distribution or
binding kinetics between individual ligand-receptor pairs, but this can be useful in the
study of cell adhesion [150].
Contact Mechanics for Biological Problems
The origins of forces between colloid particles and surfaces can be distinguished
between surface and bulk properties [148]. Surface forces result from Van der Waals
forces (forces which arise from the polarization of molecules into dipoles ) and
electrostatic forces, and can vary significantly with surface topography, bulk viscoelastic
properties, and conductivity [148]. Bulk properties are determined by such
characteristics as elastic modulus and Poisson’s ratio [148]. In actuality, contact between
the two bodies occurs over many small areas, each a single asperity [152]. At smaller
deformations, adhesive forces may potentially play a significant role in deformation,
while at large deformations mechanical forces are the main determinants of deformation
behavior. A spherical indenter geometry will minimize stress concentrations in soft
polymers and tissues [137]. The Hertz model described above has been shown to be
experimentally valid for small deformations by a non-adhesive elastic sphere against
planes and other particles [148]. Solutions for Hertz contact remain valid until applied
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load is sufficiently large so as to initiate plastic deformation, at which point yielding will
initiate in the material with the lower yield strength [152]. For adhesive spherical solid
particles, the influence of the surface forces, which was not incorporated in the original
Hertz theory, must be taken into account. Johnson-Kendall-Roberts (JKR) and
Derjaguin-Muller-Toporov (DMT) contact theories have been widely used to correct
behavior of Hertzian contact in presence of surface forces. JKR assumes that adhesive
forces are confined to the contact area, while DMT assumes adhesive forces act outside
the contact area [152]. They modify Hertz theory for two adhering smooth, elastic
spheres by including thermodynamic work of adhesion, Δγ. Simulated results indicate
that JKR theory is generally applicable to systems with large, soft bodies and high
surface energies, while DMT provides a better description of small, hard solid particles
with low surface energies [148]. JKR method may be more applicable in cases where
there is significant adhesion, and an obvious “snap to contact” point is visible between
the AFM probe and sample [137]. It should be +also noted that both JKR and DMT are
limited to cases of small contact area (contact radius is generally less than 10% of
particle’s radius) [148].
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CHAPTER TWO
RESEARCH AIMS
Aim 1: Characterization of VSMC Mechanical Changes Associated With Phenotypic
Shifts
The phenotypic state of VSMCs can be affected by numerous different stimuli,
including humoral factors, cell-cell interactions, and mechanical forces [4]. Smooth
muscle cells are unique among the three major types of muscle cells (skeletal, cardiac,
smooth) in their retention of phenotypic plasticity, where as both skeletal and cardiac
muscle cells are terminally differentiated [4, 29] . Although present as a reparative
mechanism, this plasticity can often give rise to the development of atherosclerotic
lesions. In certain cases, such as during vascular development, and in disease states such
as atherosclerosis and restenosis, a shift from a contractile to a synthetic phenotypic takes
place. This shift from the normal contractile state to a synthetic state, known as
modulation, is associated with a decrease in contractile protein content, as well as
increased rates of proliferation, migration, and matrix production [29]. Changes to
intrinsic VSMC mechanical properties could alter the cell’s response to mechanical
stimuli, thereby disrupting vital signaling pathways and contributing to the positive
feedback phenomenon that is characteristic of atherosclerotic lesion development [153].
By inducing phenotypic changes in vitro via serum deprivation, we are able to
create a model system for studying the cellular mechanical consequences of such
changes. Employing AFM indentation, along with data analysis using the Hertz model,
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we have the ability to determine what, if any, mechanical differences emerge from
VSMC phenotypic shifts.

Aim 2: Measurement and Modeling of VSMC Stress Relaxation
Until recently, the majority of AFM cell mechanics research has focused on
simple indentation curves, whereby cantilever deflection (force) is related to indentation
depth, and an apparent elastic modulus is calculated, often employing Hertzian contact
equations. While this technique has been useful for comparative purposes, linear elastic
models greatly oversimplify the true mechanical behavior of a living cell. More recently,
researchers have begun to explore the technique of using the AFM to measure stress
relaxation behavior [149, 154, 155]. In doing so, the power of the AFM to extract
cellular viscoelastic properties has been greatly enhanced. However, In order to
maximize the potential of this technique, appropriate mechanical models need to be
employed.
The theory of quasilinear viscoelasticity (QLV) was originally developed by Fung
in order to model the viscoelastic behavior of biological tissues[132]. While it has been
extensively utilized in that capacity, it has yet to be applied to cells. As such, QLV
modeling is a candidate for potential improvement over existing AFM relaxation models.
Additionally, while the role of various cytoskeletal constituents (e.g. actin &
microtubules) has been investigated in regards to AFM indentation experiments and
various forms of dynamic mechanical measurements, their role in governing relaxation
behavior is not as well understood. Numerous cytoskeletal agents, causing assembly,
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disassembly, or stabilization of cytoskeletal components, are commercially available for
studies of this nature. In the present study, we attempt to determine the roles of both
actin and microtubules in governing vascular smooth muscle cell relaxation behavior, and
in the process, identify a suitable model for representing that behavior. This is
accomplished by developing novel methods and protocols for AFM relaxation
experiments.

Aim 3: Measurement and Characterization of VSMC Frictional Properties
While significant steps have been made towards understanding the bulk
mechanical properties of living cells, very little is known about their frictional or surface
shear properties. Understanding surface shear properties is of interest from a basic
science viewpoint. For example, cellular frictional properties are of interest for the study
of physiological phenomena including red blood cell flow [156] , cartilaginous tissues
subject to articulation [157], and cell migration [158]. Cells lining the vascular lumen
are subject to shear forces from blood flow, and it is believed that these forces play a
significant role in the regulation of vascular health [159]. In regards to the study of
endovascular surgical procedures, increased knowledge of these properties could also be
of great clinical value. Deployment of endovascular devices results in significant shear
forces on underlying vascular cells [160]. Complex lesions are of particular interest, as
reduction of friction has been shown to ease delivery of endovascular devices in such
cases [161]. Stent struts remain in constant contact with underlying vascular smooth
muscle cells following stent deployment. Any stent migration or micro-motion that
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occurs will therefore result in shear forces at stent strut/cell interfaces. Along these same
lines, a better understanding of the frictional properties of vascular cells would allow
more accurate computer modeling of in vivo stent behavior [160, 162] . Finite element
models of AFM cell mechanics experiments have thus far relied on assumptions of slip or
no-slip conditions, due to the lack of much hard data in support of either scenario [163,
164]. Atomic force microscopy has been utilized extensively to measure frictional
properties of various materials [141]. However, no such measurements have performed
using intact living cells. By functionalized the AFM probe with self-assembled
monolayers (SAMs) of various known properties (e.g. hydrophobic or hydrophilic) we
will be able to quantify surface shear forces between the cell and probe, and in doing so,
develop a new method with further potential biological applications. Our working
hypothesis is that the primary friction-reducing component at the cell surface is the
glycocalyx, a layer of glycoproteins and proteoglycans, which in VSMCs, is composed
mostly of chondroitin sulfate and heparin sulfate, and is believed to play a role in
mechanotransduction.[165] In vascular endothelial cells, the glycocalyx is believed to
play a major role in lubrication [156], raising the possibility that the same function is
served in VSMCs.

Aim 4: Effects of OxLDL on VSMC Viscoelastic and Frictional Properties
The links between oxidized low-density lipoprotein (oxLDL) and atherosclerosis
have been well-documented by numerous researchers [166, 167] . Oxidized LDL is
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believed to be one of the most significant factors in vascular disease development [168].
Among the numerous observed effects of oxLDL, has been the alteration of cytoskeletal
structure in both endothelial [169] and vascular smooth muscle cells (VSMCs) [170,
171]. In the case of endothelial cells, cytoskeletal have been shown to result in cellular
mechanical changes as well [169]. To date, no such investigation of oxLD- associated
VSMC mechanical changes has been performed. Changes in cytoskeletal structure can
have considerable effects on cellular function, particularly in terms of
mechanotransduction [116]. Given that the cytoskeleton plays a dominant role in
governing mechanical properties in most cell types, alterations to cytoskeletal
composition can result in changes to cellular deformation in response to mechanical
loading. As a result, the subsequent mechanotransduced biochemical response can be
altered as well. Vascular smooth muscle cells can be subjected to mechanical loading
from several sources, including blood pressure and endovascular devices such as stents
and angioplasty balloons. For these reasons, a better understanding of VSMC mechanical
changes caused by clinically relevant stimuli, such as oxLDL, is important not only in
terms of gaining a basic understanding of the underlying phenomena, but in
understanding vascular disease progression as well.
The atomic force microscope (AFM) is an extremely useful tool in the
measurement of cellular mechanical properties [147, 172, 173]. Recently, techniques
have been developed to measure stress relaxation behavior of living cells using an AFM
[154, 155]. As cells typically exhibit viscoelastic behavior, the use of AFM stress
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relaxation techniques can serve as a useful compliment to more widely used techniques
such as cell indentation, which is commonly analyzed using Hertzian elastic models.
In the current study, it was hypothesized that oxLDL alters the viscoelastic
properties of VSMCs through cytoskeletal and morphological changes. To test this
hypothesis, we examined the effects of oxLDL on cellular morphology, actin and
microtubule distribution, and cellular viscoelasticity.
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CHAPTER THREE
EFFECTS OF SERUM DEPRIVATION ON THE MECHANICAL PROPERTIES OF
VASCULAR SMOOTH MUSCLE CELLS
Abstract: Vascular smooth muscle cell (VSMC) function plays a key role in regulating
the development and progression of vascular lesions. Among the more significant
phenomena that occur during the development of these lesions is the phenotypic
switching of VSMCs from a contractile to a synthetic state. A better understanding of the
concurrent changes to VSMC mechanical properties that occur with phenotypic shifts can
help elucidate the role of VSMC mechanics in the development of vascular diseases. In
the current study, the mechanical properties of adherent cultured rat aortic VSMCs were
assessed by atomic force microscopy (AFM). Serum starvation was used to induce a
phenotypic shift in vitro. It was concluded that serum starvation led to a statistically
significant increase in apparent elastic modulus after 5 days, as well a statistically
significant decrease in hysteresis after 3 days in culture. If this trend of VSMC
mechanical properties changing concurrently with phenotypic shifts were to hold true in
vivo, such changes could affect the processes of mechanotransduction and/or arterial
mechanical properties, thereby contributing to the progression of vascular disease.
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Introduction
Vascular smooth muscle cells (VSMCs) are one of the main constituents of the
arterial medial layer and therefore are continuously exposed to mechanical stresses from
arterial blood pressure. It is known that alterations in a cell’s mechanical properties can
have profound effects on the response to such external mechanical forces [115]. For this
reason, the study of single cell mechanical properties has become an increasingly
valuable research area in recent years [146, 174] as investigators have begun uncovering
the importance of mechanical cues in numerous disease pathologies [115, 134, 175]. Any
disease that affects the cytoskeleton may, in turn, affect cellular mechanical properties.
Furthermore, the mechanical behavior of individual cells often shares many
characteristics with macroscopic tissues [134]. Given the relationship between vascular
disease and mechanical stimuli, a better understanding of VSMC mechanical properties
would provide valuable data to our knowledge of the complex atherosclerotic and
restenotic disease processes.
Vascular SMCs typically take on a synthetic phenotype after a short time in
culture, but a shift towards a contractile phenotype has been shown to be possible in vitro
through serum starvation and reversible through the subsequent re-addition of serum
[176]. Serum starvation can have numerous affects on VSMCs in culture, including
upregulation of cytoskeletal and contractile proteins [176-179], alterations in growth
factor receptor expression [180], changes in integrin binding characteristics [181], altered
Ca2+ response and chemotaxic behavior [179], decreased attachment and proliferation
[182], decreased cell volume [183], and increased collagen expression [184]. It has been
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demonstrated that in vitro VSMC serum starvation for 3 or more days results in
restoration of contractility and significant upregulation of intracellular proteins
characteristic of the contractile phenotype [176, 177]. Although serum starvation has not
always been shown to induce complete restoration of the contractile phenotype [185], it
has consistently been found to upregulate expression of the cytoskeletal and contractile
proteins, which would contribute to cellular mechanical properties [176-179]. It is
unlikely that VSMCs in culture would ever precisely mimic the mechanical behavior of
VSMCs in vivo due to factors such as a lack of exposure to an in vivo physiological
mechanical environment, differences in ECM composition, and the effects of a 2-D rather
than a 3-D environment. However, serum deprivation has consistently been shown to
result in a shift along the phenotypic continuum [32]. This makes this system a suitable
model for the purpose of this study, which addresses mechanical properties of different
phenotypes of VSMCs.
Previous studies have been performed examining the tensile elastic properties of
VSMCs using a custom-designed micro-pipette system, with the data indicating that
synthetic VSMCs have a lower tensile elastic modulus than contractile VSMCs [125127]. Nagayama and collaborators also reported that tensile properties of VSMCs were
affected by the quantity, organization, and distribution of α-actin filaments [127]. These
previous studies however, were performed using trypsinized non-adherent VSMCs, and
only elastic properties were measured, despite cellular mechanical behavior being
viscoelastic in nature [112]. Nonetheless, this previous research has provided some
insight into the mechanical properties of VSMCs, which could be expanded upon by
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additional characterization of the mechanical properties of adherent VSMC utilizing
nanoindentation with an atomic force microscope (AFM).
The major objective of the present study was to assess the differences in
mechanical properties between serum-fed and serum-starved VSMCs using AFM
nanoindentation. As measures of elastic and viscous properties, VSMC apparent elastic
modulus was quantified, along with the degree of hysteresis between indentation and
retraction curves at different indentation speeds. It was hypothesized that serum-starved
VSMCs would exhibit greater elastic moduli due to their increased cytoskeletal and
contractile protein content. A secondary objective was to quantify intracellular
variations in VSMC elastic modulus.

Materials and Methods
Cell Culture
Rat aortic VSMCs (Vectechnologies, Rensselaer, NY) from an established cell
line were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech,
Herndon, VA) with fetal bovine serum (FBS) (10%) (Sigma, St. Louis, MO) and
antibiotic/antimycotic solution (1%) (Sigma). Cells were maintained in T-75 polystyrene
flasks in an incubator at 37ºC with 5% CO2, and fresh media was exchanged every 48
hours. Cells were utilized between passages 5 and 8. For all AFM force measurements,
cells were allowed to grow to ~80% confluency in the flasks then trypsinized with 0.25%
trypsin (Mediatech) / 0.02% EDTA (Sigma) and seeded in a sub-confluent layer onto 22
x 22 mm glass coverslips (VWR, West Chester, PA). Coverslips had each been coated
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with 40 μl of 50 μg/ml monomeric type I collagen (Vitrogen 100, Cohesion
Technologies, Palo Alto, CA) 24 hours prior to cell seeding. Cells were seeded subconfluently in order to minimize overlapping and to control for the mechanical stiffening
effects known to be imparted upon cells once they reach confluency in culture [174]. For
each experiment, the seeded cells were divided into two groups, serum-starved and
serum-fed. Seeded coverslips in the serum-starved groups were maintained in serum-free
(0% FBS) DMEM for 3 or 5-days, while the serum-fed groups were concurrently
maintained in DMEM with 10% FBS. Serum-starved cells were washed with phosphate
buffered saline (PBS) (Mediatech) prior to switching to serum-free media. All of the
cell-seeded coverslips were maintained in 6-well plates at 37ºC with 5% CO2, and media
was exchanged every 48 hours prior to AFM experimentation.

AFM Indentation
Atomic force microscopy (AFM) experiments were performed 3 or 5 days after the cells
were seeded onto the coverslips, depending upon the designated number of days of serum
starvation for each group. For all AFM experiments, a Digital Instruments Dimension
3000 AFM with a Nanoscope IV controller (Veeco Metrology, Santa Barbara, CA) was
operated in contact mode with a fluid cell. During AFM experiments, cells were kept on
the coverslips in their respective culture media, which was exchanged approximately
every 30 minutes with warm 37ºC media throughout the course of the AFM experiments,
each lasting for approximately 2 h in total. For each experiment, representative cells
(n=15) were chosen based on their appearance as being either “spread” for the serum-fed
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group, or “spindle-shaped” for the serum-starved group. This was based on previous
reports of morphological changes of serum-starved VSMCs [176, 177] and ensured that
only cells that had responded to serum starvation were chosen for analysis. The AFM
probe was positioned over the central region of each cell body, avoiding the thin cell
edges, and the cell was indented 5 times consecutively at each of 3 different approach
speeds (0.095 Hz (0.50 μm/s), 0.498 Hz (2.62 μm/s), 1.94 Hz (10 μm/s)) for a total of 15
indentations per cell. Approach speeds were randomized for some samples in order to
control for any mechanical changes that may be caused by repeated indentation. The
approximate depth of each indentation was 500 to 600 nm, although the Hertz model was
only applied at 150 to 200 nm of each force curve, as described below. Indentation depth
was regulated by adjusting the triggering force (~ 20 nN) as necessary. A single 5 μm
diameter borosilicate spherical-tipped AFM probe (BioForce Nanosciences, Ames, IA)
on a silicon-nitride cantilever with a nominal spring constant of 0.58 N/m, was utilized
throughout the study. Prior to each experiment, deflection sensitivity (nm/V) was
determined by indenting onto a clean glass coverslip in DMEM.
Several cells were also imaged in contact mode using a 0.58 N/m pyramidal AFM
probe (Veeco Metrology). These images were then used to determine cell height and to
construct 40 × 40 point force-curve maps — covering a total area of approximately 1600
μm2 — by using the “point and shoot” function in the NanoScope v6.13R1 software
(Veeco Metrology) for the purpose of quantifying spatial variations in intracellular elastic
modulus. In order to determine intracellular variations in elastic modulus, the indentation
depth at 20 nN for each point in the force-curve matrices was calculated and mapped.
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Additionally, the coefficient of variation (COV) for elastic modulus in the central region
(~ 25 μm2 area) of the cell was calculated. Intracellular modulus measurements were
conducted as a means to gauge the intracellular variability of elastic modulus values and
therefore the validity of reported measurements from single-point AFM indentation
throughout the current study.

Force Curve Analysis
Following the AFM experiments, a MATLAB (MATLAB 7.0, The MathWorks,
Inc., Natick, MA) script was used to normalize the force curves and shift them as needed
to a common zero point. Contact points were determined by visually identifying the
region at which the slope of each curve shifted upwards. In addition, and as a
comparison, other methods for determining the contact point were also employed. The
first method calculates the contact as the point where the force increases above the level
of noise [186]. In the second method, the contact point is calculated as the point where
the slope of the curve changes by fitting the curve to a 2-region model [146]. These
methods gave a contact point similar to the visual inspection of the curve and did not
significantly affect the calculated moduli or trends observed.
To obtain a measure of individual cell stiffness, the apparent elastic moduli of the
cells were calculated using the Hertz model for a spherical indenter [173]:
F=

1 3
4 E
2 2
δ
R
2
3 (1 − υ )
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where F is the measured force (N), δ is indentation depth (m), E is apparent elastic
modulus (Pa), υ is Poisson’s ratio (0.5) [187], and R is the spherical indenter radius (2.5
μm). A “normalized indentation depth” was calculated for both serum-fed and serumstarved VSMCs. This was chosen to be approximately 10% of the cell height, as this is
the depth at which the Hertz model remains accurate [188]. As average cell height was
measured using contact mode AFM imaging as ~ 1.5 μm for serum-fed cells and ~ 2.0
μm for serum-starved cells (Figure 3.1), the corresponding depths at which the Hertz
model was applied were 150 and 200 nm respectively. The “pointwise modulus” method
of cellular mechanical analysis developed by Costa, et al.[145] was utilized in addition to,
and as support usage of the Hertzian method described above. This method illustrates
variations in elastic modulus as a function of indenter depth and geometry. Indentation
force Fi is related to the pointwise apparent elastic modulus Êi by the equation:
Fi = 2πΦ(Di) Êi
where Φ(D) is a function relating the contribution of indenter geometry to depth
dependence of the indentation response [145]. In essence, this is a rearrangement of the
Hertz model that allows for the determination of elastic modulus variations as a function
of indentation depth. Performing this calculation allows one to determine whether
significant variations in elastic modulus values would be obtained should the Hertz model
be applied at different depths.
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30 nm

1.5 μm

(a)

(b)

(c)

Figure 3.1. Serum-fed VSMC imaged in contact mode; (a) Height image illustrating
variations in cell height in reference to underlying substrate, (b) 3D height image, (c)
Deflection image illustrating cell surface details.
In addition to the elastic modulus calculations, the degree of hysteresis exhibited
by each cell was calculated by subtracting the area under the entirety of each retraction
curve from the area under the entirety of its corresponding indentation curve and then
normalizing by the area under the indentation curve in order to account for variations in
indentation depth (Figure 3.2) [143]. This calculation of hysteresis, combined with the
changes in modulus with indentation speed, provided a measurement of non-elastic
behavior and viscous energy dissipation [189]. Calculating hysteresis in the force curves
provided a measure of viscous contributions that is independent of any concerns that
would arise regarding the validity of various existing viscoelastic models.
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= hysteresis

Figure 3.2. A force curve obtained using an AFM is comprised of both an indent and a
retract curve. The contact point was determined by visually identifying the region at
which the slope of the indent curve turned upward. Hysteresis can be calculated by
finding the area between the two curves and normalizing by the indent curve in order to
account for variations in indentation depth.
Immunofluorescence
Immunofluorescence staining of SM-α-actin, which is one of the most abundant
proteins in VSMCs and is known to be downregulated during phenotypic modulation
[176, 190], was used as a means of visualizing any changes in α-actin distribution or
expression level. Cells designated for immunofluorescence were fixed in 100% ethanol
at room temperature for 30 minutes at the same time points as the cells for the
corresponding AFM experiments. The cells were then incubated with blocking solution
consisting of PBS (90%) (Sigma), bovine serum albumin (3.8%) (Sigma), donkey serum
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(3.0%) (Sigma), and Triton-X (0.2%) (Sigma) for 30 minutes, followed by incubation
with rat SM-α-actin monoclonal primary antibody (Abcam, Inc., Cambridge, MA)
overnight. A FITC-conjugated secondary antibody (Invitrogen, Inc., Carlsbad, CA) was
added the following day for 2 hours, followed by incubation with DAPI for 5 minutes
(Invitrogen, Carlsbad, CA). Immunostained cells were visualized on glass slides using a
Nikon Eclipse TE2000-S fluorescence microscope (Nikon USA, Melville, NY) with a
FITC-filter, and digital images were captured using QCapture 2.68 imaging software
(QImaging, Inc., Burnaby, BC).

Statistics
Repeated measures ANOVA was used to determine any statistically significant
differences in apparent elastic modulus or hysteresis within experimental groups at
different probe speeds, while Student’s t-tests were used to determine any statistically
significant differences in apparent elastic modulus or hysteresis between experimental
groups at a given speed. In cases where normality tests failed (P < 0.05), Friedman
repeated measures ANOVA on ranks and Mann-Whitney rank sum tests were used in
place of repeated measures ANOVA and Student’s t-tests respectively, due to their
greater stringency. All statistical analyses were performed using SigmaStat 3.1 software
(Systat Software, Inc., Richmond, CA). An alpha level of 0.05 was used for all
performed tests. Coefficients of variation (standard deviation / mean) were calculated
within each experimental group as a measure of cell-to-cell variations in modulus, within
each cell loading session as a measure of data repeatability on a single point of
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indentation, and within the force-curve matrices to determine intracellular modulus
variation.

Results
Hertzian Apparent Elastic Modulus
Statistically significant increases in hysteresis were observed with the increase of
approach speeds in all VSMC groups (p < 0.05). Furthermore, increased approach speeds
resulted in greater measured apparent elastic modulus values in all experimental groups,
as is commonly observed in viscous materials including cells [189]. Accordingly, the
lowest AFM approach speed used in this study (0.5 um/s) was used for all calculations of
apparent elastic modulus in order to minimize any viscous effects on the calculated
estimate of the elastic modulus. Approach speed randomization revealed no temporal
changes in modulus measurements throughout indentation cycles. Serum starvation for 5
days resulted in a statistically significant increase in apparent elastic modulus. All 3-day
serum-starved groups exhibited non-significant increases in apparent elastic modulus.
The mean apparent elastic for VSMCs was 13.5 ± 2.8 and 15.1 ± 6.2 kPa for the serumfed and 3-day serum-starved groups respectively (p = 0.842, Fig 3). For VSMCs serumstarved for 5-days, the mean apparent elastic modulus was 15.3 ± 4.3 kPa, compared to
11.1 ± 4.1 kPa for serum-fed cells (p = 0.010, Figure 3.3).
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Indenter Speed:
Black = 10 µm/s
White = 0.5 µm/s

3-day Fed 3-day Starved 5-day Fed

(p = 0.010)

5-day Starved

Figure 3. 3. Apparent elastic moduli of serum-fed and serum-starved (3 and 5-days) rat
aortic VSMCs measured with a 5 μm diameter borosilicate spherical AFM probe at
approach speeds of 0.5 (white) and 10.0 μm/s (black), with 10% indentation depths
approximated at 150 and 200 nm for serum-fed and serum-starved groups respectively (n
= 15 cells per group). At greater indenter speeds, artificially inflated elastic modulus
values are commonly observed in materials exhibiting significant hysteresis. Therefore,
data from 0.5 µm/s measurements were used for statistical comparisons of elastic
modulus. Data are presented as mean ± SE.
Histograms were plotted from the 5-day group in order to more clearly illustrate the
differences in elastic modulus distribution between treated and control groups (Figure 3.
4).
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Figure 3.4. Histograms illustrate the distribution of apparent elastic modulus values for
5-day serum-starved VSMCs and controls. As is commonly found with cell mechanics
measurements, there is a relatively high degree of deviation in mechanical properties.
However, the serum-starved group clearly exhibits a greater proportion of high modulus
samples as compared to the serum-fed group.
Averaged indentation curves (Figure 3.5a) with the standard deviation, noted at the depth
of Hertz model application, illustrate the observed difference between treated and control
groups. Additionally, representative force curves from both a serum-fed and a serum-
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starved sample (Figure 3.5b&c) with the Hertz model overlaid at the fitted region visually
represent the fit of the model.
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Figure 3.5. Averaged force curves of serum-fed (solid) and serum-starved (hashed)
VSMCs with respective points of Hertz fit (± SE) denoted by vertical bars (a).
Representative force curves from 5-day serum-starved (b) and serum-fed (c) groups,
overlaid by corresponding Hertz model fits.

79

The cell-to-cell apparent elastic modulus COV had a mean of 32.0 ± 9.5%. The mean
COV for moduli measured at a single point was 6.0 ± 5.3%. Cell-to-cell apparent elastic
modulus COVs and repeated indentation COVs for each experimental group are
summarized in Table 3.1.

Table 3.1. Cell-to-cell and repeated point elastic modulus COVs
Cell-to-Cell COV Repeated Point COV
(%)

(%)

3- day Serum-fed

20.6

4.1

3-day Serum-starved

42.3

4.2

5-day Serum-fed

36.8

10.3

5-day Serum-starved

28.4

5.3

All (mean ± SD)

32.0 ± 9.5

6.0 ± 5.3
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Pointwise Elastic Modulus
Averaged pointwise elastic modulus normalized to the Hertz model was plotted
for both 5-day serum-starved cells and controls (Figure 3.6 a&b). For the relevant
regions of these plots, which includes the first 200 nm of indentation, both the serumstarved and control groups appear relatively flat, providing evidence that the Hertz model
is suitable in this region [145]. Beyond 200 nm, the plots do begin to exhibit increasing
nonlinearity (Figure 3.6 c&d). However, these larger indentation depths were not taken
into account for modulus calculations and are therefore irrelevant to the current
discussion.
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Figure 3. 6. Pointwise modulus normalized to Hertz model modulus of 5 day serum-fed
(a&c) and serum-starved (b&d) groups shown to 200 nm depth (a&b) and to 500 nm
depth (c&d). Up to 200 nm, the plots are relatively linear and centered around a value of
1, indicating applicability of the Hertz model. However, beyond that depth, nonlinearity
increases (particularly for the serum-starved cells).
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Intracellular Elastic Modulus Variation
Spatial intracellular variations in apparent elastic modulus for 3 mapped cells
were found to be similar to cell-to-cell variations (COVs of ~ 35 to 40%). The
indentation depth at 20nN varied from approximately 100 nm to 1 µm over the entire cell
(Figure 3.7). However, in the more relevant central region, with an area of approximately
25 µm2, which was probed for elastic modulus measurements, indentation depth at 20 nN
varied only between ~ 500 to 600 nm. Since only these inner regions of the cells were
targeted for indentation throughout this study, the thinner peripheral regions are of lesser
relevance.

Figure 3.7. Indentation depth at 20 nN (left) and height image (right) from a
representative serum-starved VSMC. Lighter pixels represent greater indentation depth
(lower elastic modulus). The soft region in the upper-left quadrant of the indentation
depth image is most likely due to a region of overlapping cells which was noticed during
the imaging experiment.
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Hysteresis
Hysteresis was statistically significantly greater at higher AFM probe approach
speeds for all experimental groups in this study (p < 0.05). It was therefore determined
that the maximum probe approach speed that was used, 10 μm/s, would be utilized for all
calculations of hysteresis in order to accentuate any differences in viscous contributions
between cell phenotypes. Hysteresis was statistically significantly lower for early
passage 3-day serum-starved VSMCs (0.41 ± 0.08 and 0.32 ± 0.09 for serum-fed and
serum-starved respectively, p = 0.007) (Figure 3.8). Hysteresis was also statistically
significantly lower in 5-day serum-starved than in serum-fed VSMCs (p < 0.001) (Figure
3.8).

Figure 3. 8 . Hysteresis of VSMCs, serum-fed or serum-starved for three or five days,
measured at an approach speed of 10.0 μm/s. Data are presented as mean ± SE.
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Immunofluorescence
Serum starvation resulted in decreased cell spreading at both 3 and 5 day
timepoints. Immunofluorescence staining revealed that both serum-fed and serumstarved VSMCs were positive for SM-α-actin. In the majority of serum-fed VSMCs,
SM-α-actin was randomly distributed; however, many cells did appear to stain darker
around the cellular periphery. Actin filaments were typically thin in appearance and were
randomly oriented. Serum-starved VSMCs exhibited a more heterogeneous staining
profile, as some cells appeared to be very similar to the serum-fed cells while others had
become elongated, with thicker actin filaments that were more evenly distributed, and ran
parallel to the major axis. Given that these elongated VSMCs were selected for
indentation, the actin filament distribution within them is of greater relevance to the
current study. No obvious differences were noted in SM-α-actin content between 3 and
5-day serum-starved cells. Representative SM-α-actin images are shown in Fig. 9.
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Figure 3.9. Representative smooth muscle alpha-actin immunofluorescence images of an
elongated serum-starved VSMC (left) and spread serum-fed VSMC (right) at 40x.
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Discussion

The present study was designed to model a phenotypic shift of VSMCs in vitro
through the use of serum-starved and serum-fed VSMCs and to identify any trends in
cellular mechanical property changes that occur during such a phenotypic shift.
Differences in cell height between serum-fed and serum-starved VSMCs were accounted
for by using a “normalized indentation depth” of ~10%. This parameter is closely related
to other factors, namely indenter radius and layer thickness. Recent computational
research suggests that modulus values are not significantly in error with a 2.5 µm radius
indenter when the ratio of indentation depth to sample thickness is at or below 0.1, as in
the current study [191]. Support of the Hertz model using the pointwise modulus method
was also undertaken. Plots of pointwise elastic modulus were relatively flat for the first
200 nm. Therefore, as stated by Costa, et al.[145] the Hertz model is reasonably
appropriate for modeling this region (~ 200 nm). Regions beyond 200 nm in depth
exhibiting increasing nonlinearity were not modeled and are therefore of lesser relevance.
It is well-documented that the Hertz model has significant deficiencies when it comes to
cell mechanical modeling, resulting in part from the fact that cells and tissues do not meet
several assumptions of the Hertz model, e.g. linearity and isotropicity. However, as a
means of comparative analysis, Hertzian modeling does provide a quantitative measure
relating to cellular mechanical properties, which can be useful under certain conditions.
The validity of Hertzian analysis under the conditions of the current study was
strengthened through the use of Costa’s pointwise modulus method. This does not mean,
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however, that use of the Hertz model is appropriate under all conditions and for all cell
types. Indeed, as demonstrated by Costa, there are scenarios in which significant
nonlinearities are evident following pointwise analysis, and it is in these cases that the
Hertz model should be deemed less appropriate.
To the best of our knowledge, this is the first AFM study examining the changes
in mechanical properties of VSMCs adhered to an arterial ECM constituent. In addition
to the basic science motivations behind this research, it also carries clinical significance,
as it is known that elastic and/or viscous properties of single cells can be altered during
many different diseases states and that these cellular mechanical properties can have
significant effects on the process of mechanotransduction [115, 134]. In the case of
vascular lesion development, VSMC mechanical changes may indeed have detrimental
effects.
In the current study, in vitro serum starvation of VSMCs resulted in statistically
significantly increased apparent elastic modulus and statistically significantly decreased
hysteresis. The observed differences in elastic modulus are likely due, in part, to changes
in expression level, organization, and orientation of cytoskeletal and contractile proteins
[190]. However, two factors that have not yet been taken into account to explain the
differences in mechanical properties between the serum-fed and serum-starved groups are
cell adhesion and cell morphology (spreading). There is evidence that increased cell
adhesion [192] and increased cell spreading [193] both correlate with increased stiffness.
In the present study, the serum-fed groups consistently displayed stronger adhesion and
greater spreading, which may have offset cytoskeletal changes brought about through
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serum starvation. One possible limitation of measuring “elongated” serum-starved cells
and “spread” serum-fed cells is that in actuality one would be assessing the mechanical
differences associated with these two distinct morphologies. However, it should be noted
that such morphological differences are one of the key distinguishing features used to
define VSMC phenotype [194]. Furthermore, under the conditions used in the current
study very few (less than 5%) elongated cells were observed in serum-supplemented
media. Nevertheless, a potential means to address this limitation in future studies would
be the addition of a contractile agent to the media, and the subsequent mechanical
measurement of responsive versus non-responsive cells.
Previous studies relating VSMC mechanical changes to phenotype utilized tensile
strains of unattached, freshly isolated contractile and synthetic VSMCs, while the current
study utilized indentation of attached serum-starved and serum-fed VSMCs in culture.
Despite the differences in study protocols, data from the current study are in agreement in
finding that a shift towards the synthetic phenotype results in a decrease in elastic
modulus. In terms of cell-to-cell elastic modulus variation, the present study yielded a
mean COV of 32.0 ± 9.5%, which is towards the lower end of previously reported COVs
from AFM cell indentations studies [174].
The relatively low spatial intracellular variations in elastic modulus exhibited by
the VSMCs in the current study provide evidence that indenting a single point near the
center region of the cell serves as an adequate measure of cellular elastic modulus.
Although a few previous studies have found differences in stiffness in a localized center
of the cell due to contributions from the nucleus [142, 189], this was not observed in our
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measurements. In this study, indentations of 10% of the total cell height were used to
obtain modulus values, and the full-force indentation curves themselves were typically in
the range of 500-600nm. At these small indentations, it is likely that any effect on
stiffness due to the underlying nucleus is negligible. Additionally, cell-to-cell elastic
modulus variability was found to be in the same range as intracellular variability.
Repeated indentations at a single point did not appear to affect measured modulus values,
nor damage the cell in any significant manner. The mean COV for moduli measured at a
single point was 6.0 ± 5.3% in the present study.
Fluorescent microscopic images of FITC-labeled SM-α-actin revealed that both
serum-fed and serum-starved VSMCs were SM-α-actin positive. However, a larger
percentage (~ 25%) of serum-starved cells appeared to be elongated, with SM-α-actin
distributed uniformly throughout the cells, while most (~ 95%) of the serum-fed cells
exhibited random orientation of thinner SM-α-actin filaments. Given the previous data
regarding changes in SM-α-actin during modulation [176, 190, 195] and its relationship
to mechanical properties [127], it is hypothesized that such changes, along with
morphological and adhesive alterations, contributed to the altered mechanical properties
reported here.
The extent to which serum starvation in culture can accurately replicate in vivo
phenotypic changes is arguable. Nonetheless, most available evidence does suggest that
serum starvation in culture serves to mimic in vivo phenotypic changes through altered
morphology, upregulation of intracellular cytoskeletal and contractile proteins, inhibition
of proliferation and migration, and restored contractility [176, 177, 196]. Furthermore,
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use of the current protocol can be justified by the fact that populations of VSMCs within
even a single blood vessel in vivo are known to be highly heterogeneous [4], and the
process of phenotypic shift itself occurs along a continuum [32]. It was demonstrated
that a shift along this continuum significantly affects VSMC viscoelastic properties.
Conclusions
In vitro 5-day serum-starved VSMCs exhibit statistically significantly greater
apparent elastic moduli and statistically significantly lower hysteresis than serum-fed
VSMCs. Further study is required to determine whether the observed in vitro trends
accurately reflect an in vivo pathological scenario, and if so, how significant an impact
such mechanical changes may have on mechanotransduction and vascular lesion
development.
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CHAPTER FOUR
ROLE OF CYTOSKELETAL COMPONENTS IN STRESS RELAXATION
BEHAVIOR OF ADHERENT VASCULAR SMOOTH MUSCLE CELLS
Abstract: A number of recent studies have demonstrated the effectiveness of atomic force
microscopy (AFM) for characterization of cellular stress relaxation behavior. However,
this technique’s recent development creates considerable need for exploration of
appropriate mechanical models for analysis of the resultant data and of the roles of
various cytoskeletal components responsible for governing stress relaxation behavior.
The viscoelastic properties of vascular smooth muscle cells (VSMCs) are of particular
interest due to their role in the development of vascular diseases, including
atherosclerosis and restenosis. Various cytoskeletal agents, including cytochalasin D,
jasplakinolide, paclitaxel, and nocodazole, were used to alter the cytoskeletal architecture
of the VSMCs. Stress relaxation experiments were performed on the VSMCs using
AFM. The quasilinear viscoelastic (QLV) reduced relaxation function, as well as a
simple power-law model, and the standard linear solid (SLS) model, were fit to the
resultant stress relaxation data. Actin depolymerization via cytochalasin D resulted in
significant increases in both rate of relaxation and percentage of relaxation; actin
stabilization via jasplakinolide did not affect stress relaxation behavior. Microtubule
depolymerization via nocodazole resulted in nonsignificant increases in rate and
percentage of relaxation, while microtubule stabilization via paclitaxel caused significant
decreases in both rate and percentage of relaxation. Both the QLV reduced relaxation
function and the power-law model provided excellent fits to the data (R2 = 0.98), while
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the SLS model was less adequate (R2 = 0.91). Data from the current study indicate the
important role of not only actin, but also microtubules, in governing VSMC viscoelastic
behavior. Excellent fits to the data show potential for future use of both the QLV
reduced relaxation function and power-law models in conjunction with AFM stress
relaxation experiments.

93

Introduction
The importance of mechanotransduction in regulating numerous physiological
processes has become increasingly evident in recent years [115]. Mechanical stimuli
have been found to play a significant role in the cellular pathology of numerous diseases,
including atherosclerosis [197], cancer [198], and arthritis [199]. Thus, the behavior of a
cell in reaction to mechanical stimuli appears to affect the cell’s subsequent biochemical
response to those stimuli. These findings have prompted development of improved
techniques to further elucidate the complex mechanical behavior of cells and tissues
[129]. One commonly used tool for the study of cell mechanics is the atomic force
microscope (AFM) [134]. Until recently, the majority of AFM cell-mechanics research
focused on simple indentation curves, whereby cantilever deflection (force) is related to
indentation depth, and an apparent elastic modulus is calculated (often employing
Hertzian contact equations) [143, 200]. The AFM, however, has also been used to
quantify viscoelastic properties of living, adherent cells via stress-relaxation [149, 154,
155] and cyclic-loading measurements [187]. While previous AFM stress relaxation
work demonstrated the technique’s potential, it did not explore cytoskeletal roles in
governing stress relaxation, and it relied on linear viscoelastic models [149, 154, 155,
187]. Thus, understanding the overall process of mechanotransduction requires
identification of the contributions of cytoskeletal components and development of
appropriate viscoelastic models [110].
The mechanical behavior of vascular smooth muscle cells (VSMCs) is particularly
important from a clinical perspective. Because these cells have been implicated in the
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pathogenesis of various vascular diseases (e.g., hypertension, atherosclerosis, and
restenosis) [197], elucidating their intrinsic mechanical properties is essential to
understanding the role of mechanotransduction in these disease processes. The role of
VSMCs in the regulation of hemodynamics and their exposure to a range of mechanical
stimuli (from sources including shear blood flow, blood pressure, and endovascular
devices) underscore the value of characterizing their mechanical behavior. Although
stress relaxation of individual VSMCs has been measured [201, 202], the cells used in
these studies were not adherent to a substrate, and custom tensile testers were used to
obtain the data.
The goal of the present study was to determine the roles of both actin and
microtubules in governing VSMC viscoelastic behavior. Thus, we measured the stress
relaxation response of VSMCs via AFM and compared three existing models to analyze
that behavior.
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Materials and Methods
Smooth muscle cells isolated from adult male Sprague-Dawley rat aortal explants
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Herndon,
VA) supplemented with fetal bovine serum (FBS) (10 %) (Sigma, St. Louis, MO) and
antibiotic/antimycotic (1 %) (Sigma). Cells were maintained in a humidified, 37 ºC, 5%
CO2, 95% air environment. Prior to AFM experiments, cells were seeded onto 22 x 22
mm glass coverslips coated with type I collagen (Vitrogen 100, Cohesion Technologies,
Palo Alto, CA) at a density of 150,000 cells per coverslip. Seeded coverslips were
incubated in 6-well plates with DMEM (10% FBS) at 37 ºC with 5% CO2 for 3 to 5 days
prior to AFM experimentation. Cells were used in experiments between passages 5 and
8.
AFM Stress Relaxation Experiments
For all AFM experiments, a Veeco Dimension 3000 AFM with a Nanoscope IV
controller (Veeco Metrology, Santa Barbara, CA) and hybrid x-y-z head was operated in
contact mode with a fluid cell. A single borosilicate spherical-tipped AFM probe (5 μm
diameter) (NovaScan, Ames, IA) on a silicon-nitride cantilever with a nominal spring
constant of 0.12 N/m was used throughout the study. AFM experiments were performed
after VSMCs had formed a confluent layer. Following the identification of a target cell,
the AFM probe was positioned over the central region of the cell body. Relaxation tests
were controlled using the strip-chart feature within the PicoForce mode of the NanoScope
v6.13R1 software (Veeco Metrology). Channel 1 was set to record cantilever deflection,
while channel 2 was set to record Z-piezo movement. Before each relaxation test was
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run, the approximate separation distance between probe and cell was determined by
visually inspecting a single force/displacement curve, Figure 4.1.
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Figure 4.1. Sample indentation curve illustrating approximate probe-cell separation
distance.
The estimated Z-separation gap was then minimized by lowering the probe in
appropriate submicron increments using the step motor. This method provided a good
approximation for starting each ramp at or near the cell surface. During AFM
experiments, cell-culture media was changed approximately every 30 minutes; each
experiment lasted no longer than 2 hrs in total.
For each relaxation test, a ramp speed of 50 µm/s was used during both the approach
and the retract phase. This strain rate allowed for a reasonable approximation of a step
strain while staying well below the Z-piezo’s maximum programmable velocity (~200
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µm/s) to assure accuracy of measurement and reduce the presence of fluid-related
artifacts. To evaluate strain dependence, VSMCs were subjected to step indentations of
0.5, 1.0, and 1.5 µm for 120 seconds (Figure 4.2) consecutively; to allow time for
mechanical recovery, approximately one minute was allowed to elapse between tests.

Figure 4.2. Top, cantilever deflection force vs. time; Bottom, Z-piezo movement vs.
time.
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The order in which the three ramp distances were used was randomized for each cell. For
all experiments evaluating the effects of various cytoskeletal agents, a ramp distance of 1
µm was chosen. During the 120-second holding period, the fluctuation in strain in most
cases was found to be on the order of 1% (5 to 15 nm), which was considered negligible.
At the conclusion of all relaxation tests, the probe was retracted 2 µm to ensure probe/cell
detachment in case any adhesion occurred during the relaxation phase. Data were
collected at a sampling rate of 100 Hz for the duration of each relaxation test.

Cytoskeletal Agents
To assess the role of actin filaments in VSMC stress relaxation behavior, cells were
treated with either 1 µM cytochalasin D (Sigma, St. Louis, MO) or 0.1 µm jasplakinolide
(Fisher Scientific, Pittsburgh, PA) at 37 °C for 1 hour prior to tests. Cytochalasin D is an
actin depolymerizing agent that caps the barbed end of F-actin, while jasplakinolide is an
actin stabilizing agent that binds to both ends of actin filaments, preventing
depolymerization. Likewise, to determine the role of microtubules in stress relaxation
behavior, groups of cells were treated with either 20 µm nocodazole or 10 µM paclitaxel
(both from Sigma) at 37 °C for 1 hour to induce microtubule depolymerization or
hyperpolymerization, respectively. Both nocodazole and paclitaxel bind to β-tubulin;
however, the former disrupts and the latter stabilizes microtubules. Concentrations of all
cytoskeletal agents were chosen based on published research [143, 147, 203] or based on
our own experience, as in the case of cytochalasin D, where we chose the maximum
concentration that can be used without inducing cell detachment. Control groups for each
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experiment consisted of cells treated only with the equivalent amount of vehicle (DMSO)
for these cyoskeletal agent treatments.

Relaxation Data Analysis
Following data collection, all stress relaxation curves were shifted to give a baseline
force value of 0 and were then normalized by their respective t=0.01 s force values to
obtain a starting (maximum) force value of 1.0 for each relaxation curve. The 0.01 s
time point was used for normalization due to the usage of logarithmic time spacing and
the 100 Hz initial sampling rate. Following normalization, data were resampled using
logarithmic spacing with 100 data points from the start to the finish of each test. The
percentage of relaxation was calculated for each relaxation curve, with the parameter
G(120), denoting G at t=120 s, representing 1 – % relaxation. Custom MATLAB scripts
(MATLAB 7.0, The MathWorks, Inc., Natick, MA) were written to fit each curve using
three different relaxation models: quasilinear viscoelastic (QLV) reduced relaxation
function, Eq. (1); power-law, Eq. (2); and standard linear solid (SLS), Eq. (3). The
reduced relaxation function, G(t), Eq. (1) contains 3 parameters, c, τ1, and τ2, with a
continuous relaxation spectrum, S(τ ) = c/τ, between τ1 and τ2, which are time constants
governing short and long term relaxation behavior, respectively.

τ 2 e -t/τ

G (t ) =

1+ c ∫

τ1 τ
τ2

dτ

1
1 + c ∫ dτ

τ1τ
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(1)

The constant, c, is unitless, and represents a relative measure of viscous energy
dissipation (damping).
The power law relaxation model used was of the form

At −α

(2)

where A and α are constants governing the rate of decay.
The relaxation behavior of a standard linear solid is defined by the equation:

G (t ) = ER ⎢1−(1−τσ ) e− t /τε ⎥
⎡
⎣

⎤ (3)
⎦

τε

where ER is the reduced relaxation modulus, and τε and τσ are the relaxation times for
constant strain and constant stress, respectively [132].

Immunofluorescence
Immunofluorescence staining was used to visualize actin filaments and
microtubules. Cells were fixed in 4% paraformaldedyde at room temperature for 30
minutes following cytoskeletal-agent treatments at the same time points as the cells for
the corresponding AFM experiments. The cells were then incubated with blocking
solution consisting of PBS (90%) (Sigma), bovine serum albumin (3.8%) (Sigma),
donkey serum (3.0%) (Sigma), and Triton-X (0.2%) (Sigma) for 30 minutes. This was
followed by incubation with either alexa fluor 488 conjugated phalloidin (Sigma) at room
temperature for 15 minutes for actin staining or alpha- and beta-tubulin primary
antibodies (Hybridoma Bank, U. of Iowa) at 4°C overnight for microtubule staining. The
microtubule-stained cells were further incubated with a TRITC-conjugated secondary
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antibody (Invitrogen, Inc., Carlsbad, CA) the following day for 2 hours and then with
DAPI for 5 minutes (Invitrogen, Carlsbad, CA). All samples were viewed using an
Olympus IX71 inverted microscope (Olympus, Tokyo, Japan); images were subsequently
collected and processed using HCImage software (Hamamatsu Corp., Bridgewater, NJ).

Statistical Analyses
Coefficients of determination (R2) were determined for each individual curve fit for
all 3 models. Constants derived from each model are presented as a mean ± standard
deviation. Values of G(120) and α for respective treatment and control groups were
compared using Student’s t-tests. The effect of indentation depth (strain dependence)
was evaluated using a Repeated Measures one-way ANOVA (on ranks when normality
tests failed), followed by Tukey tests for pairwise comparison. P-values < 0.05 were
considered statistically significant for all tests.

Results
Vascular smooth muscle cells pretreated with cytochalasin D exhibited significantly
(p=0.033) greater relaxation percentage, G(120) , and relaxation rate, α, (p = 0.002) than
controls (Table 4.1). In contrast, similar stress relaxation was observed between
jasplakinolide-treated cells and controls, G(120) and α (p=0.931 and 0.436, respectively)
(Table 4.1). Paclitaxel-treated cells exhibited significantly lower relaxation percentage
(p=0.008) and relaxation rate (p=0.011) compared to controls (Table 4.1). Nocodazoletreated cells exhibited nonsignificant decreases in relaxation percentage (p=0.220) and
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relaxation rate (p=0.091) compared to controls (Table 4.1). Averaged relaxation curves
for each cytoskeletal agent were plotted vs. respective control groups on a logarithmic
time scale, Figure 4.3.
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Table 4.1. G(120) values for each cell treatment and corresponding control group.
(* Denotes p < 0.05).
G(120)

α

Cytochalasin D (n=9)

0.11±0.12*

-0.29±0.06*

Control (n=5)

0.29±0.09

-0.16±0.06

Jasplakinolide (n=12)

0.41±0.09

-0.09±0.02

Control (n=12)

0.41±0.08

-0.09±0.02

Paclitaxel (n=12)

0.44±0.08*

-0.08±0.02*

Control (n=12)

0.32±0.11

-0.11±0.03

Nocodazole (n=23)

0.44±0.13

-0.09±0.03

Control (n=15)

0.38±0.14

-0.11±0.03
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Figure 4.3. Averaged normalized VSMC relaxation curves plotted vs. logarithmic time
from (a) Cytochalasin D, (b) Jasplakinolide, (c) Paclitaxel, (d) Nocodazole. Arrows
indicate the direction that curves of treated cells are shifted relative to controls. Due to
the usage of logarithmic spacing and the 100 Hz initial sampling rate, the initial time
point of each curve is 0.01 seconds.

The power-law exponent, α, and the normalized percentage of relaxation at the
conclusion of each test , G(120), were used as statistical measures of strain dependence to
examine the validity of the reduced relaxation function under current study conditions.
Mean power-law exponents were similar for 0.5, 1.0 and 1.5 µm indentations (p=0.499)
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(Table 4.2). Repeated measures ANOVA indicated that the mean G(120) values also did
not statistically vary with strain level (p=0.062) (Table 4.2). Consecutive relaxation tests
at 1 um depth revealed no statistically significant changes with each successive trial (data
not shown).

Table 4.2. Mean G(120) and power-law exponent (α) vs. indentation depth for untreated
VSMCs. (n=24 cells ± SD).
Indentation Depth
(µm)

G(120)

α

0.5

0.39 ± 0.14

-0.10 ± 0.03

1

0.42 ± 0.11

-0.10 ± 0.03

1.5

0.44 ± 0.12

-0.10 ± 0.03

The effects of the cytoskeletal agents used in this study are also reflected in the
constants derived from the QLV reduced relaxation function. In general, increased
relaxation percentage and rate were observed to correspond to greater C values, lower τ2,
and greater α values, while the short-term time constant, τ1, appeared to be unaffected
(Table 4.3). Due to the relatively poor fit of the SLS model, these parameters were not
included in any further analysis.
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Table 4.3. QLV parameters from VSMCs treated with cytoskeletal agents and respective
controls. C is a unitless measure of damping; τ1 and τ2, short and long-term QLV time
constants, respectively, serve as the bounds for the continuous spectrum of relaxation.
C

τ1 (s)

τ2 (s)

Cytochalasin D (n=9)

3.4±3.7

0.06±0.02

76±130

Control (n=5)

0.34±0.17

0.07±0.02

96±50

Jasplakinolide (n=12)

0.17 ± 0.06

0.09 ± 0.04

240 ± 310

Control (n=12)

0.15 ± 0.03

0.08 ± 0.05

270 ± 290

Paclitaxel (n=12)

0.16±0.06

0.09±0.04

400±310

Control (n=12)

0.23±0.17

0.08±0.02

190±200

Nocodazole (n=23)

0.14±0.06

0.08±0.03

230±250

Control (n=15)

0.20±0.08

0.08±0.04

320±320

Relaxation curves were fit very well by both the QLV reduced relaxation function, (R2
= 0.98 +/- 0.02, n=120), Figure 4.4(a), and the power-law relaxation model, (R2 = 0.98
+/- 0.03, n=125), Figure 4.4(b). The standard linear solid model, however, provided a
less adequate fit, (R2 = 0.91 +/- 0.03, n=117), Figure 4.4(c).
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Figure 4.4. Representative examples of normalized VSMC relaxation curves plotted vs.
logarithmic time with curve fits of (a) QLV reduced relaxation, (b) power-law, and (c) SLS
models. Due to the usage of logarithmic spacing and the 100 Hz initial sampling rate, the initial
time point of each curve is 0.01 seconds.

Untreated VSMCs exhibited normal actin (Figure 4.5(a)) and microtubule structure
(Figure 4.5(b)). Immunofluorescence imaging of actin (Figure 4.5(c)) and microtubules
(Figure 4.5(d)) in cytochalasin D-treated VSMCs revealed significant disruption of actin
stress fibers and no identifiable changes to microtubule structure.
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Nocodazole-treated

VSMCs showed significant microtubule disruption (Figure 4.5(f)) without any changes to
actin structure (Figure 4.5(e)). No consistent visual differences were observed with actin
or microtubule structure in paclitaxel-treated VSMCs (Figure 4.5(g) and 4.5(h)), although
some cells did appear to exhibit denser microtubule content with less free tubulin. No
visual differences were observed in actin or microtubules (Figure 4.5(i) and 4.5(j)) of
jasplakinolide-treated VSMCs.
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Figure 4.5. Immunofluorescence images of untreated VSMC (a ) actin and (b)
microtubules; cytochalasin D-treated VSMC (c) actin and (d) microtubules; nocodazoletreated VSMC (e) actin and (f) microtubules; paclitaxel-treated VSMC (g) actin and (h)
microtubules; jasplakinolide-treated VSMC (i) actin and (j) microtubules. Scalebars
represent 50 µm.
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Discussion
Mechanotransduction, the process by which mechanical stimuli are converted into
physiological responses, is important in regulating a wide array of biological processes.
Major human diseases, including atherosclerosis [197], cancer [198], and arthritis [199],
are affected by mechanobiological phenomena. At the cellular level, mechanical stimuli
and resultant deformations are converted into physiological responses that affect growth,
migration, differentiation, and protein processing. Detailed knowledge of the role
cytoskeletal components play in governing cellular mechanics is necessary for
comprehensive understanding of mechanotransduction in disease development.
Acquiring this knowledge requires development of techniques to better quantify cellular
viscoelastic behavior using commercially available equipment and identification of
simple yet accurate models for the description of the resultant data. In this study, the
effects of four cytoskeletal agents on the viscoelastic properties of VSMCs were
evaluated. Subsequently, three distinct viscoelastic models were applied to the collected
AFM stress relaxation data, and the strengths and weaknesses of each were evaluated.
Data from this study provided evidence that actin disruption with cytochalasin D greatly
altered the viscoelastic behavior of cultured vascular smooth muscle cells. In agreement with
previous cellular viscoelastic research [187], actin disruption increased damping behavior and
decreased viscosity. With the actin cytoskeleton largely disassembled, the more fluid-like
cytoplasm dominates viscoelastic behavior, so the observed increases in relaxation and damping
are unsurprising. In contrast to cytochalasin D, 0.1 µM jasplakinolide had no significant effects
on relaxation behavior. Jasplakinolide has been shown to have little effect on the relaxation
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behavior of protoplasts at 10 µM [204]; in another study, however, it increased storage and loss
moduli of airway smooth muscle cells as measured via magnetic twisting cytometry at 0.07 µM
[205]. In the current study, pretreatment with 1 µM concentrations of jasplakinolide resulted in
cell death and detachment from the cover slip within approximately 30 minutes. It has been
suggested that stabilizing actin (and thereby inhibiting the dynamic nature of actin filaments)
disturbs the actin cytoskeleton in a manner similar to that observed in actin depolymerization
[206] with cytochalasin D. This effect may be what was observed when the VSMCs treated with
1µM jasplakinolide detached from the substrate. Given the complex effects of jasplakinolide that
were seen when it was used under other conditions [203, 207] and the lack of reported use due to
its relatively recent discovery, differences in the reported data are not surprising. The variety of
results among studies pertaining to effects of jasplakinolide on cellular viscoelasticity may
warrant further investigation.

The role of microtubules in cellular mechanical behavior is more controversial than
that of actin and can depend greatly on factors such as the degree of cell spreading [113].
For example, previous studies have demonstrated an increase in cellular stiffness from
microtubule disruption [123, 208], while others have found the opposite effect [209]. In
the present study, microtubule disruption via nocodazole resulted in statistically
nonsignificant decreases in the percentage and rate of relaxation. A possible explanation
for these observations is that microtubule disrupting agents, including nocodazole, have
been found to induce the formation of actin stress fibers via a Rho signaling mechanism
[210]. In the present study, evidence of increased actin stress fiber content was not
observed from immunofluorescence images (Fig. 6), and further analysis of gene
expression or actin protein content was not conducted. An alternative explanation for the
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effects of nocodazole observed here is that microtubule disruption resulted in a decrease
in the level of prestress balanced by the microtubules [113]. Although elastic shear
modulus (normally associated with prestress) is a parameter that is distinct from the stress
relaxation data obtained in the current study, a comparison between the two might
provide a framework for understanding the effects of cytoskeletal treatments on stress
relaxation behavior. This is because cellular prestress has been found to positively
correlate with both storage and loss moduli [211]. The precise physical mechanisms
behind this correlation are not yet known.
Given that microtubule disruption with nocodazole resulted in decreased relaxation
rate and percentage in the current study, it would seem counterintuitive that microtubule
stabilization with paclitaxel resulted in statistically significant decreases in both
parameters. However, previous researchers have also observed increased viscosity as a
result of paclitaxel treatment in cardiomyocytes [212, 213], endothelial cells [209], and
isolated sections of cardiac muscle [214]. In addition to stabilizing microtubules,
paclitaxel has been found to decrease microtubule flexural rigidity [215, 216], induce
microtubule bundling [217], cause internal protofilament sliding [218], and increase
microtubule relaxation time [216]. Each of these secondary effects resulting from
paclitaxel treatment could conceivably affect whole-cell viscoelastic properties.
Although the exact mechanisms involved in these changes are not well understood, the
viscoelastic effects observed in the current and in past studies may be due to one or a
combination of several factors: internal microtubule friction (i.e., viscous sliding of
protofilaments); frictional interactions among microtubule bundles; frictional interactions
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between microtubules and cytoplasmic constituents; and intrinsically altered relaxation
behavior of the microtubule filaments. In the context of the mechanical-testing protocol
used in the current study, a proposed hypothetical scenario could involve rapid
displacement of flexible paclitaxel-stabilized microtubules and cytoplasm caused by the
high-velocity impact of the AFM probe. The high-viscosity flow of microtubules caused
by these displacements could cause friction that could then lead to decreased rate of
relaxation and relaxation percentage. Therefore, the apparently similar viscoelastic
effects of nocodazole and paclitaxel on VSMCs may be the result of two distinct
phenomena. The findings related to paclitaxel reported here are particularly interesting
from a clinical perspective because paclitaxel is used in some drug-eluting stents to
prevent VSMC hyperplasia.
The theory of quasilinear viscoelasticity (QLV) was originally developed by Fung to
model the viscoelastic behavior of biological tissues [132]. The QLV model contains the
reduced relaxation function, G(t), describing stress relaxation behavior. Although
numerous studies have dealt with the successful application of the QLV model to whole
tissues, including blood vessels [219], heart valves [220], and ligaments [221], the model
has yet to be applied to isolated cells. For the QLV reduced relaxation function to be
valid for the cells used in the current study, strain independence had to be demonstrated;
i.e., relaxation should be a function of time only. To test this relationship between strain
and relaxation, we compared both the rate of relaxation, α, and the total percentage of
relaxation, G(120), at varying strains. Both rate of relaxation and total percentage of
relaxation were found to be independent of initial strain, a finding that could be viewed as

115

supportive of the validity of the reduced relaxation function under the conditions of the
current study [222]. The reduced relaxation function exhibited an excellent fit (R2 =
0.98) for AFM stress relaxation data of VSMCs. When applied to cellular viscoelastic
research, the reduced relaxation function provides the ability to compare data to previous
studies on whole tissues. Tanaka and Fung found C parameter values an order of
magnitude lower for circumferential and longitudinal mechanical testing of intact aortas
[219]. Cytochalasin D-treated VSMCs were the lone exception to this trend: Their
significantly increased damping behavior was reflected in C values two orders of
magnitude greater than those of intact aortas. Short-term time constants (τ1) in the
current study did not vary significantly with the various cytoskeletal treatments.
However, they were found to be on the same order as those of the abdominal aorta and
lower than those of the thoracic aorta [219]. A possible explanation for this finding could
be the higher collagen and elastin content of the thoracic aorta compared to the
abdominal aorta [223], which result in larger contributions of those ECM components to
viscoelastic behavior. The long-term time constant (τ2) values in the current study were
of the same order as intact aortas [219], although standard deviations were exceptionally
large, and many values were greater than the 120-second duration of the stress relaxation
tests. However, long-term QLV time constants vary widely in the literature and within
given test protocols [224]. Future AFM stress relaxation studies utilizing the QLV
reduced relaxation function could perhaps specify longer relaxation protocols; these
would more accurately capture long-term relaxation behavior. The viscoelastic
differences between whole aortas and isolated VSMCs are unsurprising since the
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comparatively stiffer and less viscous ECM plays a large role in governing mechanical
behavior of whole tissues.
The attention that power-law behavior of cells has lately received is in part due to
recent experiments examining the behavior of cells under cyclic loading conditions [225].
Creep behavior of cells has also been modeled using a power-law function, J(t) = At

α

[226]. In the present study, stress relaxation data of VSMCs were fit very well (R2 =
0.98) using the power-law model. It has been suggested that power-law behavior is an
intrinsic cellular feature that is independent of measuring technique [226]. This issue, to
which the current data may be relevant, warrants continued investigation. Power-law
fitting complements the QLV model, as it can be used to validate or invalidate use of the
latter, as it was in this study. A simple power-law stress relaxation fit provides a
numerical gauge of the rate of decay, but no other information is provided, i.e. there are
no time constants, etc. Nonetheless, the data reported here add to a growing body of
literature pertaining to power-law behavior of cells mainly from dynamic mechanical
analyses, but also from creep measurement [226, 227], and now AFM stress relaxation.
Future AFM stress relaxation studies may employ the power-law equation used herein or
perhaps variations thereof.
The SLS model has previously been applied to cells [228] and tissues [229]. Previous
indentation tests and analyses of the intimal vessel wall of healthy human arteries using
an AFM-based technique and the SLS model [229] found SLS parameters τε & τσ with
values of 16.9 and 29.3, respectively. These SLS parameters are an order of magnitude
greater than typical SLS parameter values measured in the current study for untreated
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attached VSMCs, though the SLS model fit was unsatisfactory for VSMCs. Additional
elements (springs and dashpots) could possibly be added to the SLS model to improve the
fit; however this would require extra fitting parameters and more complex analyses.
Extracellular matrix contributions to whole tissue mechanics possibly explain the
differences in SLS parameters between whole tissues and the current VSMCs. In
summary, although the SLS model has been used to successfully for tissue relaxation data
in the past, it did not provide an adequate fit to the current VSMC data.
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Conclusions
To our knowledge, the data presented herein are the first describing the role of actin
and microtubules in governing stress relaxation behavior of adherent VSMCs. This
information adds to previous work pertaining to the role of cytoskeletal components in
governing the viscoelastic behavior of cells under dynamic conditions [123, 187]. While
it is generally agreed that actin stress fibers play the primary role in governing cellular
viscoelastic properties, these data indicate the relevance of the contributions of
microtubules. This relevance underscores a major limitation of relying solely upon
elastic modulus measurements to describe the mechanical properties of viscoelastic
materials such as cells.
In the current study, the QLV reduced relaxation function was applied to isolated cells
rather than to whole tissues. Validity of the QLV reduced relaxation function under the
current conditions was checked by testing the strain dependence of both rate and
percentage of relaxation [222]. It must be recognized that applicability here does not
indicate that the QLV reduced relaxation function will be universally valid for cell
mechanics studies.

For AFM stress relaxation studies, the use of the QLV reduced

relaxation function in combination with a power-law model may serve as a simple
method of describing the viscoelastic behavior of cells under various treatment
conditions. The reduced relaxation function will permit comparisons to data from whole
tissue. With the power-law model, comparisons of AFM stress relaxation data with
power-law data collected using other techniques will be possible. As previous studies
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have suggested, when modeling whole tissues, it may be desirable to model the
viscoelastic contributions of the cellular and ECM components separately [230]. Thus,
data from the current study may aid future AFM-based analyses of arterial mechanics.
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CHAPTER FIVE
FRICTIONAL PROPERTY MEASUREMENT OF INDIVIDUAL VASCULAR
SMOOTH MUSCLE CELLS
Abstract: With the advancement of the field of biotribology, considerable interest has
arisen in the study of cell and tissue frictional properties. From the perspective of
medical device development, the frictional properties between a rigid surface and
underlying cells and tissues is of a particular clinical interest. As with many bearing
surfaces, it is likely that contact asperities exist at the size scale of single cells and below.
Thus, a technique to measure cellular frictional properties would be beneficial from both
a clinical and a basic science perspective. In the current study, an atomic force
microscope with a 5 µm diameter borosilicate spherical probe was used to measure the
surface frictional properties of vascular smooth muscle cells (VSMCs).

Various

treatments were used to alter cell structure, in order to better understand the cellular
components and mechanisms responsible for governing frictional properties. It was
found that untreated VSMCs had a frictional coefficient of approximately 0.06. The
friction coefficient has been shown to be greatly affected by cellular rigidity.
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Introduction
While significant steps have been made towards understanding the bulk
mechanical properties of living cells, comparatively little is known about their surface
frictional properties. The study of cellular frictional properties is of interest for a variety
of reasons. For example, numerous physiological processes including blood flow [156] ,
articulating cartilaginous tissues [157], respiration [231], cell adhesion [232], and cell
migration [158], are all affected in some manner by cellular and tissue frictional
properties. In regards to endovascular surgical procedures, increased knowledge of
cellular frictional properties could also be of a significant clinical value. The deployment
of endovascular devices results in the exertion of mechanical shear forces on underlying
vascular endothelial and vascular smooth muscle cells (VSMCs) [160]. In cases of
complex or tortuous vascular lesions, a reduction of friction has been shown to ease
delivery of endovascular devices [161]. The process of stent placement typically results
in endothelial denudation [233]. As a result, stent struts are in direct contact with
underlying VSMCs. More accurate computer modeling of in vivo stent behavior could be
accomplished if the frictional properties of vascular cells were elucidated [160, 162].
Similarly, finite element models of atomic force microscope (AFM) cell mechanics
experiments have thus far relied on assumptions of frictional conditions, due to a lack of
experimental data [163, 164].
Numerous cellular constituents may play a role in governing frictional properties.
The glycocalyx, an extracellular matrix of proteglycans and glycoproteins is believed to
play a role in the lubrication of red blood cells [156] and endothelial cells [234].
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Additionally, the glycocalyx is involved in mechanical signal transduction in both
endothelial cells and VSMCs [165]. In the case of VSMCs, the glycocalyx is composed
primarily of chondroitin sulphate and heparan sulphate [235]. Located beneath the
glycocalyx, the cell membrane is composed of a lipid bilayer containing a wide array of
transmembrane proteins. Lipid bilayers alone have complex frictional and viscous
properties [236], and in the case of intact living cells, these properties are likely made
even more complex by the presence of transmembrane molecules and surface charge
distribution. Finite element research on the frictional properties of soft biological tissues
has shown a positive correlation between the friction coefficient and the modulus of
elasticity [231]. It is quite possible that this same relationship would exist for individual
cells, in which case the cytoskeleton, the main determinant of cellular elastic modulus,
would also play a significant role in governing cellular frictional properties. In many cell
types, actin and microtubules are the cytoskeletal components primarily responsible for
determining cellular mechanical properties [237]. All of these cellular constituents
(glycocalyx, cell membrane, cytoskeleton) are of course physically linked with one
another, making it rather difficult to fully separate the effects of each on whole-cell
frictional properties.
The atomic force microscope (AFM) is a useful tool for the measurement of
frictional forces at the nano- and micro- scales [141], a technique often referred to as
lateral force microscopy. Numerous studies have examined frictional properties on a
range of materials, including various polymers, films, and lipid bilayers [141]. Currently
however, very little data exist relating to the frictional properties of living cells or tissues
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at the micro-scale. However, recent studies have examined macro-scale frictional
properties of vascular endothelial cells [160] and corneal epithelial cells [238, 239]. The
AFM technique described herein is capable of providing microscale frictional data to
complement the available macroscale data. A significant advantage of AFM-based
cellular friction measurements is the use of considerably lower normal loading forces as
compared to macro-scale, reducing the chances of any cell damage occurring during the
experimental procedure.
The main goal of the current study was the development of an AFM-based
technique for micro-scale measurement of individual cell surface frictional properties, as
well as elucidation of the cellular physical constituents responsible for governing
frictional behavior. Vascular smooth muscle cells were chosen for this research due to
the clinical relevance of their frictional properties with respect to endovascular surgical
procedures.
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Materials and Methods
Cell Culture
Rat aortic VSMCs were isolated from adult male Sprague-Dawley rats and
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Herndon, VA)
with fetal bovine serum (FBS) (10 %) (Sigma, St. Louis, MO) and antibiotic/antimycotic
solution (1 %) (Sigma). Cells were maintained in T-75 polystyrene flasks in an incubator
at 37 ºC, with 5% CO2, and fresh media was exchanged every 48 hours. Cells were
allowed to grow to ~80% confluency in the flasks, then trypsinized with 0.25% trypsin
(Mediatech) / 0.02% EDTA (Sigma) and seeded onto 22 x 22 mm glass coverslips
(VWR, West Chester, PA) at a density of 150,000 cells per coverslip Seeded coverslips
were incubated in 6-well plates with DMEM (10% FBS) at 37 ºC with 5% CO2, and
media was exchanged every 48 hours prior to AFM experimentation. Cells were utilized
between passages 5 and 8.

AFM Friction Experiments
Atomic force microscopy (AFM) experiments were performed once cells had
formed a confluent monolayer on coverslips, typically between 5 to 6 days. For all AFM
experiments, a Veeco Dimension 3000 AFM with a Nanoscope IV controller (Veeco
Metrology, Santa Barbara, CA) was operated in contact scanning mode. A borosilicate
spherical-tipped AFM probe (5 μm diameter) (NovaScan, Ames, IA) on a silicon-nitride
cantilever with a nominal spring constant of 0.12 N/m, was used throughout the study. A
5 µm AFM probe was chosen, in part, due to its proximity in size to that of asperities
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previously observed on the surface of endovascular stents in our laboratory, Fig 1.
During AFM experiments, cells were kept on the coverslips in their culture media
(DMEM w/ 10% FBS), which was exchanged approximately every 30 minutes with
warm 37 ºC media throughout the course of the AFM experiments, each lasting for
approximately 1 hr in total.

Figure 5.1. Scanning electron micrograph of a stainless steel stent, illustrating size and
prevalence of surface asperities.

Cells received one of the following treatments prior to AFM friction experiments;
fixation with 3% glutaraldehyde overnight at room temperature, incubation with 0.2 U/ml
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of chondroitinase ABC and 0.2 U/ml heparinase III (Sigma, St. Louis, MO) for 30 min. at
37 °C, incubation with 5µM cytochalasin D (Sigma) for 30 min. at 37 °C. Each of these
agents was chosen due to their known effects on cellular structure. Glutaraldehyde is a
commonly used fixative for cells and tissues that induces significant crosslinking.
Cytochalasin D is an agent known to disrupt the actin network of living cells.
Chondroitinase ABC and heparinase III are responsible for the enzymatic degradation of
the glycocalyx constituents chondroitin sulphate and heparan sulphate, respectively.
Untreated VSMCs were used as controls.
Following the identification of a target cell, the AFM probe was positioned over
the central region of the cell body. Elongated cells were chosen for friction testing, with
the AFM probe reciprocating along the major axis of each test cell as in Figure 5.2, thus
preventing the probe from coming into contact with adjacent cells or substrate. Friction
measurements were performed at a 90° scan angle with a scan size (reciprocating cutoff
length) of 10 µm.
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Figure 5.2. Screen capture of AFM probe positioned over an elongated VSMC, with
reciprocation along the major axis of the cell.

Most measurements were performed at tip velocity of 20 µm/s, however for some
experiments a velocity of 2 µm/s was used in order to evaluate velocity-dependence.
Normal forces were incrementally increased by adjusting the deflection setpoint from -2
to +8 volts, or approximately 0 to 100 nN, in 0.25 to 0.5 volt increments. For each
deflection setpoint on a given cell, 16 lines of trace and retrace frictional data were
recorded, with 512 data points recorded per line (Figure 5.3).
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Figure 5.3. Representative raw trace and retrace curves from a VSMC. 512 data points
were collected on each line. Recording trace and retrace data allows one to distinguish
frictional from topographical effects on the lateral signal.

The maximum normal force exerted on each cell was in the range of 100 nN, with
the exact value dependent upon deflection sensitivity and cantilever spring constant. At
the start and finish of each experiment, frictional force data were also collected on a clean
glass coverslip in media. The resulting friction coefficients could then be compared to
existing data on the coefficient of friction between 2 glass surfaces under lubricated
conditions, revealing whether the values determined for cells were reasonably accurate.
The lateral sensitivity of the cantilever was determined using the previously
published “modified wedge method” for calibration of micro-sized tips [240, 241].
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Briefly, the probe was used to collect frictional force data on a flat mica surface, as well
as a mica surface positioned at a known angle of incline. The resulting voltage vs.
normal force plots are used to determine the lateral sensitivity, α, of the cantilever. This
lateral sensitivity value is then used to convert all lateral deflection signals (V) into lateral
force values (nN). Cell surface frictional coefficients (µ) were then calculated based on
the equation:
FL = µ × FN,
where FL is the lateral force acting on the AFM probe, and FN is the normal force. The
normal force applied at each deflection setpoint was determined by the product of the
deflection setpoint (V), deflection sensitivity (nm/V), and cantilever spring constant
(N/m). For untreated and glutaraldehyde-treated VSMCs, a Stribeck curve was plotted
using data from 5 separate cells, with an approximation of the Sommerfeld number
calculated as:
(η × v)/FN,
where η is the dynamic viscosity of DMEM (0.00078 Pa·s)[242], v is probe velocity (20
µm/s), and FN is normal force (N),.
Data Analysis
Following each experiment, data were processed using custom MATLAB (The
Mathworks,Inc., Natick, MA) scripts. Excessive noise was filtered from the data by
eliminating all data points greater than 2 standard deviations away from the mean lateral
signal value at a given normal force. The net lateral signal from each pair of trace and
retrace lines is calculated as half of the difference between the two of them. Laser drift

130

that occurred during frictional measurements was accounted for by recording the lateral
voltage on the photodiode at the start and finish of each cell, and correcting using a linear
algebraic function. Mean lateral forces and standard deviations were plotted vs. normal
forces, from which a linear fit was used to determine the slope of each line, i.e., the
coefficient of friction, µ.
Statistical Analysis
Coefficients of friction between groups were compared using one-way analysis of
variance (ANOVA) tests with subsequent pairwise comparison using Students t-tests. All
tests were performed with an alpha of 0.05, and p-values less than 0.05 were considered
statistically significant.
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Results
For the AFM cantilever used in these experiments, the lateral sensitivity, α, was
found to be approximately 68 nN/V, based on two separate calibration measurements. In
total, 16 data points were collected at each given normal force, for each individual cell,
Figure 5.4.

Figure 5.4. Representative frictional data (lateral force vs. normal force) from each
VSMC group in the current study. Each curve corresponds to an individual cell chosen
as a representative example due to its proximity to its respective VSMC group mean
frictional coefficient. Each data point within a curve represents the mean ± SD for a
particular normal force.
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One-way ANOVA comparison of friction coefficients indicated a statistically
significant difference between groups, p<0.001. Subsequent pairwise comparisons
indicated significantly greater friction coefficients for glutaraldehyde treated VSMCs
(µ=0.21 ± 0.04) vs. controls (µ=0.06 ± 0.02), p = 7.8 x 10-6, and significantly lower
friction coefficients for cytochalasin D treated VSMCs (µ = 0.01 ± 0.01) vs. controls, p =
3.4 x 10-6. No significant difference was found between chondroitinase/heparinase
treated VSMCs (µ = 0.06 ± 0.01) and controls (p = 0.41). There was no significant
difference between untreated VSMCs measured at 20 or 2 µm/s (µ = 0.05±0.001), p =
0.17. The mean coefficient of friction on glass coverslips in media was 0.18 ± 0.09,
which is in the range of the coefficient of friction for glass on glass under lubricated
conditions (0.1 to 0.6) [243]. Measured coefficient of friction values for all VSMC
groups are compared in Figure 5.5.

Figure 5.5. VSMC coefficients of friction. Data are presented as mean ± SD.
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A linear fit to data in the approximated Stribeck curve for untreated VSMCs, revealed a
positive slope with increasing (η × v)/FN ratio, Figure 5.6.

Figure 5.6. Coefficient of friction for untreated VSMCs plotted versus an approximated
Sommerfeld number. The data points are from 5 separate VSMCs, and were fit with a
linear trendline, R2 = 0.539.

In contrast, the approximated Stribeck curve for glutaraldehyde-treated VSMCs revealed
a relatively flat relationship between friction coefficient and (η × v)/FN, Figure 5.7.
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Figure 5.7. Coefficient of friction for glutaraldehyde-treated VSMCs plotted versus an
approximated Sommerfeld number. The data points are from 5 separate VSMCs, and
were fit with an exponential trendline, R2 = 0.0002.
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Discussion
The principal goal of the current study was to investigate the development of an
AFM-based method for measurement of cell surface frictional properties on the microscale, with a specific interest in vascular smooth muscle cells. Secondly, an attempt was
made to elucidate which cellular structural components are responsible for governing
frictional behavior. To the best of the authors’ knowledge, the current data represent the
first reporting of cellular surface frictional coefficients obtained via AFM. The mean
coefficient of friction for untreated VSMCs found in the current study (0.06 ± 0.02) is
similar to macroscale values previously reported for endothelial cells (μ = 0.03–0.06)
[160] and corneal epithelial cells (μ = 0.05± 0.02) [239]. It should be noted that not only
were these previous cellular friction studies conducted on different cell types on the
macroscale, but probe speed, diameter, and velocity were all substantially different than
the current study. Each of these studies was carried out in media with 10% serum,
meaning there was undoubtedly significant protein adhesion to the probe. Such protein
adhesion however, is precisely what one would expect from almost any implant material
once it comes in contact with blood. Protein adsorption has been found to increase
friction on polymer surfaces [244], and it may very well have had an effect under the
current conditions, although this was not investigated. No detachment or noticeable
displacement of cells was observed in any of the VSMC sample groups during friction
testing, indicating that the cells were firmly adhered to the substrate. The lone exception
to this was the observation that cytochalasin D treated VSMCs underwent a noticeable
bulk reciprocating motion in phase with probe motion. Through microscopic
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observation, cells did not appear to be physically damaged as a result of AFM probe
contact. Furthermore, the use of spherical as opposed to pyramidal AFM probes, greatly
reduces contact stresses at a given normal force and lessens the chances of cell damage
[245].
The observation that glutaraldehdye (a crossklinking agent) and cytochalasin D
(an actin depolymerizing agent) caused significant increases and decreases in frictional
coefficients, respectively, serves as evidence that bulk cellular modulus does correlate
positively with frictional coefficient, as it does with whole tissue [231]. Although VSMC
exposure to the glycocalyx degrading enzymes for chondroitin sulphate and heparin
sulphate did not significantly affect frictional coefficients in the current study, this does
not mean that the glycocalyx should be ruled out as a source of VSMC lubrication. It is
unlikely that the glycocalyx would be completely removed from enzymatic treatment at
the concentrations used in this study [165]. Consequently, further investigation is
warranted.

It has been suggested that fluid film lubrication, and in particular

elastohydrodynamic lubrication, is a common

lubricating mechanism in biological

systems [246]. Certainly, vascular smooth muscle cells such as those used in the current
study are soft enough to be subject to deformation under most loading regimes.
However, given that fluid film coefficients of friction are typically in the range of 0.001
to 0.01, while boundary lubrication yields friction coefficients closer to 0.1, it is also
possible that the intermediate values found for untreated VSMCs are indicative of a
mixed lubrication regime [247] for the contact and tribological conditions used in this
study. The Stribeck curve for untreated VSMCs plotted in the current study revealed a
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positive correlation between frictional coefficient and the approximated Sommerfeld
number. This behavior is representative of fluid film lubrication. This is in agreement
with previously a published finite element simulation of elastohydrodynamic lubrication,
showing decreasing frictional coefficients with increased pressure in soft biological
tissues [231]. It is possible that glutaraldehyde-fixed VSMCs exhibited a different
lubrication profile either due to mechanical changes (increased stiffness) or chemical
changes at the cell surface. If the former cause is true, and VSMC mechanical and
frictional properties also varied in vivo, this could result in intrinsic variable contact
stresses within the tissue, and a variable frictional profile over the surface, leading to
disturbed contact stresses [248].
Future mechanistic studies examining VSMC lubrication regimes are indeed
warranted, especially to further determine the effects of velocity, load, and lubricant
viscosity. One potential benefit of an AFM-based cellular friction technique is the ability
to modify the AFM probes with any number of different surface chemistries, for instance
based on charge or hydrophilicity. In combination with treatments altering the physical
chemistry and makeup of the underlying cells, such experiments could help reveal the
underlying mechanisms of cellular and tissue lubrication. The technique described in the
current study could be used to gather valuable information in the area of biotribology.
Given the mechanical and material complexity of living cells, innovative and accurate
frictional measurement techniques will be needed to determine the underlying
mechanism(s) of friction and lubrication.
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Conclusions

Measurement of cellular surface frictional properties via AFM is a viable, albeit
complex technique. In the current study, frictional coefficients of untreated VSMCs were
found to be approximately 0.06. Frictional coefficients were increased by cellular
crosslinking, and decreased by cytoskeletal depolymerization. Further study using this
technique is needed to determine the precise mechanisms underlying cellular lubrication.
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CHAPTER SIX
THE EFFECTS OF OXLDL ON MECHANICAL PROPERTIES OF VASCULAR
SMOOTH MUSCLE CELLS
Abstract: The study of single cell mechanics has gained considerable interest recently,
due in part to the recognition that mechanical properties can greatly affect physiologic
behavior. Vascular smooth muscle cells (VSMCs) and oxidized low density lipoprotein
(oxLDL) are two of the key players in the development of vascular disorders, including
atherosclerosis and restenosis. Recently, it has been observed that oxLDL can affect the
cytoskeleton of vascular smooth muscle cells. In light of this evidence, it was
hypothesized in the current study that oxLDL-associated cytoskeletal changes would
have effects on VSMC mechanical properties. This hypothesis was tested using atomic
force microsopy based elastic and viscoelastic measuring techniques. It was found that in
vitro, oxLDL at a concentration of 50 µg/ml induced cytoskeletal and morphological
changes in VSMCs similar to those associated with a transition towards a synthetic
phenotype. After 5 days of exposure, oxLDL caused significant reductions in apparent
elastic modulus, and significantly increased rate and percentage of stress relaxation, when
compared to controls. These findings raise the possibility that similar VSMC mechanical
changes may result from oxLDL exposure in vivo.
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Introduction

Oxidized low-density lipoprotein (oxLDL) is believed to be one of the most
significant factors in vascular disease development [168], and the links between oxLDL
and atherosclerosis have been well-documented by numerous researchers. [166, 167]
Among the observed effects of oxLDL, is the alteration of cytoskeletal structure in both
endothelial [169] and vascular smooth muscle cells (VSMCs) [170, 171]. Changes in
cytoskeletal structure can have considerable effects on cellular biochemical responses to
mechanical loading [116], given that the cytoskeleton plays a dominant role in governing
mechanical properties of most cell types. In endothelial cells, oxLDL-related
cytoskeletal changes have been shown to result in cellular mechanical changes [169].
However, no such investigation of oxLDL-associated VSMC mechanical changes has yet
been performed. Vascular smooth muscle cells are subjected to mechanical loading from
several sources, including blood pressure, blood flow, and in some cases, endovascular
devices such as stents and angioplasty balloons. For these reasons, a better understanding
of VSMC mechanical changes associated with clinically relevant biochemical stimuli,
such as oxLDL, is important not only in terms of gaining a basic understanding of the
underlying phenomena, but in understanding vascular disease progression, and
potentially developing targeted treatments.
The atomic force microscope (AFM) is an extremely useful tool in the
measurement of cellular mechanical properties, allowing for experimentation on living
cells in aqueous media [147, 172, 173]. Recently, techniques have been developed to
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analyze stress relaxation behavior of living cells using an AFM [154, 155, 249]. As cells
typically exhibit viscoelastic behavior, AFM stress relaxation techniques can serve as a
useful compliment to other AFM-based mechanical techniques such as cell indentation,
which assume elastic behavior.
In the current study, it was hypothesized that oxLDL alters the viscoelastic
properties of VSMCs through cytoskeletal and morphological changes. To test this
hypothesis, we examined the effects of oxLDL on cellular morphology, actin and
microtubule distribution, as well as cellular viscoelastic and surface shear properties.
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Materials and Methods
Cell Culture
Rat aortic VSMCs previously isolated from adult male Sprague-Dawley rats were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Herndon, VA)
with fetal bovine serum (FBS) (10 %) (Sigma, St. Louis, MO) and antibiotic/antimycotic
solution (1 %) (Sigma). Cells were maintained in T-75 polystyrene flasks in an incubator
at 37 ºC, with 5% CO2, and fresh media was exchanged every 48 hours. Cells were
allowed to grow to no greater than ~70% confluency in the flasks, then trypsinized with
0.25% trypsin (Mediatech) / 0.02% EDTA (Sigma) and seeded onto 22 x 22 mm glass
coverslips (VWR, West Chester, PA) at a density of 10,000 cells per coverslip. Seeded
coverslips were incubated in 6-well plates with DMEM (10% FBS) at 37 ºC with 5%
CO2, for 24 hours. After 24 hours, FBS-supplemented DMEM was replaced with serumfree DMEM supplemented with insulin-transferrin-selenium (ITS) media supplement
(Sigma, St. Louis, MO) at a concentration of 5 µg/ml insulin, 5 µg/ml transferrin, and 5
ng/ml sodium selenite. Cells were kept in ITS-supplemented serum-free media for 72
hours prior to addition of lipoproteins.

All cells in the current study were used between

passages 4 and 6.
Lipoprotein Supplementation
Native LDL and OxLDL were obtained from Biomedical Technologies,Inc
(Stoughton, MA). The oxidation level of OxLDL was 17.7 nmoles of MDA/mg protein,
as determined by the supplier. Following 72 hours in ITS-supplemented DMEM,
VSMCs were exposed to either native LDL or OxLDL at a concentration of 0.05 mg/ml
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for periods of 1,3, and 5 days. Control VSMCs remained in media only for the same time
periods. Media was exchanged every 24 hours, along with fresh aliquots of LDL and
OxLDL.

Immunofluorescence
Immunofluorescence staining was used to visualize actin filaments and
microtubules. At each timepoint, VSMCs were fixed in 4% paraformaldedyde at room
temperature for 30 minutes. The cells were then incubated with blocking solution
consisting of PBS (90%) (Sigma), bovine serum albumin (3.8%) (Sigma), donkey serum
(3.0%) (Sigma), and Triton-X (0.2%) (Sigma) for 30 minutes. This was followed by
incubation with a beta-tubulin primary antibody (Invitrogen, Inc. Carlsbad, CA) at 4°C
overnight for microtubule staining. The cells were then incubated the following day with
a TRITC-conjugated secondary antibody (Invitrogen, Inc., Carlsbad, CA) for 2 hours,
followed by alexa fluor 488 conjugated phalloidin (Sigma) at room temperature for 15
minutes for actin staining, and DAPI nuclear staining for 5 minutes (Invitrogen, Carlsbad,
CA). All samples were viewed using an Olympus IX71 inverted microscope (Olympus,
Tokyo, Japan); images were collected and processed using HCImage software
(Hamamatsu Corp., Bridgewater, NJ). Cells from the 5 day treatment group were
measured along their major and minor axes using HCImage software (Hamamatsu Corp.,
Bridgewater, NJ), as an approximate measure of any changes to cell size and shape that
resulted from oxLDL treatment. For each group, 25 randomly selected cells were used
for measurements.
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Confocal Microscopy
Confocal microscopy was performed using a Zeiss LSM 510 (Carl Zeiss
MicroImaging, Inc., Thornwood, NY). As with the conventional fluorescence
microscopy, cells were fixed on glass coverslips with 4% paraformaldehyde, and F- actin
was labeled with alexa fluor 488 conjugated phalloidin, while beta-tubulin was labeled
with anti-beta tubulin and a TRITC-conjugated secondary antibody (Invitrogen). Some
samples were also stained with amphipathic Cellmask™ Deep Red, a Membrane Stain
(Invitrogen), both prior to and after plasma membrane permeabilization in order to
visualize cell shape. Coverslips containing labeled cells were mounted on glass slides
along with SlowFade Gold antifade reagent (Invitrogen). Confocal images were
processed using Zeiss LSM Image Browser software (Carl Zeiss Microimaging).

AFM Mechanical Measurements
Cellular indentation and stress relaxation tests were performed on VSMCs in
succession. Briefly, the AFM probe was first positioned over the center of a target cell.
Three consecutive indentation curves were taken at an approach speed of 500 nm/s. The
quasi-static loading was then followed by a 120 sec stress relaxation test, with an
indentation distance of 1 µm at 50 µm/s approach speed, as previously described [249].
At 3 and 5 day timepoints, 11 cells were subjected to indentation and stress relaxation
testing for both control and oxLDL groups, while 6 cells were tested for each group at 1
day. Lateral force microscopy measurements were also performed on some cells, during
which the AFM probe was reciprocated at a 90° angle along a 10 µm path length at 20
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µm/s, with incremental increases in normal force up to approximately 100 nN.

For all

measurements, a 5 µm diameter borosilicate probe with a spring constant of 0.12 N/m
was used.
Modeling
Following AFM experiments, indentation curves were fit using the modified
Hertz model for a spherical indenter [250]
1 3
4 E
F=
R 2δ 2
2
3 (1 − υ )

where F is the measured force (N), δ is indentation depth (m), E is apparent elastic
modulus (Pa), υ is Poisson’s ratio (0.5) [187], and R is the spherical indenter radius (2.5
μm). The Hertz model was fit to an indentation depth of 300 µm, which is approximately
10% of VSMC height on the glass substrates used in the current study. Apparent elastic
moduli were calculated by averaging the three indentation curves from each cell.
Hysteresis exhibited by each indentation loop was calculated by subtracting the area
under the entirety of each retraction curve from the area under the entirety of its
corresponding indentation curve, and then normalizing by the area under the indentation
curve in order to account for variations in indentation depth. Nonspecific adhesion
between VSMCs and the AFM probe was quantified by measuring the maximum
separation force from each retraction curve.
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Stress relaxation curves were fit using the QLV reduced relaxation function,

τ 2 e -t/τ

G (t ) =

1+ c ∫

τ1 τ
τ21

dτ

1 + c ∫ dτ

τ1τ

where τ1 and τ2 are time constants governing short and long term relaxation behavior,
respectively, and c is a unitless constant, representing a relative measure of viscous
energy dissipation (damping).
Relaxation curves were also fit with a power-law relaxation model,

At −α
where A and α are constants governing the rate of decay.
All stress relaxation curves were shifted to give a baseline force value of 0 and
were then normalized by their respective force values at time, t=0.01 s to obtain a
starting (maximum) force value of 1.0 for each relaxation curve. The 0.01 s time point
was used as the initial time point for normalization due to the usage of logarithmic time
spacing and the 100 Hz initial sampling rate. Following normalization, data were
resampled using logarithmic spacing with 100 data points from the start to the finish of
each test. The degree of relaxation was quantified for each relaxation curve using the
parameter G(120), denoting G at t=120 s. Nonspecific adhesion during relaxation tests
was quantified using the breakaway force during tip retraction.
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For lateral force data, excessive noise was first filtered from the data by
eliminating any data points greater than 2 standard deviations away from the mean lateral
signal value at a given normal force. The net lateral signal from each pair of trace and
retrace lines was calculated as half of the difference between the two lines. Laser drift
that occurred during lateral force measurements was accounted for by recording the
lateral voltage on the photodiode at the start and finish of each cell, and correcting using
a linear algebraic function. Mean lateral voltage and standard deviations were plotted
against normal forces, and a linear fit was used to determine the slope of each line, µ,
which represents the magnitude of lateral probe deflection from shear forces at the cell
surface. All numerical data were processed using custom MATLAB (The Mathworks,
Natick, MA) scripts.

Statistical Analyses
Two-way analysis of variance (ANOVA), with time and LDL treatment as
factors, was used for comparison of Hertzian apparent elastic moduli, hysteresis, G(120),
and the power-law exponent, α. Post-hoc pairwise analyses were performed using the
Holm-Sidak method. In addition, correlations between measured variables were
compared using coefficients of correlation. Coefficients of determination (R2) were
calculated for each individual curve fit for both stress relaxation models. Constants
derived from each model are presented as a mean ± standard deviation. P-values < 0.05
were considered statistically significant for all tests.
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Results
Immunostaining and fluorescence imaging revealed no changes to cell
morphology, actin, or microtubule structure, for native LDL-treated VSMCs at any
timepoint in the current study, Figure 6.1. However, treatment with oxLDL led to
changes in VSMC morphology and cytoskeletal structure were noted at both 3 and 5
days. More specifically, at 3 days oxLDL-treated VSMCs exhibited elongated processes
extending from the cell body, and greater dispersion of microtubules when compared to
untreated VSMCs, Figure 6.2.
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Figure 6.1. LDL-treated VSMC actin stained with phalloidin at 1,3, and 5 days (a,c,e)
and LDL-treated VSMC microtubules stained with anti-alpha tubulin at 1,3, and 5 days
(b,d,f). Images were captured using a fluorescent microscope at 20x magnification, and
processed using HCImage software.
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Figure 6.2 (a) OxLDL-treated VSMC microtubules stained with anti-alpha tubulin at day
3 (b) Control VSMC microtubules stained with anti-alpha tubulin at day 3

At 5 days, the oxLDL group displayed fewer actin stress fibers in the central cell regions,
along with continued microtubule dispersion. In contrast, control VSMCs exhibited
greater actin fiber content, and a concentrated microtubule aster in the perinuclear region
with longer microtubules radiating from it, Figure 6.3.
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Figure 6.3. (a&b) Control VSMCs at day 5, green regions are F-actin, red regions are
microtubules ; (c&d) OxLDL-treated VSMCs at day 5, green regions are F-actin, red
regions are microtubules.
Staining of oxLDL-treated VSMCs with CellMaskTM revealed substantial lipid
staining throughout the cytoplasm, particularly in dense microtubule regions, in both
permeabilized and unpermeabilized VSMCs at day 5, Figure 6.4, d,e,f. In contrast,
control VSMCs stained with CellMask exhibited lipid staining only in the perinuclear
region, again colocalized with dense microtubule structure, Figure 6.4, a,b,c.
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Figure 6.4. Confocal microscopy images of (a) membrane permeabilized control
VSMCs stained with CellMask (white) and anti-beta tubulin (red), showing staining
predominantly in the central region of each cell, and colocalization of CellMask staining
with microtubules, (b) Membrane permeabilized control VSMCs stained with CellMask
(white), (c) unpermeabilized control VSMCs fixed and stained with CellMask (red), (d)
membrane permeabilized oxLDL-treated VSMCs stained with CellMask (white) and
anti-beta tubulin (red), showing staining throughout each cell, and colocalization of
CellMask staining with microtubules, (e) Membrane permeabilized oxLDL-treated
VSMCs stained with CellMask (white), and (f) unpermeabilized oxLDL-treated VSMCs
fixed and stained with CellMask (red).

The mean cell dimensions were similar in oxLDL-treated VSMCs (140 and 50
µm along the major and minor axes, respectively), and control VSMCs (120 and 50 µm
along the major and minor axes, respectively), n=25.
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OxLDL-treated VSMCs had mean elastic moduli of (4.4 ± 3.1, 1.6 ± 0.7, and 1.6
± 0.8 kPa at 1, 3, and 5 days, respectively), Figure 6.5. A mean elastic modulus of (3.1 ±
1.4, 2.9 ± 1.6, and 3.6 ± 1.4 kPa at 1, 3, and 5 days, respectively) was determined for
control VSMCs, Figure 6.5. Two-way ANOVA revealed a statistically significant effect
of time after allowing for the effects of treatment (p=0.029) and a statistically significant
interaction between time and treatment (p=0.012). Subsequent pairwise analyses
revealed a significant difference between oxLDL and control at day 5 (p=0.003) and
significant differences within the oxLDL group when comparing days 1 vs. 3 and 1 vs. 5,
(p=0.001) for each.

p= 0.001
p= 0.001
p= 0.003

Figure 6.5. Apparent elastic moduli of oxLDL-treated VSMCs (black) and controls
(white) at 1,3, and 5 days. Data represent means ± SD.
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Analysis of indentation loop hysteresis, showed a significant effect of time after
allowing for the effects of treatment (p=0.012), treatment after allowing for the effects of
time (p=0.026), and significant interaction between time and treatment (p<0.001).
Subsequent pairwise analyses revealed a significant difference between oxLDL and
control (p<0.001) at day 5 and significant differences within the oxLDL group when
comparing days 1 vs. 5 and 3 vs. 5, (p<0.001 for each), Figure 6.6. OxLDL-treated
VSMCs had mean hysteresis values of (0.24 ± 0.1, 0.31 ± 0.2, and 0.64 ± 0.3 at 1, 3, and
5 days, respectively), Figure 6.6. Control VSMCs had mean hysteresis values of (0.3 ±
0.1, 0.3 ± 0.2, and 0.25 ± 0.1 at 1, 3, and 5 days, respectively), Figure 6.6

p < 0.001
p < 0.001

p < 0.001

Figure 6.6. Indentation loop hysteresis of oxLDL-treated VSMCs (black) and controls
(white) at 1,3, and 5 days. Data represent means ± SD.
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Nonspecific adhesion between VSMCs and the AFM probe was significantly greater (p
<0.001) at 5 days for oxLDL-treated VSMCs compared to controls, (2.3 ± 0.9 pN vs. 0.9
± 0.4 pN, respectively).
In quantifying stress relaxation via the parameter G(120), there was a significant
interaction between time and treatment (p=0.008). Subsequent pairwise analysis revealed
a significant difference between oxLDL and control at day 5 (p=0.001), Figure 6.7.
OxLDL-treated VSMCs had mean G(120) values of (0.25 ± 0.1, 0.31 ± 0.1, and 0.18 ±
0.1 at 1, 3, and 5 days, respectively), Figure 6.7. Control VSMCs had mean G(120)
values of (0.18 ± 0.2, 0.31 ± 0.1, and 0.4 ± 0.1 at 1, 3, and 5 days, respectively), Figure
6.7.

p = 0.001

Figure 6.7. G(120) of oxLDL-treated VSMCs (black) and controls (white) at 1,3, and 5
days. Data represent means ± SD.
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For the power-law relaxation exponent, α, there was a significant interaction
between time and treatment (p=0.005), with subsequent pairwise analysis revealing a
significant difference between oxLDL and control at day 5 (p<0.001), Figure 6.8.
OxLDL-treated VSMCs had mean α values of (-0.12 ± 0.1, -0.12 ± 0.1, and -0.17 ± 0.1 at
1, 3, and 5 days, respectively), Figure 6.8. Control VSMCs had mean α values of (-0.14
± 0.04, -0.13± 0.06, and -0.08 ± 0.02 at 1, 3, and 5 days, respectively), Figure 6.8.

p < 0.001

Figure 6.8. Power-law exponent, α, of oxLDL-treated VSMCs (black) and controls
(white) at 1,3, and 5 days. Data represent means ± SD.
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Both the QLV reduced relaxation function and the power-law model fit the stress
relaxation data well (R2 = 0.98 ± 0.02 and 0.96 ± 0.05, respectively). OxLDL-treated
VSMCs had greater C values, and lower τ1 values at all three timepoints, while τ1 was
greater in the oxLDL group at 1 and 3 days, but lower at day 5, Table 5.1.

Table 5.1. QLV reduced relaxation function parameters.
Day

Group
Control
oxLDL

C
0.45±0.21
0.73±1.2

τ1
0.16±0.12
0.09±0.04

τ2
150±160
380±290

3

Control
oxLDL

0.33±0.32
0.70±1.2

0.13±0.21
0.06±0.02

170±260
300±310

5

Control
oxLDL

0.15±0.06
1.0±1.7

0.09±0.07
0.05±0.03

480±390
220±250

1

No significant difference in cell adhesion was observed between oxLDL and control
VSMCs following stress relaxation tests at day 5, (1.34 vs. 1.87 nN, respectively,
p=0.20).
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Strong correlations were found between the different measures of viscous energy
dissipation, G(120), α, C, and to a lesser extent, indentation hysteresis, used in the current
study (gray shaded cells in Table 5.2). Apparent elastic modulus showed moderate
correlations with viscous measures (green shaded cells in Table 5.2). Lateral force
measurements were strongly correlated with measures of viscous dissipation (yellow
shaded cells in Table 5.2).

Table 5.2 Correlation coefficients of VSMC mechanical parameters.

E
G120
C
α
Hys
µ

E
1.00
0.20
-0.29
0.41
-0.46
-0.25

G120

C

α

Hys

µ

1.00
-0.61
0.76
-0.49
-0.66

1.00
-0.61
0.41
0.86

1.00
-0.76
-0.72

1.00
0.58

1.00
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Discussion
The study of single cell mechanics has gained considerable interest in recent
years, as researchers have begun to recognize the importance of cellular mechanical
properties in regulating many physiological processes. Among the key tasks within this
field of study is the determination of what stimuli, either mechanical or chemical, affect
cellular mechanical properties. With regard to vascular function and disease progression,
oxLDL is known to have numerous effects, including the potential to alter cytoskeletal
structure in both ECs and VSMCs. Based upon these prior observations, the purpose of
the current study was to determine whether oxLDL caused mechanical changes to
VSMCs in an in vitro environment
After 5 days of exposure, oxLDL-treated VSMCs displayed fewer actin stress
fibers, increased cytoplasmic organelle content, and lamellopoid-like protrusions. All of
these observations are characteristic of cell cycle and phenotypic changes [45, 251]. It
has been proposed that oxLDL causes a shift towards a synthetic phenotype via the
induction of cell cycle proteins [252], with involvement of MAPK pathways [253]. The
decreased cell stiffness of VSMCs observed in this study, due to a reduction in actin
stress fiber content, would agree with previous VSMC mechanical measurements relating
to phenotype [126, 250]. The reduced actin stress fibers in the oxLDL-treated cells
would also mean an increased role of the viscous cytoplasm in governing viscoelastic
behavior, providing a possible explanation for the reduced viscosity and more fluid-like
behavior of the oxLDL group in the present study.
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The precise effects of microtubule dispersion in the mechanical behavior of
oxLDL-treated VSMCs are unclear. However, it is possible that the highly organized
microtubule asters found in the central region of control VSMCs contributed to the
greater stiffness and viscosity. Previous research in our laboratory demonstrated that
VSMCs treated with the microtubule stabilizing agent paclitaxel, showed significantly
increased viscosity[249]. . The microtubule dispersion observed in the oxLDL group
may be a result of their role in cell motility, cell cycle changes, or intracellular organelle
transport [254, 255], which rely on the dynamic instability of microtubules. Together, it
can be speculated that relative stability or instability of the microtubular network may
play a key role in cellular viscoelastic behavior.
The CellMask stain used in this study is amphipathic, that is, it is largely
hydrophobic, but includes a hydrophilic moiety at one end in order to anchor onto
phospholipid membranes. It is for this reason, that the observed staining patterns likely
reflect the presence of cytoplasmic organelles, which are surrounded by phospholipid
membranes. Increased synthetic organelle content within oxLDL-treated VSMCs may
actually serve to increase cytoplasmic viscosity [256]. It is not known what effect, if
any, this may have had in the current study, but nonetheless this provides an interesting
question for further investigation. The increased nonspecific adhesion for oxLDL-treated
cells at 5 days between the AFM probe and cell, may relate to previous observations that
oxLDL upregulates adhesion receptors, and that VSMCs isolated from atherosclerotic
arteries have been found to exhibit greater levels of adhesion to underlying substrates
[257, 258].
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Cytoskeletal and morphological changes of VSMCs in response to oxLDL
treatment have been observed previously [171, 259]. Both minimally modified LDL
(mmLDL) and more highly oxidized oxLDL were shown to induce actin disruption in
VSMCs, with the former binding to LDL receptors, while the latter binds to scavenger
receptors [260]. Previous studies have shown that VSMCs treated with 50ug/ml of
oxLDL in the presence of ITS-supplemented media show significantly increased cell
proliferation [252]. However, oxLDL has been shown to have dramatically varying
effects on VSMCs, ranging from increased proliferation at concentrations of 35 and 50
µg/ml, to apoptosis at concentrations over 100 µg/ml.[252, 261] In vivo, VSMCs
contribute to the development of atherosclerotic plaques in several different ways,
including cell proliferation, migration, and apoptosis. In light of this and the varying in
vitro results reported in the literature, it is clear that the effects of oxLDL on VSMCs are
highly dependent on numerous variables, including concentration, extent of LDL
oxidation, and exposure time.
In the current study, changes to actin an microtubule structure were associated
with significant changes in viscoelastic mechanical measurements. Based upon the
immunfluorescence staining results, oxldl-treated and control VSMCs were mechanically
tested at 1, 3, and 5 day timepoints. LDL-treated VSMCs were not mechanically tested,
due to the lack of observed cytoskeletal or morphological effects. When compared to
controls, oxLDL-treated VSMCs showed significantly increased relaxation rate and
percentage (alpha and G(120)) at 5 days. Indentation loop hysteresis was significantly
greater for oxLDL compared to controls at 5 days, with an increasing trend over time.
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Together with apparent elastic modulus also being significantly lower in the oxLDL
group compared to controls at 5 days, these data suggest increasing fluid-like behavior of
VSMCs when subjected to prolonged oxLDL treatment, with the opposite occurring in
control cells, most likely due to serum withdrawal and contractile protein upregulation
[250].
Both the QLV reduced relaxation function and the power-law model used in this
study provided very good fits to the data (R2=0.96 and 0.98, respectively). For the
reduced relaxation function, the mean short term time constant, τ1, was lower for oxLDLtreated VSMCs compared to controls at each timepoint, and in both groups, decreased at
each successive timepoint. In viscoelastic materials, relaxation time constants generally
decrease with lower viscosity or greater elasticity. When approached from this
perspective, the decrease in τ1 in the oxLDL cells can be viewed as resulting from
decreased viscosity, in light of the decreased elastic behavior, as quantified via apparent
elastic modulus. However, in control VSMCs, decreasing τ1 more likely resulted from
increasing contribution from elastic elements (e.g. actin fibers). The mean long term time
constant, τ2, consistently increased with time for control groups, while it consistently
decreased for ox-LDL groups. Recent evidence suggests that actin stress fibers are
viscoelastic in their behavior, with retraction behavior after severing characterized by a
viscoelastic element with a spring and dashpot in parallel [262]. In the current study, an
increasing long term time constant in the control group, τ2, may reflect the viscous
behavior of the actin stress fibers over longer time periods, while the decreasing τ2 in
oxldl-treated cells reflects the disappearance of these fibers, and a heightened role of
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other cellular constituents in determining viscoelastic behavior. It should be noted that
too much weight should not be assigned to the precise values found for the short and long
term time constants, as QLV time constants, especially τ2, can vary greatly [224].
The range of power-law exponents describing VSMC relaxation behavior in the
current study demonstrate a weak frequency dependence in agreement with previous
studies examining power-law behavior of other cell types [263]. The power-law
exponent, α, while not an indicator of physical mechanisms governing relaxation
behavior, does provide a simple means of comparing the physical rates of relaxation
between different materials. Values of the power-law exponent in the current study
indicate that after 5 days, oxLDL-treated VSMCs display more fluid-like behavior (i.e.,
stronger frequency dependence), when compared to controls, in agreement with the
reduced relaxation function damping constant, C.
When comparing the mechanical parameters calculated from the experiments in
this study, strong correlations emerged between the different measures of viscous
behavior, which provides further support for the validity of each. The relatively lower
correlation between apparent modulus and viscous measures underscores the idea that
indentation measurements do not capture all relevant viscoelastic properties, and cannot
be solely relied upon to quantify cellular mechanical behavior. Lateral force
measurements were found to correlate positively with measures of viscous energy
dissipation, although the sample size was relatively small (n=10) and variations within
lateral force measurements were minute as well. Nonetheless, this observation may result
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from greater contact area between cell and probe during lateral force measurements in
less viscous (more fluid-like) cells.
Plasma oxLDL levels are a strong predictor of acute coronary heart disease
events[264] and restenosis after stent placement[265]. The lipoprotein concentration
used in this study was close to that found in serum of human subjects with coronary
artery disease [266]. However, oxLDL levels found within subendothelial space in
vascular lesions are likely to have much higher levels of oxLDL than those found in
blood, due to antioxidation defenses within the bloodstream [267]. Further investigation
is necessary to determine any physiological changes that may result from oxLDLassociated mechanical changes. From the perspective of arterial mechanics, oxLDLinduced cellular phenotypic shifts, as hypothesized to have occurred in the current
research, would likely cause a drop in cell stiffness. However, there would also likely be
increased ECM deposition, thereby explaining the previously observed correlation
between oxLDL levels and decreasing arterial compliance [268, 269].
Conclusions
Data from the current study indicate that oxLDL can induce significant changes to
the viscoelastic properties of VSMCs in vitro, including decreased stiffness and viscosity.
The potential clinical implications of this finding warrant further research.
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CHAPTER SEVEN
CONCLUSIONS AND RECOMMENDATIONS
Conclusions

The current research was motivated by the desire to gain a better understanding of
VSMC mechanical and frictional behavior at the single cell level, and to develop useful
techniques to quantify that behavior and its responses to clinically relevant conditions and
stimuli. The atomic force microscope was chosen as a platform for this research due to
the ability to perform measurements on living cells in media, versatility in mechanical
and frictional measurement, imaging capabilities, and commercial availability.
The first aim of this research was to determine whether or not VSMC phenotypic
shifts resulted in cellular mechanical changes. A better understanding of the concurrent
changes to VSMC mechanical properties that occur with phenotypic shifts can help
elucidate the role of VSMC mechanics in the development of vascular diseases. In the
current study, the mechanical properties of adherent cultured rat aortic VSMCs were
assessed by atomic force microscopy (AFM). Serum starvation in DMEM was used to
induce a phenotypic shift toward a contractile state in vitro, while control groups were
kept in DMEM with 10% FBS. Cellular indentation with the AFM was conducted, and
the resulting force curves were fit using the Hertz model. The Hertz model allows for
computation of an apparent elastic modulus for each cell. In addition, viscous energy
dissipation (hysteresis) was calculated for each indentation curve. It was concluded that
serum starvation caused a statistically significant increase in apparent elastic modulus
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after 5 days, as well a statistically significant decrease in hysteresis after 3 days in
culture. Furthermore, serum starved VSMCs became more elongated than controls,
which exhibited more spreading. Use of the Hertz model was validated by calculating
apparent elastic modulus as a function of indentation depth, over the range of depths used
in this study. This demonstrated sufficient linearity in elastic modulus, one of the key
assumptions of the Hertz model. Indentation force maps over the surface of the cells
revealed relatively small variations in elastic modulus over the central region of the cell,
validating the usage of a single indentation point with a sufficiently large probe. The
current mechanical data are in agreement with previously published research dealing with
the relationship between phenotypic state and mechanical properties of non-adherent
VSMCs. If these observed trends in VSMC mechanical property alterations were to hold
true in vivo, such changes could affect the processes of mechanotransduction and/or
arterial mechanical properties, thereby contributing to the progression of vascular disease.
As proliferative VSMCs are typically associated with a disease state, this study served as
proof of concept that significant mechanical differences exist between “healthy” and
diseased VSMCs.
The second aim was to determine the role of specific cytoskeletal components in
determing VSMC stress relaxation behavior. Given that the first phase of research
showed that significant mechanical changes can occur during phenotypic changes, an
understanding of the roles of specific cytoskeletal components responsible for such
changes was needed. Furthermore, given the viscoelastic behavior of living cells, the
Hertzian elastic modeling commonly used for AFM cell mechanics research was deemed
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inadequate on its own. As a means to quantify viscoelastic properties, a novel method of
AFM stress relaxation experimentation and modeling was developed. Various
cytoskeletal agents with known effects on actin or microtubules, including cytochalasin
D, jasplakinolide, paclitaxel, and nocodazole, were used to alter the cytoskeletal
architecture of the VSMCs. Stress relaxation experiments were performed on the
VSMCs using AFM. Indentation was performed with a 5 µm spherical probe at 50 µm/s
in order to approximate a step strain. The quasilinear viscoelastic (QLV) reduced
relaxation function, as well as a simple power-law model, and the standard linear solid
(SLS) model, were fit to the AFM stress relaxation data. As a necessary condition for use
of the reduced relaxation function, strain independence was investigated and confirmed.
Statistical comparisons of stress relaxation behavior were performed using the
percentage of relaxation (G(120) and rate of relaxation (power-law exponent, α). In
addition, the reduced relaxation function yields two time constants, and a unitless
measures of damping, while the SLS model yields two time constants as well. Actin
depolymerization via cytochalasin D resulted in significant increases in both rate of
relaxation and percentage of relaxation, while actin stabilization via jasplakinolide did
not affect stress relaxation behavior. Microtubule depolymerization via nocodazole
resulted in nonsignificant increases in rate and percentage of relaxation, while
microtubule stabilization via paclitaxel caused significant decreases in both rate and
percentage of relaxation. Both the QLV reduced relaxation function and the power-law
model provided excellent fits to the data (R2 = 0.98), while the SLS model was less
adequate (R2 = 0.91). Failure of the SLS model to properly fit the data, illustrate the
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divergence in mechanical characteristics of living cells from many common viscoelastic
materials. Data from the current study indicate the important role of not only actin, but
also microtubules, in governing VSMC viscoelastic behavior. Depolymerizatin of actin
leads to more fluid-like behavior of the cell. Based upon these data, as well as
previously published research, the role of microtubules in governing cellular
viscoelastic behavior appears to be highly dependent on specific experimental conditions,
and more complex than that of actin. From a clinical perspective, the significant
mechanical changes induced by paclitaxel are relevant, due to its usage in drug eluting
stents that are already available on the market. Further research into potential adverse
physiological effects of these mechanical changes is necessary. Additionally, this
research underscores the need and benefit of characterizing cell mechanics using
viscoelastic, rather than purely elastic models.
The third aim was to develop a method to measure surface cellular frictional
properties. With the advancement of the field of biotribology, considerable interest has
arisen in the study of cell and tissue frictional properties. Much interest exists in the
determination of how cells crawl, migrate, and flow through narrow spaces in vivo. From
the perspective of medical device development, the frictional properties between a rigid
surface and underlying cells and tissues is of a particular clinical interest. As with many
bearing surfaces, it is likely that contact asperities exist at the size scale of single cells
and below. Thus, a technique to measure cellular frictional properties would be
beneficial from both a clinical and a basic science perspective. In the current study, an
atomic force microscope with a 5 µm diameter borosilicate spherical probe was used to
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measure the surface frictional properties of vascular smooth muscle cells (VSMCs). A
technique commonly used for frictional measurement of synthetic materials, known as
lateral force microscopy (LFM), was adapted for use with VSMCs in media. A 5 µm
borosilicate spherical probe, a 10 µm reciprocating path length over the major axis of
single cells, speeds of 2 and 20 µm/s, and normal forces up to approximately 100 nN
were used for experimental parameters. All experiments were performed in DMEM.
Various treatments were used to alter cell structure, in order to better understand the
cellular components and mechanisms responsible for governing frictional properties.
Actin depolymerization, and therefore cell softening, was induced using cytochalasin D,
while crosslinking (cell stiffening) was achieved using paraformaldehyde fixation. In
addition, the main constituents of the VSMC glycocalyx, chondroitin sulfate and heparan
sulfate, were partially degraded via enzymatic treatment with the enzymes chondroitinase
and heparinase, respectively. In some experiments, the AFM probe was chemically
modified via SAMs, to make the surface hydrophobic or hydrophilic, or else give a
positive or negative charge. It was found that untreated VSMCs had a frictional
coefficient of approximately 0.06. This frictional coefficient also appears to be greatly
affected by cellular rigidity, with softer cells treated with cytochalasin D having a lower
coefficient of friction than paraformaldehyde treated cells. This positive correlation
between cell stiffness and frictional coefficient is also what has been found for whole
tissues. No changes to frictional properties resulted from glycocalyx degradation, and
data from chemically modified probes were inconclusive. The technique of measuring
frictional properties at the surface of cells using lateral force microscopy appears to be a
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viable one, with potential for investigation of various probe chemistries in the future.
However, further research is required to determine the exact nature of the interactions
between the AFM probe and cell surface, as well as the sensitivity of this technique. This
includes treatment to manipulate the cell surface and/or AFM probe. Investigation into
the mode of lubrication is also warranted. Data from the current study indicate the
possibility of an elastohydrodynamic or mixed lubrication regime, but further research is
needed before any definitive conclusions can be drawn.
The fourth and final research aim was the application of the elastic, viscoelastic,
and frictional measurement techniques developed in the prior 3 aims, toward the
investigation of frictional and mechanical effects resulting from clinically relevant
VSMC stimuli. For this purpose, the lipoproteins LDL and oxLDL were chosen. Both
LDL and oxLDL are well known to be associated with vascular disease development.
Past studies have shown that oxLDL in particular can cause cytoskeletal changes to
VSMCs in vitro. In light of this evidence, it was hypothesized in the current study that
oxLDL-associated cytoskeletal changes would have also effect VSMC mechanical
properties. This hypothesis was tested using AFM-based elastic and viscoelastic
measuring techniques, including stress relaxation, Hertz indentation, and hysteresis
measurement. In addition to these mechanical measurements, imaging of cytoskeletal
components (actin and microtubules) was carried out using fluorescent and confocal
microscopy. VSMCs were serum deprived (with the addition of ITS media supplement)
for 72 hours prior to lipoprotein supplementation It was found that in vitro, oxLDL at 50
µg/ml induced cytoskeletal and morphological changes in VSMCs similar to those
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associated with a transition towards a synthetic phenotype. Specifically, oxLDL
treatment was associated with a reduction in actin stress fiber content, as well as
increased microtubule and organelle dispersion. No changes were observed in LDL or
control VSMCs, and as a result, LDL groups were not mechanically tested. After 5 days
of exposure, oxLDL caused significant reductions in apparent elastic modulus, and
significantly increased rate and percentage of stress relaxation, when compared to
untreated controls. These findings raise the possibility that similar VSMC mechanical
changes may result from oxLDL exposure in vivo. Strong correlations were found among
the different measures of viscous energy dissipation, supporting the validity of their
usage. Furthermore, there was a strong positive correlation between cellular frictional
coefficients, and mechanical damping. This finding seems to contradict the results from
aim 3, however it should be noted that different chemical treatments were used in the two
studies, and their effects on cellular surface chemistry and frictional behavior are as yet
unknown. Data pertaining to frictional effects of oxLDL were inconclusive. The results
from this aim represent the collective and successful usage of the AFM-based
measurement techniques developed over the course of the prior aims. Using these
techniques, it was demonstrated that oxLDL causes significant changes in both elastic
and viscoelastic behavior. As such, these measurement techniques or variations thereof,
can serve as an in vitro test bed for evaluation of the effects of various stimuli on cellular
mechanics in future studies. One of the most important points raised by this study, is the
need to use several mechanical measurement techniques in combination, when evaluating
the effects of a stimulus, as no single measure captures al l pertinent data.
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Based upon the results of this research, it can be concluded that numerous
clinically relevant stimuli, including oxLDL (aim 4) and paclitaxel (aim2) exposure,
affect VSMC mechanical properties in a significant manner. In addition the role of
various cytoskeletal components in governing mechanical behavior has been further
elucidated. In both aims 1 and 4 of this study, evidence was found that VSMC
phenotypic shifts are associated with mechanical changes, the physiological effects of
which require further exploration. Perhaps most importantly, AFM-based techniques and
associated mechanical models have been identified that will allow for easily repeatable
assessment of any number of clinically relevant stimuli related to vascular disease. It is
believed that a test platform such as this will allow for the evaluation of not only
pharmaceutical and biological agents, but also of mechanical contact from different
materials and surface chemistries with potential applications for endovascular devices.
From a mechanical standpoint, implantation of vascular devices represents a complex
system with numerous variables and components. Using these AFM techniques, it will
be possible to provide data for the creation of better computational and experimental
models of the mechanical interactions between endovascular devices and underlying
cells.
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Recommendations

1. Simultaneous AFM mechanical testing and live cell fluorescence imaging.
One of the most significant drawbacks of the AFM cell techniques described in
this research, is the reliance on the investigator on conventional light microscopy
for identification of target cells and probe positioning. Development of reliable
methods for fluorescent staining of live cell cytoskeletal components would not
only make cell identification far less difficult, but would also allow the correlation
of cytoskeletal structure within specific cells with the mechanical properties of
that cell. This would represent a vast improvement over the current methodology,
in which cell populations exposed to a given treatment are heterogeneous in their
response, creating great difficulty in discerning if and how a given cell has
responded, and how that response is manifested mechanically.

2. AFM dynamic mechanical analyses. The AFM has been used in the past to
conduct dynamical mechanical tests on living cells, as have various other
techniques, such as magnetic twisting cytometry . Utilization of such techniques
would allow comparison with the stress relaxation data from the current research,
as viscoelastic behavior over a certain frequency spectrum could be compared and
validated using the separate techniques. If necessary, refinement of the current
mechanical models and identification of better models could be accomplished.
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3. In vitro screening of biomaterials and biomolecules. The current AFM
techniques carry great potential for use as an in vitro tool to screen clinically
relevant biomolecules (e.g. pharmaceuticals, cytokines, lipoproteins) and
biomaterials (e.g. stent materials and coatings) for mechanical effects and
frictional behavior on VSMCs. In particular, further exploration of lipoproteins,
and their effects on cytoskeletal structure and cell mechanics is warranted, in light
of the current research findings. Attention should be focused on the identification
of agents that inhibit any observed changes to cellular structure and mechanics,
with the eventual goal being the identification of targeted therapies that block
mechanical changes. Such an approach may help bring some of the clinical
benefits of cellular mechanics research to fruition.

4. Investigate the roles of intermediate filaments, focal adhesions, cytoplasmic
properties, and cell contractility on cellular mechanical behavior. The current
research focused primarily on the mechanical effects actin and microtubules.
However, these components are by no means the only factors in governing
cellular mechanical behavior. Strength of attachment (via focal adhesions),
intermediate filaments (typically effecting large strain behavior), cytoplasmic
content, and especially in the case of vascular smooth muscle cells, contractility,
all warrant future investigation. In each of these areas, existing methods and
techniques exist that could be employed for investigation of their role in overall
cell mechanics. Doing so will provide a more comprehensive picture of VSMC
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mechanical behavior than that provided by the current research.

5. Mechanical investigation of different cell types. The only cell type investigated
in the current research was VSMCs. However, the usefulness of these AFM
techniques should be investigated using other cell types as well. It is not known
whether the specific techniques and models employed in the current research will
be applicable over a wide range of cell types, or if they are VSMC specific. From
the perspective of a vascular researcher, the most obvious candidate would be
vascular endothelial cells, given their large role in vascular disease development.

6. 2.5-D or 3-D cell culture for mechanical analysis. Another significant
drawback of the current AFM techniques, is the fact that the cells were adherent
to a flat substrate (2-D culture). Although this is usually preferable to nonadherent cells (for instance tested using micropipette techniques) it still leaves a
great deal to be desired in terms of replicating the in vivo cell environment. One
possible solution to this is the fabrication of 2.5-D cell culture wells, in which
cells are seeded within a depressed region of a substrate, allowing for attachment
on all sides with the exception of the top plane, which would then be accessible to
an AFM probe. Mechanical testing of cells in a full 3-D environment would most
likely necessitate the use of techniques other than AFM, but this is certainly a
research goal worth pursuing.
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7. Comparison with whole tissue (arterial) mechanics. In the current research,
the effects of various treatments on VSMC mechanical properties have been
investigated. Utilizing these data, an interesting avenue of investigation would be
quantifying the effects of these same treatments (e.g. paclitaxel, oxLDL) on whole
arterial tissue, whether in vivo or ex vivo. Doing so will provide insight into the
role of VSMC mechanics in the behavior of the artery as a whole.

8. Frictional measurements using modified probes/cell modifications. Although
frictional measurements using chemically modified AFM probes were thus far
unsuccessful, this is still an area that warrants further investigation. Building of
SAMs on AFM probes is a relatively easy and reproducible process, and further
investigation to better understand probe/cell interactions in the context of lateral
force microscopy is warranted. Different probe materials could also be examined,
in addition to chemical modification similar to that done in the current research.
This is of particular importance when dealing with the effect of different stent
materials on underlying cells. Varying probe speeds and mechanical loads will
also yield useful data pertaining to cellular lubrication mechanisms. Lastly,
modification of the cell surface could be looked at as an alternative to probe
modification. Careful selection of chemical treatments that alter either the
glycocalyx or plasma membrane will also provide insight into these areas.
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9. Use of primary cells. In the current study, cells were generally utilized between
passages 4 and 8. Although this is within the commonly accepted passage range
for VSMC in vitro work, there is still the possibility of substantial changes taking
place in between the time of isolation, and passage 4. As soon as cells are
removed from their in vivo environment, certain changes will be irreversible. So,
in addition to the use of earlier passage cells, this fact makes development of a 2.5
or 3D mechanical testing scaffold all the more important.
(as suggested in #6 above) in order to replicate the in vivo environment as closely
as possible.

10. Quantitative analysis of cytoskeletal structure. In the current research,
descriptions of cytoskeletal architecture were largely qualitative. Future work
should focus on the development of methods to quantitatively characterize the
amount and orientation of cytoskeletal difference cytoskeletal components, and
the correlation of those variables with viscoelastic measurements.
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Appendix A
Additional AFM Indentation Data
To obtain a measure of individual cell stiffness, the apparent elastic moduli of the cells
were calculated using the modified Hertz models for a pyramidal indenter [173]:

F=

1
2

1
2

E
tan(α )δ 2
2
(1 − υ )

where F is the measured force (N), δ is indentation depth (m), E is apparent
elastic modulus (Pa), υ is Poisson’s ratio (0.5) [187], and α is cone angle of the pyramidal
indenter (35°). The mean apparent elastic moduli of early passage VSMCs measured
using a pyramidal probe were 72.0 ± 24.9 and 80.5 ± 18.3 kPa for serum-fed and 3-day
serum-starved groups respectively (p = 0.207). For late-passage VSMCs measured using
a pyramidal probe, the mean apparent elastic moduli were 60.2 ± 14.2 and 70.0 ± 21.4
kPa for the serum-fed and 3-day serum-starved groups respectively (p = 0.161), Figure
A.1. Based on these data from the pyramidal AFM probes, there were no statistically
significant differences in apparent elastic modulus between early-passage and latepassage serum-fed VSMCs (p = 0.197), or early- and late-passage 3-day serum-starved
VSMCs (p = 0.163). However, late passage VSMCs did exhibit non-significant
decreases in modulus.
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Figure A.1. VSMC apparent elastic moduli measured using a pyramidal probe. E=Early
passage, L=Late passage, F=Serum fed, S=Serum starved. Data represent mean ± SE.

Elastic modulus values were significantly greater than those obtained with spherical
probes for both early-passage serum-fed VSMCs (p < 0.001) and early-passage 3-day
serum-starved VSMCs (p < 0.001). The cell-to-cell apparent elastic modulus COV had a
mean of 28.1 ± 5.9% and 32.0 ± 9.5% for pyramidal and spherical AFM probe groups
respectively. The mean COV for moduli measured at a single point were 12.9 ± 12.0%
and 6.0 ± 5.3% for pyramidal tips and spherical tips respectively. Cell-to-cell apparent
elastic modulus COVs and repeated indentation COVs for each experimental group are
summarized in Table A.1.
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Table A.1. Cell-to-Cell and Repeated Point Elastic Modulus COVs
pyr=pyramidal tip, sphere=spherical tip
Cell-to-Cell COV

Repeated Point COV

(%)

(%)

Early Passage (Serum-fed, pyr)

35.2

24.3

Early Passage (3-day Serum-starved,

22.7

8.2

Early Passage (Serum-fed, sphere)

20.6

4.1

Early Passage (3-day Serum-starved,

42.3

4.2

Early Passage (5-day Serum-fed, sphere)

36.8

10.3

Early Passage (5-day Serum-starved,

28.4

5.3

Late Passage (Serum-fed, pyr)

23.7

8.1

Late Passage (Serum-starved, pyr)

30.6

11.3

All Pyramidal (mean ± SD)

28.0 ± 5.9

12.9 ± 12.0

All Spherical (mean ± SD)

32.0 ± 9.5

6.0 ± 5.3

All Serum-fed (mean ± SD)

29.0 ± 8.1

12.5 ± 12.4

All Serum-starved (mean ± SD)

31.0 ± 8.2

6.1 ± 4.1

pyr)

sphere)

sphere)
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Hysteresis was statistically significantly lower for early passage 3-day serumstarved VSMCs in both the pyramidal probe groups (0.62 ± 0.20 and 0.30 ± 0.10 for
serum-fed and serum-starved respectively, p < 0.001) and the spherical probe groups
(0.41 ± 0.08 and 0.32 ± 0.09 for serum-fed and serum-starved respectively, p = 0.007).
Hysteresis was also statistically significantly lower in 5-day serum-starved than in serumfed VSMCs (p < 0.001). There was a non-statistically significant decrease in hysteresis
for late-passage serum-starved VSMCs compared to late-passage serum-fed VSMCs (p =
0.181). Serum-fed early-passage VSMCs exhibited statistically significantly greater
levels of hysteresis than serum-fed late passage VSMCs (p<0.001), while no statistical
difference was observed between serum-starved late- and early-passage VSMCs (p =
0.469). Hysteresis data are compared in Figure A.2.
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Figure A.2. Hysteresis of early (E) and late passage (L) serum fed (F) and serum starved
(S) rat aortic SMCs measured with pyramidal (p) and spherical (s) AFM probes at an
approach speed of 10.0 μm/s. Data are presented as mean ± SE.

There has recently been discussion in the literature regarding the efficacy of
various AFM probe geometries in determining cellular mechanical properties [173]. It
has been reported that mean modulus values yielded from a pyramidal AFM probe are
greater than those yielded from a spherical probe [173]. Data from the current study are
in agreement on this matter. It is likely that modulus data from spherical probes are more
accurate, due to the relative ease of characterizing spherical contact geometry compared
to pyramidal geometry, as well as the larger contact area, lesser strains at lower
indentation depths, and lower COVs on a repeated point of indentation. In terms of cell-
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to-cell elastic modulus variation, the present study yielded mean COVs of 28.0 ± 5.9 and
32.0 ± 9.5% for pyramidal and spherical AFM probe groups respectively, which are both
towards the lower end of previously reported COVs from AFM cell indentations studies
[174].
The effect of probe speed on measured elastic modulus values was investigated
using a spherical indenter. Single cells were indented 5 times consecutively at both 10
µm/s and 0.5 µm/s. Apparent elastic modulus was non-significantly greater at 10 µm/s
for each group tested, Figure A.3.

Figure A.3. VSMC apparent elastic moduli measured at indentation speeds of 10 µm/s
(black) and 0.5 µm/s (white). F = Serum-fed, S=Serum-starved. Data presented as mean
± SD.
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The mean COV for moduli measured at a single point were 12.9 ± 12.0% and 6.0 ± 5.3%
for pyramidal tips and spherical tips respectively in the present study. Pyramidal AFM
probes do however retain the advantage of enabling the user to easily switch between
force and imaging mode without a change of tips and thus allow the creation of
intracellular force maps and measurements of localized nanoscale mechanical property
variations. The larger spherical probes are more suitable for providing “averaged” values
for whole-cell mechanical behavior [146].
In vitro aging has previously been used as a model for examining changes in
mechanical properties of epithelial cells in an AFM study, with the finding that in vitro
aging led to increased cell stiffness [144]. However, in the present study, cells were
found to have a slightly decreased modulus after in vitro aging (~ 15 passages). This
discrepancy may be accounted for by the fact that in the current study the “early passage”
cells were from passages 5 to 8, perhaps beyond the point of initial in vitro phenotypic
changes. Data from the current study indicate that late-passage VSMCs did not respond
in as significant a manner to serum starvation as early-passage VSMCs, as there were no
statistically significant changes in either modulus or hysteresis. It is therefore likely, that
past a certain length of time in culture, redifferentiation of VSMCs becomes increasingly
difficult, and in vitro aging of cells renders them unusable for studies of this nature.
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Appendix B
IL-6 and HIL-6 Experiments

Interleukin-6 (IL-6) and Hyper-IL-6 (HIL-6) treatment did not result in any
significant changes to VSMC mechanical properties, as measured by AFM indentation
and stress relaxation experiments. HIL-6 is a “designer cytokine” produced and provided
by the laboratory of Professor Stefan Rose-John at the Institute of Biochemistry at the
Christian Albrechts Univerity Kiel. It consists of IL-6 chemically joined to its soluble
receptor, sIL-6R. Il-6 was added at a concentration of 1000 ng/ml for a period of 24
hours, while HIL-6 was added at a concentration of 10 ng/ml for 24 hours. These
concentrations were based on clinically relevant serum levels of IL-6, and upon the fact
that HIL-6 is 100 to 1000 times more active than IL-6 alone. Despite prior evidence that
IL-6 substantially alters the cytoskeletal makeup of VSMCs, no significant effects were
observed during the current research.
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Appendix C
Chemical Modification of AFM Probes

Gold coated 5 um diameter spherical particle tips were utilized for the formation
of self-assembled monolayers (SAMs), Figure A.4. This technique enables the creation
of an AFM probe with specified chemical properties (e.g. hydrophilic/phobic, charged).
For these experiments, a hydrophilic surface was created using the hydroxyl (-OH)
terminated alkanethiol 11-hydroxy-1-undecanethiol (Asemblon, Redmond, WA), and a
hydrophobic surface was created using the methyl (-CH3) terminated alkanethiol 1Dodecanethiol (Asemblon). In addition, a positively charged surface was created using
the amine-terminated alakenthiol 11-Amino-1-undecanethiol, and a negatively charged
surface was created using the carboxyl-terminated alkanethiol, 11-Mercaptoundecanoic
Acid (Both from Asemblon). Briefly, 1 mmol ethanol solutions of each respective
alkanethiol were made, in which the 5 µm colloidal gold coated 0.12 N/m AFM probes
(NovaScan) were submerged overnight. Probes were left in the alkanethiol solution until
usage.
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Figure A.4. Interactions between the SAM adhered to the AFM probe, and molecules at
the cell surface, may allow for the elucidation of the molecular mechanisms affecting cell
surface shear.

The data yielded from these experiments was unusable, although it is not known whether
this is a result of instrumentation (AFM) problems or methodological difficulties. Using
chemically modified AFM probes for the examination of cell surface frictional
phenomena may be a viable technique for future research.
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Appendix D
Membrane Permeabilization
Triton X-100 and Escin used for permeabilization of VSMC cell membrane.
Triton-X resulted in complete skinning of cell, and was therefore ruled out. Escin, used
at concentrations of 1000, 100, and 10 uM, permeabilized cell membrane successfully.
However, immunofluorescence imaging revealed significant changes to cytoskeletal
structure at higher concentrations (1000 and 100 uM), when cells were placed in PBS,
DMEM, or intracellular medium. Lower escin concentrations did not alter cellular
mechanical properties in any way. After reviewing these data, this aim was dropped from
the current research.
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Appendix E
MATLAB Scripts
Hertz Modeling Scripts:
AFMConvertAvgCells.m (reads in text files of raw AFM force curves, and converts to
for force-distance or force-indentation)
function [Forces, M, FileNums]= AFMConvertAvgCells(Name, startnum, endnum, RampSize, spring, ds,
type)
%function [Forces, M, FileNums]= AFMConvertAvgCells(Name, startnum, endnum, RampSize, spring,
ds, type)
%
% AFMConvertAvgCells.m reads in text files of the raw AFM force curves (in
% Volt units) and converts it to force-distance or force-indentation
% curves. Be sure to export the data in the AFM software by doing Save As
% ASCII and make sure your do NOT export the header.
%
% Name is the basename of the files you are reading in (for example: if
%
your files are called CellForces051106.000.txt to
%
CellForces051106.099.txt then the basename is 'CellForces051106')
% startnum is the smallest file number in the range you are reading in
% endnum is the largest file number that you are reading in
% RampSize is the length in nm of the Z piezo ramp
% spring is the spring constant in N/m
% ds is the deflection sensitivity in V/nm (if you input ds = 0 and type =
%
'forces', the program will calculate the deflection sensitivity
%
from the data in the first file)
% type is either 'forces', for HRFS data, or 'indent', for nanoindentation
%
data.
%
% Forces is the matrix of distances and forces of the converted data (i.e.
%
[distApproach FApproach distRetract ForceRetract distApproach...])
% M is the raw data from each file
% FileNums is the list of the file numbers that got converted
FileNums = [];
M = [];
reply = 'y';
display('Commands:');
display ('y = yes: include this curve,');
display ('n = no: do not include this curve,');
display ('p = pass: include this curve and just do the rest of the curves (stop prompting me!),');
display ('q = quit: do not include this curve and do only the curves up to this point');
display ('b = back: go back one curve');
display('if something goes wrong and you want to stop the program completely without saving anything
type cntrl-C')
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reply2 = input('Name of input file of numbers? [if none, just press enter] ', 's');
if isempty(reply2),
i = 0;
while i <(endnum-startnum+1),
i = i+1;
if startnum+i-1<10
FileName = strcat(Name,'.00', num2str(startnum+i-1),'.txt');
elseif startnum+i-1<100
FileName = strcat(Name,'.0', num2str(startnum+i-1),'.txt');
else
FileName = strcat(Name,'.', num2str(startnum+i-1),'.txt');
end
FileName
fid=fopen(FileName,'r');
if fid ~= -1
tline1=fgetl(fid); %Read-off first line containing titles
temp = fscanf(fid, '%f %f', [2 inf])';
if reply ~= 'p',
plot([linspace(RampSize, 0, length(temp))' linspace(0, RampSize, length(temp))'], temp);
reply = input('Do you want to include this curve? y/n/p/q/b [y]: ', 's');
if length(reply)>1,
reply = input('
only one character please! y/n/p/q/b [y]: ', 's');
end
if isempty(reply)
reply = 'y';
end
end
if reply == 'y' || reply =='p',
FileNums = [FileNums; startnum+i-1];
M= [M temp];
elseif reply == 'q'
break
elseif reply == 'b'
i = i-2;
end
end
fclose('all');
end
else
FileNums = load(reply2);
for i = 1:length(FileNums),
if FileNums(i)<10
FileName = strcat(Name,'.00', num2str(FileNums(i)),'.txt');
elseif FileNums(i)<100
FileName = strcat(Name,'.0', num2str(FileNums(i)),'.txt');
else
FileName = strcat(Name,'.', num2str(FileNums(i)),'.txt');
end
FileName
fid=fopen(FileName,'r');
tline1=fgetl(fid); %Read-off first line containing titles
temp = fscanf(fid, '%f %f', [2 inf])';
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M= [M temp];
fclose('all');
end
end
[Rrows, Rcolumns]=size(M);
NumSets=Rcolumns/2;
Samples=Rrows;
Data=M(:,:);
Forces =zeros(Samples, 4*NumSets);
for i = 1:NumSets,
Zext = linspace(RampSize, 0, Samples)';
Zret = linspace(0, RampSize, Samples)';
%
Defext = UnSlopeBaseCells(Zext, Data(:, i*2-1), 20)*ds;
%
Defret = UnSlopeBaseCells(Zret, Data(:, i*2), 20)*ds;
%
Defext = UnSlopeBaseCells(Sepext, Defext, 100);
%
Defret = UnSlopeBaseCells(Sepret, Defret, Samples-100);
if type == 'forces',
Data(:, i*2-1) = UnSlopeBaseCells2(Zext, Data(:, i*2-1), 50, 100);
Data(:, i*2) = UnSlopeBaseCells2(Zret, Data(:, i*2), Samples-150, Samples-50);
if ds ==0,
temp = polyfit(Data(Rrows-50:Rrows-20, i*2-1), Zext(Rrows-50:Rrows-20), 1);
ds = -temp(1)
end
Defext = (Data(:, i*2-1)-mean(Data(45:55, i*2-1)))*ds;
Defret = (Data(:, i*2)- mean(Data(Samples-55:Samples-45, 2*i)))*ds;
Sepext = Zext + Defext;
Sepret = Zret + Defret;
Defext = Defext -ones(Rrows, 1)*mean(Defext(50:100, :));
Defret = Defret -ones(Rrows, 1)*mean(Defret(Rrows-30:Rrows-20, :));
Sepext = Sepext -ones(Rrows, 1)*mean(Sepext(Rrows-30:Rrows-20, :));
Sepret = Sepret -ones(Rrows, 1)*mean(Sepret(50:100, :));

elseif type == 'indent',
Defext = (Data(:, i*2-1))*ds;
Defret = (Data(:, i*2))*ds;
Sepext = Zext + Defext;
Sepret = Zret + Defret;
Startbase = 40;
%Check for wacky up-down baseline from missing data during trigger mode
%measurements when the tip is a bit too close to the sample
while abs(Defext(Startbase)-Defext(Startbase+1))> 0.8*ds,
Startbase = Startbase + 2;
end
Endbase = Startbase+50;
% If you have a lot of base line drift, then uncomment the next line to
% take out the base line drift ( you might need to change region of points
% you are fitting)
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[Defext Defret] = UnSlopeBaseCells3(Sepext, Defext, Startbase, Endbase, Sepret, Defret);
% Smooth out the data for contact point finding methods. NOTE: this is only
% used to find the 0 point. The actual data that is returned is not smoothed
% out or processed.
DefextSmooth = Defext;
for j=51:Samples-50,
DefextSmooth(j) = mean(Defext(j-50:j+50));
end
% PICK YOUR CONTACT POINT FINDING METHOD! Uncomment out the part of code
% for the the method you want to use...
% Threshold method for picking contact point
thresh = 2; %Threshold in nm for picking the 0 point. Change this depending on the noise level of your
data
j = Startbase+50;
while min(DefextSmooth(j:Samples))< thresh+min(DefextSmooth(Startbase+50:Samples)) & j<Samples
j = j+1;
end
pt0val = Sepext(j);
[Defext Defret] = UnSlopeBaseCells3(Sepext, Defext, Startbase+20, j-50, Sepret, Defret);
DefextSmooth = Defext;
for j=51:Samples-50,
DefextSmooth(j) = mean(Defext(j-50:j+50));
end
j = Startbase+50;
while min(DefextSmooth(j:Samples))< thresh+min(DefextSmooth(Startbase+50:Samples)) & j<Samples
j = j+1;
end
pt0val = Sepext(j);
% two region fit over whole data with moving break point.
% DefextDeriv = polyderiv(DefextSmooth(Startbase:Samples), Zext, 10)';
% [point0 pt0val] = FindZeroPt(Zext(Startbase+50:Samples-30), DefextDeriv(50:length(DefextDeriv)30), 0, 1);
% point0= point0+Startbase+50;
% pt0val = Sepext(point0);
%
% moving window with 2 region fit to find contact point
% DefextDeriv = polyderiv(DefextSmooth, Zext, 10)';
% [point0 pt0val] = FindZeroPt2(Zext, DefextDeriv, 0, 1, 200, 100, 500);
% pt0val = Sepext(point0);
Sepext = -(Sepext-pt0val);
Sepret = -(Sepret-pt0val);
Defext = Defext ;
Defret = Defret ;
end
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Forces(:, i*4-3:i*4) = [Sepext Defext*spring Sepret Defret*spring];
end

AVERAGELOTSFORCESCELLS.m (calculates elastic modulus and hysteresis from
indentation curves)
function [Averages, Stiffness, Eall, Hys, FilesRemoved] = AverageLotsForcesCells(Data, Files,
NumPoints)
% function [Averages, Stiffness, Eall, FilesRemoved] = AverageLotsForcesCells(Data, Files, NumPoints)
%
% AverageLotsForcesCells.m assumes Data is a matrix where the columns are
% alternating distance vectors and force vectors of data. It basically
% averages all the force curves in the matrix Data.
%
% Data is a matrix of force curves (i.e. [distances_1 Force_1 distances_2
% Force_2...] where distances_i is the vector of distances at which the
% forces in vector Force_i were taken)
%
NOTE: it is therefore assumed that Data has an even number of
%
columns
% Files is the list of file numbers (from AFMConvertAvgCells.m output)
% NumPoints is the number of points that you would like to resample at.
%
% Averages is the matrix of averaged data resampled so that it has
% NumPoints points
% Stiffness is the average and standard deviation of the elastic modulus
% for each cell or group of curves. It is calculated using the Hertz model
% Eall is the elastic modulus calculated for each individual curve
% FilesRemoved is a list with any file number that was removed from the
% averaging set by the user.
[Rows Cols] = size(Data);
Averages = [];
Stiffness = [];
CellNumber = 0;
cell = -1;
j = 1;
Approach = [];
Retract = [];
Eall = [];
Hys = [];
FilesRemoved = [];
reply2 = 'y';
InputFile = input('Input file name? [none]: ', 's');
if isempty(InputFile),
ManualMode = 1;
else
InputList = load(InputFile);
SpeedNum = 1;
TotalCells = length(InputList)/SpeedNum;
ManualMode = 0;
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end
if ManualMode,
SpeedNum = str2num(input('How many different speeds did you use per cells? [3] ', 's'));
TotalCells = 0;
end
reply2 = input('Check curves individually? y/n [n]: ', 's');
if isempty(reply2)
reply2 = 'p';
elseif length(reply2)~= 1
reply2 = input('ERROR: please answer y or n: ', 's');
end
if reply2 == 'n' || reply2 == 'p',
reply2 = 'p';
else
figure(1)
hold off
end
if isempty(SpeedNum),
SpeedNum = 3;
end
speed = 0;
while j <=length(Files),
Approach = [];
Retract = [];
cell = cell +1;
CellNumber = floor(cell/SpeedNum)+1
if speed ==SpeedNum,
speed =0;
end
speed = speed+1
if ManualMode,
file1 = (input('
First File Number: ', 's'));
if file1 == 'q',
break
end
temp = 1;
if file1 ~= 's'
file2 = (input('
Second File Number: ', 's'));
if file2 == 'q',
break
end
file1 = str2num(file1);
file2 = str2num(file2);
end
elseif cell+1> TotalCells
break
else
file1 = InputList(cell+1, 1);
file2 = InputList(cell+1, 2);
end
temp =1;
if file1>file2,
display('ERROR: the first file number should be smaller than the second one')
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temp =0;
end
while temp==1 & j<=length(Files)
if Files(j)<file1,
j = j+1;
elseif Files(j)<=file2,
if reply2 ~= 'p',
hold off
plot(Data(:, j*4-3), Data(:, j*4-2));
axis([-1000 1000 -5 20]);
reply2 = input('Is this curve ok? y/n/p [y]: ', 's');
if isempty(reply2)
reply2 = 'y';
elseif length(reply2) ~= 1,
reply2 = input('ERROR: please answer y, n, or p only... y/n/p? ', 's');
end
if reply2 ~= 'n'
Approach = [Approach Data(:, j*4-3:j*4-2)];
Retract = [Retract Data(Rows:-1:1, j*4-1:4*j)];
j = j+1;
else
reply2 = input('Try to fix it? y/n [y]: ', 's');
if isempty(reply2)
reply2 = 'y';
elseif length(reply2)~= 1,
reply2 = input('ERROR: please answer y or n only... y/n? ', 's');
end
if reply2 == 'n',
FilesRemoved = [FilesRemoved; Files(j)];
j = j+1;
else
xoff = 0;
yoff =0;
reply2 = 'n';
while reply2 == 'n',
reply2 = input('x offset: ', 's');
xoff = xoff+str2num(reply2);
plot(Data(:, j*4-3)+xoff, Data(:, j*4-2)+yoff);
axis([0 1000 0 20]);
reply2 = input('y offset: ', 's');
yoff = yoff+str2num(reply2);
plot(Data(:, j*4-3)+xoff, Data(:, j*4-2)+yoff);
axis([0 1000 0 20]);
reply2 = input('is it ok now? y/n/q [y]: ', 's');
if isempty(reply2)
reply2 = 'y';
elseif length(reply2) ~= 1,
reply2 = input('ERROR: please answer y, n, or q only... y/n/q? ', 's');
end
end
if reply2 == 'y',
Approach = [Approach Data(:, j*4-3:j*4-2)];
Retract = [Retract Data(Rows:-1:1, j*4-1:4*j)];
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j = j+1;
if j>=length(Files)
temp = 2;
end
else
FilesRemoved = [FilesRemoved; Files(j)];
j = j+1;
end
end
end
else
Approach = [Approach Data(:, j*4-3:j*4-2)];
Retract = [Retract Data(Rows:-1:1, j*4-1:4*j)];
j = j+1;
if j>length(Files)
temp = 2;
end
end
else
temp = 2;
end
end
if (isempty(Approach) ~=1)
[x F Fs E Estd Et] = AverageForces(Approach, NumPoints);
Averages = [Averages x F Fs];
Stiffness = [Stiffness; E Estd];
%
if Estd/E > 0.5,
%
[E Estd]
%
plot(x, F, '.')
%
hold on
%
[r c] = size(Approach);
%
plot(Approach(:, 1:2:c), Approach(:, 2:2:c))
%
pause
%
end
Eall = [Eall; Et];
dx = x(2)-x(1);
HysAp = sum(F(1:NumPoints))* dx;
[x F Fs] = AverageForces(Retract, NumPoints);
dx = x(2)-x(1);
Hys = [Hys; (HysAp-sum(F(1:NumPoints))*dx)/HysAp];
Averages = [Averages x(NumPoints:-1:1) F(NumPoints:-1:1) Fs(NumPoints:-1:1)];
else
display('I was supposed to average files: ')
file1
display('through ')
file2
display('but I''m at file')
Files(j)
display('Either none of those files were good or there is a problem with the script input file?');
pause

198

Averages = [Averages zeros(NumPoints, 3)];
Stiffness = [Stiffness; 0 0];
end
end

Stress Relaxation Scripts:
HDRLOAD.m (reads in raw stress relaxation data)
Script from The MATHWORKS (Natick, MA)
http://www.mathworks.com/support/tech-notes/1400/1402.html
function [data] = hdrload(file)

% HDRLOAD Load data from an ASCII file containing a text header.
% [header, data] = HDRLOAD('filename.ext') reads a data file
% called 'filename.ext', which contains a text header. There
% is no default extension; any extensions must be explicitly
% supplied.
%
% The first output, HEADER, is the header information,
% returned as a text array.
% The second output, DATA, is the data matrix. This data
% matrix has the same dimensions as the data in the file, one
% row per line of ASCII data in the file. If the data is not
% regularly spaced (i.e., each line of ASCII data does not
% contain the same number of points), the data is returned as
% a column vector.
%
% Limitations: No line of the text header can begin with
% a number. Only one header and data set will be read,
% and the header must come before the data.
%
% See also LOAD, SAVE, SPCONVERT, FSCANF, FPRINTF, STR2MAT.
% See also the IOFUN directory.

% check number and type of arguments
if nargin < 1
error('Function requires one input argument');
elseif ~isstr(file)
error('Input must be a string representing a filename');
end

% Open the file. If this returns a -1, we did not open the file
% successfully.
fid = fopen(file);
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if fid==-1
error('File not found or permission denied');
end

% Initialize loop variables
% We store the number of lines in the header, and the maximum
% length of any one line in the header. These are used later
% in assigning the 'header' output variable.
no_lines = 0;
max_line = 0;

% We also store the number of columns in the data we read. This
% way we can compute the size of the output based on the number
% of columns and the total number of data points.
ncols = 0;

% Finally, we initialize the data to [].
data = [];

% Start processing.
line = fgetl(fid);
if ~isstr(line)
disp('Warning: file contains no header and no data')
end;
[data, ncols, errmsg, nxtindex] = sscanf(line, '%f');

% One slight problem, pointed out by Peter vanderWal: If the
% first character of the line is 'e', then this will scan as
% 0.00e+00. We can trap this case specifically by using the
% 'next index' output: in the case of a stripped 'e' the next
% index is one, indicating zero characters read. See the help
% entry for 'sscanf' for more information on this output
% parameter. We loop through the file one line at a time until
% we find some data. After that point we stop checking for
% header information. This part of the program takes most of the
% processing time, because fgetl is relatively slow (compared to
% fscanf, which we will use later).
while isempty(data)|(nxtindex==1)
no_lines = no_lines+1;
max_line = max([max_line, length(line)]);
% Create unique variable to hold this line of text information.
% Store the last-read line in this variable.
eval(['line', num2str(no_lines), '=line;']);
line = fgetl(fid);
if ~isstr(line)
disp('Warning: file contains no data')
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break
end;
[data, ncols, errmsg, nxtindex] = sscanf(line, '%f');
end % while

% Now that we have read in the first line of data, we can skip
% the processing that stores header information, and just read
% in the rest of the data.
data = [data; fscanf(fid, '%f')];
fclose(fid);

% Create header output from line information. The number of lines
% and the maximum line length are stored explicitly, and each
% line is stored in a unique variable using the 'eval' statement
% within the loop. Note that, if we knew a priori that the
% headers were 10 lines or less, we could use the STR2MAT
% function and save some work. First, initialize the header to an
% array of spaces.
header = setstr(' '*ones(no_lines, max_line));
for i = 1:no_lines
varname = ['line' num2str(i)];
% Note that we only assign this line variable to a subset of
% this row of the header array. We thus ensure that the matrix
% sizes in the assignment are equal. We also consider blank
% header lines using the following IF statement.
if eval(['length(' varname ')~=0'])
eval(['header(i, 1:length(' varname ')) = ' varname ';']);
end
end % for

% Resize output data, based on the number of columns (as returned
% from the sscanf of the first line of data) and the total number
% of data elements. Since the data was read in row-wise, and
% MATLAB stores data in columnwise format, we have to reverse the
% size arguments and then transpose the data. If we read in
% irregularly spaced data, then the division we are about to do
% will not work. Therefore, we will trap the error with an EVAL
% call; if the reshape fails, we will just return the data as is.
eval('data = reshape(data, ncols, length(data)/ncols)'';', '');
data(:,2) = [];
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STRESSRELAX.m (normalizes and truncates stress relaxation data)
% function [data_final, depth, delta_strain] = stressrelax(data, defsens, ramp)
function [data_final] = stressrelax(data)

lintime = linspace(0.01,120,12000)';
baseline_shift = mean(data(1:100));
data_shift = (data-baseline_shift);
data_small = data_shift(1:1000);
[y n] = max(data_small);
data_norm = (data_shift(n+1)).\(data_shift(n+1:n+12000));
sum(data_norm);
for i = 1:length(data_norm),
if data_norm(i) < 0
data_norm(i) = 0.01;
end
end
sum(data_norm);
data_log = [log10(data_norm(1:12000))];
logtime = log10(lintime(1:12000));
time_resample = evenspc(logtime,logtime,100);
sum(data_log);
data_resample = evenspc(data_log,logtime,100);

% data_final = [[1; 10.^data_resample] [0; 10.^time_resample]];
% sum(data_temp);
% for i = 10:length(data_temp),
% if data_temp (i) > mean(data_temp(i-2):data_temp(i-1))+1*std(data_temp(i-2):data_temp(i-1))
%
data_temp(i) = mean(data_temp(i-2):data_temp(i-1))+1*std(data_temp(i-2):data_temp(i-1));
% elseif data_temp(i) < mean(data_temp(i-2):data_temp(i-1))-1*std(data_temp(i-2):data_temp(i-1))
%
data_temp(i) = mean(data_temp(i-2):data_temp(i-1))-1*std(data_temp(i-2):data_temp(i-1));
%
% end
% end
%
% sum(data_temp);
data_final = [10.^data_resample 10.^time_resample];
% lintime2 = linspace(0,120,12000)';
% depth = [data_norm lintime2];
% delta_strain = (((defsens*y)-(defsens*data_norm(12000)))/depth)*100;
G120=data_final(100)
end
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EVENSPC.m (called by stressrelax.m)
function [F, x] = evenspc(f, d, N)
%
% [F, x] = evenspc(f, d, N)
%
% Creates an evenly-spaced force vector
%
% f = vector of forces
% d = vector of distances
% length(f) must be the same as length(d)
% N = length of desired output force vector
%
% Example:
% forces = [1000 300 600 150];
% dists = [100 70 20 5];
% F = evenspc(forces, dists, 200);
%
% F will be a force vector with 200 components representing
% forces at evenly-spaced distances from 100 down to 5.
% x will be a vector with 200 components representing the distance at which
% forces in F are done.
%
L = length(f);
[m, n] = size(f);
flag = 0;
if d(L)>d(1),
d = d(L:-1:1);
f = f(L:-1:1);
flag =1;
end
increment = (d(L) - d(1)) / (N-1);
if n==1,
F = zeros(N,1);
x = linspace(d(1), d(L), N)';
else
F = zeros(1,N);
x = linspace(d(1), d(L), N);
end
F(1) = f(1);
F(N) = f(L);
for i=2:N-1,
dist = d(1) + increment * (i-1);
j = 1;
if (i==N)
j = L-1;
else
while (d(j+1) > dist & j<L-1),
j = j + 1;
end
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end
% dist is now between d(1,j) and d(1,j+1)
% let lambda be equal to "how far between" on a
% scale of 0..1.
lambda = (dist - d(j)) / (d(j+1) - d(j));
% linearly interpolate the force based on lambda
force = f(j+1) * lambda + f(j) * (1-lambda);
F(i) = force;
end
if flag ==1,
F = F(N:-1:1);
x = x(N:-1:1);
end
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THEGFUNCTION.m (Used in conjunction with QLVFIT.m to fit QLV reduced
relaxation function data to stress relaxation data).

function G = TheGFunction(a, t)
G = 0*t;
C = a(1);
tau1 = a(2);
tau2 = a(3);
dtau = (tau2-tau1)/800;
taus = linspace(tau1, tau2,800)';
for i = 1:length(t),
% fun1 = @(tau) (exp(t(i)/tau)/tau);
% fun2 = @(tau) (1/tau);
% int1 = quad(fun1, tau1, tau2);
% int2 = quad(fun2, tau1, tau2);
int1 = sum(exp(-t(i)./taus)./taus)*dtau;
int2 = sum(1./taus)*dtau;
G(i) = (1 + C.*int1)./(1+ C.*int2);
end

QLVFIT.m (Used in conjunction with THEGFUNCTION.m to fit QLV reduced
relaxation function data to stress relaxation data).

% QLVfun2 = @ (a,t) [1+a(1).*quad((exp(-t./a(2))./a(2)),a(3),a(4))] ./ [1+a(1).*quad((1./a(2)),a(3),a(4))];
%
lintime = linspace(0.01,120,12000)';
logtime = log10(lintime);
t = evenspc(logtime,logtime,100);
% t=logspace(-2,2.079,100)';
StartingVals = [1 0.05 100];
coefEsts = nlinfit(meanjasp(:,2), meanjasp(:,1), @TheGFunction, StartingVals)
xgrid = logspace(-2,2.079,100);
plot(xgrid, meanjasp(:,1), '.')
plot(xgrid, TheGFunction(coefEsts, xgrid), 'r');
hold on
fit = TheGFunction(coefEsts, xgrid)';
R = corr2(fit, meanjasp(:,1));
R2 = R^2
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EXPONENTIALFIT.m (Used to fit power-law model to stress relaxation data)
t= logspace(-2,2.079,100)';
Expfun = @(a,t) a(1).*(t.^a(2));
StartingVals = [1 0];
coefEsts = nlinfit(t, CWilson5_final(:,1), Expfun, StartingVals)
xgrid = logspace(-2,2.079,100);
line(xgrid, Expfun(coefEsts, xgrid), 'Color','g');
fit = Expfun(coefEsts, xgrid)';
R = corr2(fit, CWilson5_final(:,1));
R2 = R^2

SLSFIT.m (Fits standard linear solid model to stress relaxation data)
t= logspace(-2,2.079,100)';
% a(1)=ER, a(2)=taustress, a(3)=taustrain
SLSfun = @(a,t) a(1).*(1-(1-a(2)./a(3)).*exp(-t./a(3)));
StartingVals = [1 1 1];
coefEsts = nlinfit(t, CWilson_final(:,1), SLSfun, StartingVals)
xgrid = logspace(-2,2.079,100);
line(xgrid, SLSfun(coefEsts, xgrid), 'Color','m');
fit = SLSfun(coefEsts, xgrid)';
R = corr2(fit, CWilson_final(:,1));
R2 = R^2

206

Friction Scripts:

loadFRICFILES.m (loads raw friction data)
% loadForceFiles
function [F]=loadForceFiles(pathName, baseName, ff, lf)
iflag_main=0;

%
F = [];
num_datas=512;
num_lines=16; %aspect ratio
% ff=51; %first file number
% lf=78; %last file number
% path='C:\Delphine''s Stuff\Lab Stuff\AFMData\10-19-04\102004_AggcolIS\'; %path for loading files
numfiles = lf-ff+1;
n=1;
for j=ff:lf
if j<10,
S=strcat(pathName, baseName,'.00',num2str(j),'.txt');
end
if j>=10,
S=strcat(pathName, baseName,'.0',num2str(j),'.txt');
end
if j>=100,
S=strcat(pathName, baseName,'.',num2str(j),'.txt');
end
S
fid=fopen(S,'r');
tline1=fgetl(fid); %Read-off first line containing titles
for i=1:num_lines,
line = fgetl(fid);
stuff = sscanf(line, '%f', inf);
temp_m(i, :) = stuff;
end
F = [F; temp_m];
tline1=fgetl(fid); %Read-off first line containing titles
tline1=fgetl(fid);
for i=1:num_lines,
line = fgetl(fid);
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stuff = sscanf(line, '%f', inf);
temp_m(i, :) = stuff;
end
F = [F; temp_m];
tline1=fgetl(fid); %Read-off first line containing titles
tline1=fgetl(fid);
for i=1:num_lines,
line = fgetl(fid);
stuff = sscanf(line, '%f', inf);
temp_m(i, :) = stuff;
end
F = [F; temp_m];
%for i=1:num_datas*num_lines
% line=fgetl(fid);
% stuff=sscanf(line,'%f %f %f');
% temp_m(:,i)=stuff;
%end
%
%
%
%
%

if j == ff
F = load(S);
else
F = [F; load(S)];
end

fclose('all');
end
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AVERAGEHEIGHTFRICCELL.m (calculates friction values)

function [Friction, StDevFric, avFric, stdFric] = AverageHeightFricCell(Datas, lines)
% [AvgHeight StDevHeight Height Friction StDevFric] =
% AverageHeightFric(Datas, Positions, lines, stagg, endagg)
% % Datas is the set of data with trace, retrace of the friction signal,
% and height.
% % Postitions is either 'midd' or 'side'. 'midd' is if your pattern is
% in
% % the middle of the image (so for example, if you have polymer in the
% % middle and some SAM outside). 'side' assumes that your pattern takes
% up
% % one side of the image (so for example the polymer is on the left side
% and
% % the SAM is on the right side of the image)
% lines is the number of lines per set of data (8, or 16 usually)
% stagg is the index at which the pattern starts
% endagg is the index at which the pattern ends (if you are using
% 'side' position then endagg doesn't matter)
%
% see also AverageHeight (if you only have height data and no friction)
[rows cols] = size(Datas);
numData = rows/(3*lines);
HeightDatas = zeros(lines, cols);
StepHeights = zeros(lines, 1);
TraceDatas = HeightDatas;
ReTraceDatas = HeightDatas;
Frics = zeros(lines,cols);
blck = lines*3;
Height = zeros(numData*lines,1);
AvgHeight = zeros(numData,1);
StDevHeight = AvgHeight;
Friction = zeros(numData*lines,1);
StDevFric = Friction;
for i = 1:numData,
HeightDatas = Datas(i*blck-blck+1:i*blck, :);
TraceDatas = Datas(i*blck-blck+lines+1:i*blck-blck+2*lines, :);
ReTraceDatas = Datas(i*blck-blck+2*lines+1:i*blck-blck+3*lines, :);
Frics = (TraceDatas-ReTraceDatas)/2;
Friction((i-1)*lines+1: i*lines) = mean(Frics, 2);
StDevFric((i-1)*lines+1: i*lines) = std(Frics, 0, 2);
avFric(i) = mean(mean(Frics, 2));
stdFric(i) = std(mean(Frics, 2));
temp = [];
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for j = 1:lines
if Friction((i-1)*lines+j) < avFric(i)+2*stdFric(i) & Friction((i-1)*lines+j) > avFric(i)2*stdFric(i)
temp = [temp; Friction((i-1)*lines+j)];
else
sprintf('deleted block %i line %i', i, j)
end
end
avFric(i) = mean(mean(temp, 2));
stdFric(i) = std(mean(temp, 2));
%
% 2);
%%
%%
% 2);
%

Friction((i-1)*lines+j,1) = mean(Frics(stagg+20:cols-50),
Friction((i-1)*lines+j,2) = mean(Frics(50:stagg-20), 2);
StDevFric((i-1)*lines+j,1) = std(Frics(stagg+20:cols-50),

StDevFric((i-1)*lines+j,2) = std(Frics(50:stagg-20), 2);
AvgHeight(i) = mean(Height((i-1)*lines+1:i*lines));
StDevHeight(i) = std(Height((i-1)*lines+1:i*lines));
end
end
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Appendix F
Reagent Dilutions
Cytochalasin D (Sigma):
507.62 g/mol
Start w/ 1 mg in powder form
Dilute into 1 ml DMSO (1 mg/ml)
Aliquot into 20 vials, each with 50 uL
For 10 uM, add 25 uL from vial to 5 ml of media in well
Nocodazole (Sigma):
301 g/mol
Start w/ 10 mg in powder form
Dilute into 2 ml DMSO (5 mg/ml)
Aliquot into 20 vials, each with 0.1 ml
For 20 uM, add 6 uL from vial to 5 ml of media in well
Paclitaxel (Sigma):
853.9 g/mol
Start w/ 5 mg in powder form
Dilute into 1 ml DMSO (5 mg/ml)
Aliquot into 10 vials, each with 100 uL
For 10 uM, add 8.5 uL from vial to 5 ml media
Jasplakinolide (Sigma):
710 g/mol
Start w/ 50 ug
Dilute into 0.1 ml DMSO (0.5 mg/ml)
Aliquot into 5 vials, each with 20 ul
For 1 uM: dilute 7 ul from stock into 5 ml media
Amine-Terminated SAM (11-Amino-1-undecanethiol) (Asemblon):
1 mmol = 0.0024 g/ 10 ml
Carboxyl-Terminated SAM (11-Mercaptoundecanoic Acid) (Asemblon):
1 mmol = 0.0022 g/10 ml
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Hydroxy-Terminated SAM (11-Hydroxy-1-undecanethiol) (Asemblon):
1 mmol = 0.002 g / 10 ml
Methyl-Terminated SAM (1-Dodecanethiol) (Asemblon):
1 mmol = 0.002 g / 10 ml
CellMask Plasma Membrane Stain (Invitrogen):
Stock is 5 mg/ml in DMSO (total of 100 uL = 500 ug)
Stock Conc. = 5 ug/uL
Working Conc. = 5 ug/ml
Dilute 1 ul stock per ml working solution, or 1.5 ul per ml for 7.5 ug/ml
Incubate for 10 minutes @ 37 C
OxLDL (Biomedical Technologies):
(Comes in 1 ml vial with 2 mg per vial) for 0.05 mg/ml, add 0.025 ml per ml DMEM; for
0.025 mg/ml, add 0.0125 ml per ml DMEM; for 0.01 mg/ml, add 0.005 ml per ml
DMEM
LDL (Biomedical Technologies):
(Comes in 5 mg per 1.0 ml per vial); for 0.05 mg/ml, add 0.01 ml per ml DMEM; for
0.025 mg/ml, add 0.005 ml per ml DMEM; for 0.01 mg/ml, add 0.002 ml per ml DMEM
Chondroitinase ABC (Sigma):
Reconstitute in a 0.01% aqueous bovine serum albumin
solution. Subsequent dilutions can be made into a
buffer containing 50 mM Tris, pH 8.0, 60 mM sodium
acetate, and 0.02% bovine serum albumin. Solutions
should be prepared fresh.
Sodium acetate = 82.03 g/mol
Sodium acetate (60mM) = 4.9 g/L = 0.005 g/ml = 0.05 g/10ml
Tris = 121.1 g/mol
Tris (50mM) = 6 g/L = 0.006 g/ml = 0.06 g/10ml
0.01% BSA = 0.0001 g/ml = 0.001 g/10ml
Heparinase III (Sigma):
This enzyme can be reconstituted in 20 mM Tris-HCl
pH 7.5, containing 0.1mg/ml BSA and 4 mM CaCl2
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CaCl2 = 111 g/mol
CaCl2 (4mM) = 0.444 g/L = 0.0004 g/ml = 0.004 g/10ml
Tris (20 mM) = 2.4 g/L = 0.002 g/ml = 0.02 g/10ml
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